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Abstract 
 
Previous studies in the UK have established that minority ethnic groups as a whole experience 
more ill-health and onset of morbidity at younger ages or at lower levels of risk than the ‘White 
British’ population. Since the Race Relations Act of 1968, the official collection of ethnic group 
statistics by all government bodies has been mandated as a pre-requisite for identifying and 
tackling ethnic inequalities. The capture of ethnicity data in routine health records across the 
UK National Health Service forms part of this initiative. Although the facility to record ethnicity 
has been available in primary care since 1991 and in secondary care since 1995, until recently, 
unsystematic recording resulted in poor quality of the initial data, limiting the usefulness of 
these data for clinical care, commissioning and research. The incentivisation of ethnicity 
recording in 2006 as part of the Quality and Outcomes Framework has resulted in an 
improvement of the quality of these data, though their suitability for use in UK-wide population-
based research, at the commencement of this PhD, had not yet been explored. 
 
The studies reported in this thesis investigated the utility of electronic health records for 
research into ethnic differences in health and comprised three sub-studies. Firstly, the 
completeness, usability and generalisability of ethnicity data captured in primary and 
secondary care databases were assessed. Results showed that in 2012, valid ethnicity was 
recorded for 78.3% of patients in the Clinical Practice Research Datalink (CPRD), 79.4% of 
inpatients, and 50% of A&E patients and outpatients in the Hospital Episode Statistics for 
England (HES). Over 80% of patients with multiple ethnicities recorded had codes which either 
were identical or fell into the same five high-level ethnic group categorisation. The ethnic 
breakdown of the CPRD was found to be comparable to that of the combined censuses for 
England, Wales, Scotland and Northern Ireland, suggesting that studies of ethnic populations 
within the CPRD can be generalised to the UK population, particularly when using data from 
2006 onwards, where completeness and consistency are highest. 
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Secondly, in collaboration with the UK Biobank study, a pragmatic and comprehensive 
definition of diabetes mellitus for use in electronic health databases was developed. Once 
applied to the CPRD, the algorithms identified 34,530 individuals with type 1 diabetes and 
355,717 individuals with type 2 diabetes. The incidence of type 2 diabetes was almost doubled 
in South Asian compared with White groups (70.7 vs 42.0 events per 10,000 person years). 
After adjustment for gender and age group, the risk of type 2 diabetes was over three times 
higher in the South Asian group compared with White the group (Hazard Ratio 3.27 95%CI 
3.19, 3.35). 
 
Finally, a prospective cohort study of 860,000 patients registered with the CPRD was 
undertaken to quantify ethnic differences in the risk of incident coronary heart disease (CHD) 
and the extent to which this relationship is modified by the presence of type 2 diabetes. The 
presence of diabetes increased the risk of CHD by 40%, although this reduced to 22% after 
accounting for age, gender and deprivation (Hazard Ratio 1.22 CI95 1.20, 1.25). The excess risk 
associated with diabetes was markedly higher for ethnic minority groups, with an adjusted 
increase of 60% and 75% in South Asian and Black African/Caribbean groups respectively, 
compared with 28% in the White groups. Adjusted rates of CHD were consistently higher in 
South Asian groups and lower in Black African/Caribbean groups, with differences more 
pronounced amongst men than women. Ethnic differences in CHD risk were consistently 
more pronounced amongst patients without type 2 diabetes than in those with type 2 diabetes. 
 
The studies have generated novel results which provide valuable information about the 
usability and generalisability of ethnicity data available in UK electronic health records. They 
have replicated findings from non-database studies of the prevalence and incidence of 
diabetes and extended our knowledge of the patterning of ethnic differences in heart disease 
outcomes. They represent the first ever use of UK routine electronic health records to answer 
these questions in relation to ethnicity. Together, the findings reported in this thesis provide a 
unique insight into the ways in which routinely recorded ethnicity data can be maximised for 
the purposes of epidemiological research into health inequalities across the UK.  
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Chapter 1  
Introduction 
 
1.1 Summary 
This chapter presents the rationale for undertaking the programme of research, describes the 
aims and research questions and outlines the content of each of the thesis chapters. 
 
1.2 Rationale for research 
The social determinants of health are widely accepted as being integral to our understanding 
of why disease and mortality affect different population groups unequally.  The concept of 
ethnicity is a vital tool with which to explore these differences, as it can provide valuable 
information about shared exposures for individuals with similar geographic origin, culture, 
language, beliefs about and access to health services. Across the UK, large-scale surveys have 
shown that minority ethnic groups experience higher rates of disease and poorer health-
related outcomes than the ‘white British’ population.(1–6)   
   
Health disadvantage accumulates over the life course, and is believed to contribute to the 
excess burden of disease amongst ethnic minority groups in the UK. As the ethnic diversity of 
the UK continues to grow, health outcomes for some white, black and south Asian ethnic 
minority groups remain worse than for the white British majority.(7–9)  
 
Diabetes and cardiovascular disease are of particular concern and are responsible for a large 
number of healthcare consultations and healthcare expenditure across the National Health 
Service, with diabetes and diabetic complications alone accounting for 10% of all healthcare 
expenditures in the UK.(10)  In the UK, as well as internationally, the burden of these diseases 
has been shown to be particularly increased amongst south Asian groups, with prevalence 
over two-fold and an incidence over six-fold higher than in White populations. Most 
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importantly, disease onset occurs at younger ages, and at lower levels of conventional risk 
factors. (11–14) 
 
Though surveys throughout the UK have identified patterns by ethnic group in terms of disease 
risk, outcomes and mortality, no large-scale epidemiological studies have been undertaken to 
explore ethnic differences in cardio-diabetic prevalence, incidence and mortality at a national 
level. Large electronic health databases offer a pragmatic way of examining relationships 
between ethnicity and health across the UK, as they collate anonymised patient data from 
general practices and hospitals across the UK and have been shown to be representative of 
the general population. Furthermore, linkages to secondary care records, measures of social 
deprivation, disease registries and death records increase the utility of these databases for 
exploring epidemiological questions around the relationship between ethnicity and health 
outcomes.  
 
These databases have been widely used to conduct observational epidemiological studies for 
a range of disease outcomes and population groups, but have not, to date, been used to 
examine ethnic differences in cardio-diabetic disease prevalence, incidence and outcomes.  
This is partly due to the historically poor quality and incompleteness of ethnicity data in 
electronic health records, which limited the suitability of these databases to investigate ethnic 
inequalities.  
 
1.3 Aim and research questions 
The aim of the research described in this thesis was to determine the extent to which ethnicity 
data in routine electronic health databases can be used for epidemiological research, and to 
utilise these data to examine how the burden of diabetes and coronary heart disease differs 
between ethnic groups across the UK. To this end, three observational studies utilising 
electronic health records from both primary and secondary care were undertaken. 
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1.3.1 Evaluating the quality of ethnicity data in electronic health records 
The first study investigated the completeness and consistency of ethnicity recording in the 
Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). 
Improvements in completeness of recording from 1990 to 2013 and the consistency of coding 
for patients with multiple and linked records were assessed. The ethnic breakdown of the 
CPRD population was compared with that of the 2011 UK Census population and 
recommendations for the pragmatic use of these data for epidemiological and social research 
were established. 
 
1.3.2 Improving classification of diabetes mellitus in electronic health records 
The second study assessed the implementation of a series of algorithms to improve the 
classification and to reduce the misdiagnosis of patients diagnosed with type 1 and type 2 
diabetes mellitus using routinely recorded diagnostic, therapeutic and clinical data. Ethnic 
differences in the incidence and prevalence of type 1 and type 2 diabetes using populations 
derived from the algorithms were quantified and the resulting estimates were compared with 
those from the original derivation cohort in the Welsh primary care database.  
 
1.3.3 Exploring ethnic differences in the risk of coronary heart disease between patients 
with and without type 2 diabetes 
The third and final study for this thesis examined ethnic differences in the incidence of first 
ever fatal and non-fatal coronary heart disease (CHD) for patients with and without type 2 
diabetes. The excess risk of CHD in type 2 diabetics compared with non-diabetics was 
estimated overall and separately by ethnic group. Within the diabetic and non-diabetic 
populations,   ethnic and gender differences in the crude and age-adjusted incidence of CHD 
and cardiac death were estimated. Finally, risk of CHD using multivariable Cox regression was 
estimated for South Asian and Black African/Caribbean groups compared with white, after 
accounting for time-varying measures of pharmacological treatment and clinical measures.  
 
 
1.4 Outline of the thesis 
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The thesis comprises 12 chapters. The background, methods and findings relating to the first 
study, investigating the quality of ethnicity data in routine electronic health records, are 
presented in Chapters 3 to 5; those relating to the second study, on improving methods for the 
identification of diabetes mellitus, are presented in Chapters 6 and 7; the study comparing the 
incidence of CHD between patients with and without diabetics encompasses Chapters 8 to 
11. A final discussion of all three studies is presented in Chapter 12. Two published papers, 
both reporting results from study 1, are included as Appendices, together with additional 
supplementary material. 
 
Chapter 2 introduces the concept of ethnicity and describes the evolution of ethnicity 
recording in the UK and its subsequent inclusion into the National Health Service framework. 
 
Chapter 3 describes the electronic health databases utilised throughout the research 
presented in the thesis and the ways in which ethnicity data are captured in each.  
 
Chapter 4 presents a review of UK-based epidemiological studies which have utilised patient-
level ethnicity data to examine health outcomes. 
 
Chapter 5 details the study examining the quality, generalisability and usability of ethnicity data 
routinely recorded in primary and secondary care. 
 
Chapter 6 begins with a brief overview of the literature on ethnic differences in diabetes and 
goes on to describe the development and implementation of a series of algorithms designed 
to improve the identification and classification of type 1 and type 2 diabetes mellitus.  
 
Chapter 7 presents the ethnicity-specific prevalence and incidence of diabetes in the UK 
according to age, gender and calendar period.  
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Chapter 8 presents a review of the published literature on diabetes and CHD and describes 
the methods of defining cohorts of diabetic and non-diabetic patients between whom the 
incidence of CHD and cardiac death is compared. 
 
Chapter 9 presents the results of the study of non-fatal CHD in the full CPRD cohort.  
 
Chapter 10 presents the results of the study of fatal and non-fatal CHD combined in a subset 
of CPRD patients with linked mortality data from the Office for National Statistics (ONS).  
 
Chapter 11 discusses the findings of the third study, in terms of ethnic differences, for both 
non-fatal CHD alone and fatal and non-fatal CHD combined. 
 
In Chapter 12, the main findings of the three studies are summarised and discussed in the 
context of what is already known on the topics and what the studies presented herein 
contribute. The limitations of the data sources and study design are considered and the 
implications of the findings for future research and clinical practice are discussed.  
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Chapter 2  
Ethnicity and health  
 
2.1 Summary 
This chapter briefly describes the current thinking around concepts of ethnicity and the key 
mechanisms by which ethnicity can influence health outcomes. This is followed by a 
description of the progress in ethnicity data collection in the UK. The chapter concludes with 
discussion of the challenges of classifying ethnicity and the ways in which the significance 
and interpretation of ethnicity as a concept evolve over time. 
 
2.2 Definitions and concepts of ethnicity  
Historically, the term ethnicity has been used synonymously with ‘race’ – the construction of 
humankind as being made up of biologically distinct subgroups. Developed in the 19 th century, 
theories about ‘race’ were used as a means to justify the superiority of ‘Caucasians’ and 
policies supporting imperialism, eugenics and slavery.(15–18) However, the notion of race as 
a genetically immutable trait has been widely discredited – it is widely accepted that 
genetically distinct races are a myth, and that the genetic diversity within so-called ‘races’ is 
greater than that between races –  and over the past 50 years definitions of race and ethnicity 
have diverged considerably. In 1951, the United Nations declared that: 
 
"National, religious, geographic, linguistic and cultural groups do not necessarily coincide with 
racial groups: and the cultural traits of such groups have no demonstrated genetic connection 
with racial traits. Because serious errors of this kind are habitually committed when the term 
'race' is used in popular parlance, it would be better when speaking of human races to drop 
the term 'race' altogether and speak of 'ethnic groups’.” (19) 
 
In contrast to ‘race’, which was defined by those in power and imposed upon others, ethnicity 
is now understood to reflect an individual’s own self-identification, which encompasses a 
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broad range of socially constructed characteristics.(20) Bhopal posits that the process of 
allowing all individuals to choose their own ethnic identity can be empowering as it respects 
the primacy of self-identify and autonomy.(19) As such, ethnic self-identification can be fluid 
over time, responding to political and cultural forces.(21,22) The UK Department of Health now 
states that ethnicity is: 
 
“complex, multifaceted and subjective, and defined by[:] a shared history, a common cultural 
tradition; a common geographical origin; descent from common ancestors; a common 
language; a common religion; and a distinct group within a larger community.” (23) 
 
 It is now widely recommended that the concept of ethnicity replace the unscientific concept 
of ‘race’ in all spheres of research, as it is a more meaningful way of grouping individuals with 
some shared identity – encompassing, but not limited to, country of birth, religion, language, 
cultural practices and geography.(17,21)  
 
Ethnic identity can evolve both within individuals over time and between generations. This is 
particularly salient for countries such as the UK, where the population has changed steadily 
with waves of large-scale immigration occurring over the past century. For example, first-
generation migrants may identify ethnically with their home country, while their offspring may 
identify more strongly with newer social networks, though both generations may adapt over 
time. Similarly, children born to parents of different ethnic origins may identify with either or 
create a new identity for themselves.(1)  
 
As such, there is no one universally accepted definition of ethnicity, as it is inherently tied to 
the social, cultural and political context in which it is used.  
 
2.3 Ethnicity and health 
When hypothesising about and interpreting the mechanisms through which ethnicity is related 
to health, it is essential to be clear that health outcomes are determined by factors  associated 
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with ethnicity, not ethnicity itself. These factors include genetic influences, socio-economic 
deprivation, migration status, cultural practices and lifestyle. Their distribution is unequal in 
different population groups, and this gives rise to what can be conceptualised as ethnic 
differences. 
 
2.3.1 Genetic influences 
Defining how ‘ethnicity’ as a social construct impacts upon health and healthcare use is 
complicated; though current uses of ‘ethnicity’ focus on social determinants of health, this does 
not preclude the existence of some pertinent and biological variation. For example, the 
prevalence of the BRCA gene for breast cancer is higher amongst Ashkenazi Jewish 
populations, while the prevalence of the gene for sickle cell trait is highest amongst 
populations from Southern Europe, Africa and the Caribbean.(24,25)  
 
Similarly, biological differences related to ethnicity are now being recognised and 
incorporated into evidence-based guidelines for clinical practice in the UK. Examples include 
the increased predisposition to type 2 diabetes and cardiovascular disease amongst South 
Asian groups, which has prompted the recommendation for the use of different thresholds for 
‘overweight’ and ‘obesity’ in this population.(11,26) 
 
2.3.2 Socio-economic deprivation 
There is a well-established social gradient in health, with individuals of lowest socio-economic 
position experiencing poorer health outcomes than less deprived groups. Experiences of 
deprivation differ between ethnic groups, with individuals from some ethnic minority 
populations more likely to live in deprived neighbourhoods and be unemployed than the 
general population.(27–29) Early research into the relationship between ethnicity and 
deprivation often assumed that all ethnic groups experience disadvantage equally. However, 
research based on the UK Census shows that while Bangladeshi and African populations are 
more likely to live in deprived areas, Indian and Chinese groups live in more affluent areas and 
experience less material deprivation.(30) Ethnic disparities in health are inextricably linked to 
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socio-economic factors, with many ethnic minority groups, more likely to live in the most 
deprived boroughs of England.(31)  
 
2.3.3 Migration  
Although individuals mostly migrate to improve life for themselves and their families, the 
experience can often have negative influences on health. In addition to the physical and 
psycho-social stress of relocating to a place where limited language skills and lack of social 
network may limit economic, professional and social opportunities, migrant groups may also 
experience stigma and prejudice, increasing the likelihood of poor health outcomes among 
this population.(32) Furthermore, new immigrants are more likely than the host population to 
live in areas of high deprivation, such as inner cities, and have poor access to health and social 
services.(33,34)  
 
These experiences may counter any initial advantage that new migrants may experience via 
the ‘healthy migrant effect’, which hypothesises that individuals who migrate long distances, 
particularly internationally, are healthier, better educated and less disadvantaged than those 
who remain in the home country.(35,36) This health selection effect is evidenced in lower 
mortality and chronic disease prevalence amongst first-generation migrants compared with 
those in the host country. However, over time, the process of ‘acculturation’ (the adoption of 
local lifestyle, dietary and cultural practices) causes the health profile of migrant populations 
and their descendants to converge with, and in some cases transcend, that of the host 
country.(37–39)  
 
The timing of migration has a great impact on health due to the differing levels of acculturation 
experienced by different ethnic groups.(37,40) The UK has experienced several waves of 
immigration, notably since the end of the Second World War, when individuals living in the 
Commonwealth were encouraged to migrate to the UK. Prior to the war, the largest migrant 
group came from the Republic of Ireland. Immediately following the war, there was a large 
influx of individuals from Poland and India. This was followed by large-scale migration from 
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the Caribbean, starting in the 1950s. During the 1960s, a large increase in the Indian- and 
Pakistan-born population occurred. This was followed by an influx of residents from African 
Commonwealth countries in the 1970s. The UK’s Bangladeshi population largely settled from 
the 1980s onwards. According to the 2011 Census, the proportion of individuals born outside 
the UK increased from 4.3% in 1950 to 13.4% in 2011.(41) In 2011, the largest foreign-born 
population was from India, with those from Poland second and those from Pakistan third.(41) 
 
2.3.4 Cultural practices and lifestyle 
Shared cultural norms around health-seeking behaviours, diet, exercise and religious 
practices may directly impact health in both positive and negative ways. For example, the 
fourth Health Survey for England found that while rates of smoking are higher in Bangladeshi 
men than other men in England, over 90% of all Bangladeshi adults are non-drinkers.(42)  
Targeting services and interventions at specific risk groups has demonstrated success in 
diffusing ideas and practices for improving health.(43) 
 
2.4 History of ethnicity data collection in the UK 
The UK is one of the few countries in Europe that emphasises the need for positive action to 
promote ethnic equality via the collection of official ethnic group statistics. In a recent review 
of practices of data collection in censuses across Europe, only 5 out of 35 countries surveyed  
collected ethnicity data in the most recent census, of which the UK was one.(44) Since the 
Race Relations Act of 1968, the official collection of ethnic group statistics has been mandated 
as an essential first step towards identifying and actively reducing ethnic inequalities.(45–50) 
 
The origins of the modern system of ethnic group data collection in the UK can be traced to 
the Census Act of 1920, which recommended that ‘race and nationality’ statistics be collected 
as part of the Census for Great Britain in order to better understand the needs and 
circumstances of the population.(51)  However, at that time it was felt that the existing question 
on country of birth, which had been used since 1841, was sufficient; the recommendation 
would not be acted upon until 70 years later.  
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In lieu of a national programme to capture ethnicity information for the whole population, the 
collection of ethnic statistics was incorporated into national surveys, the first of which was the 
General Household Survey (GHS) for Great Britain. Launched in 1971, the GHS captured 
information on aspects of family life, education, health and employment in order to inform 
social policy and resource allocation by the government.  Contrary to principles widely held 
today, the GHS required that ethnicity be assigned by the interviewer, who was asked to record 
whether, upon visual inspection, the respondents appeared ‘White’, ‘Coloured’ or ‘Unknown’. If 
a child was unseen, his or her ethnicity was ‘imputed’ from that of the parents. Self-
classification of ethnic origin was introduced to the GHS in 1983 and used unti l the survey’s 
close in 2012.(49,52,53) 
 
2.4.1 The 1981 Census 
The question of recording ethnicity in the Census was revisited in the years leading up to the 
1981 Census when it became clear that country of birth was no longer sufficient for tracking 
the growth of the increasingly diverse UK population. As an interim measure, a question on 
parents’ country of birth had been included in the 1971 Census, with the intention of deriving 
ethnicity indirectly.  
 
However, large-scale immigration from both the Commonwealth and Europe dating back to 
the 1950s meant that questions on country of birth, and parents’ country of birth, became 
increasingly irrelevant given the growth in second- and third-generation ethnic minority 
populations born in the UK. Despite extensive pilot testing and the development of a draft 
question, the plan to incorporate an ethnicity question was eventually abandoned due to 
strong opposition from civilian groups and the poor acceptability of the question to Afro-
Caribbean populations following tensions in the 1970s.(1,54)  
 
Following the 1981 Census, an enquiry by the House of Commons Home Affairs Committee 
on Race Relations concluded that questions on ethnicity and language should be included in 
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the 1991 Census. A House of Commons Select Committee Report set out the positive aspects 
of monitoring ethnic information, stating:  
 
“The object of asking ethnic questions is, in conjunction with other indicators of general 
disadvantage, to assist Government and local authorities to identify and work against all 
aspects of racial disadvantage and racial discrimination.” (55) 
 
2.4.2 The 1991 Census  
Bolstered by high levels of support from the 1989 post enumeration survey, a question on 
ethnicity was added to the 1991 Census for England, Wales and Scotland, but not Northern 
Ireland, where a question on ethnicity was not introduced until 2001.(56–58) The term ‘ethnic 
group’ was used instead of ‘ethnic origin – which was found to be less acceptable to 
respondents, due to the implied meaning of historical background.(59) 
 
The concept of ethnicity adopted by the Census was, and remains, that of self-classification, 
as recommended by the Commission for Racial Equality, ensuring that ethnicity refers to the 
individual’s self-perception, rather than how they appear to others, recognising the fact that an 
individual’s self-conceptualisation may change over time.1 The 1991 Census ethnic group 
question for Great Britain consisted of the nine pre-coded categories visible on the household 
form plus 28 additional ethnic groups derived from any multi-ticking of the boxes and the 
written descriptions given in either of free text boxes under ‘Black other’ and ‘other’  (Table 2.1). 
Written descriptions which had the same or similar meaning to one of the pre-coded 
categories were assigned the relevant code between 0 and 6. Written responses for ‘Black 
other’ were assigned a code between 7 and 17, while written responses for “any other ethnic 
group” were allocated a code between 18 and 34. In the 1991 Census, 98.6% of respondents 
selected a pre-coded category while 1.4% specified their ethnic group as ‘Any other ethnic 
group’. Output from the 1991 Census was collapsed into 10 categories for England and Wales. 
For Scotland, this was further reduced to 4 categories. Many outputs from the 1991 Census 
also included a ‘born in Ireland’ category derived from the country of birth question. 
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There is criticism that the 1991 Census managed only to separate out two broad ethnic 
minority groups, Black and South Asian, and grouped together “White” populations, despite 
the known  social and health disparities.(18,60–62)  Furthermore, the 1991 Census did not allow 
individuals to identify themselves as British, regardless of their geographic or ancestral origin.  
For example, 26% of the free text responses under the “Black- other” category stated “British”. 
 
2.4.3 The 2001 Census 
In response to lobbying for the recognition of the poor social conditions for Irish populations 
born both inside and outside Great Britain, the 2001 Census expanded the White category to 
differentiate British, Irish and Other white. The most significant change from the 1991 Census 
was the addition of a mixed ethnicity category, which recognised the significant population of 
individuals born to parents of different ethnic groups.(60) This increased the number of ethnic 
group categories to 16 in England and Wales, 14 in Scotland and 12 in Northern Ireland.  
 
Religion was added for the first time to the 2001 Census for Great Britain as an optional 
question. Pilot testing of the 2001 Census found that some respondents felt that religion was 
a more useful indicator, particularly for individuals from south Asia and Ireland, where religion 
may form the primary measure of identity, rather than  ethnicity.(61)  
 
According to the 2001 Census for England and Wales, 8% of the population identified 
themselves as members of minority ethnic groups. Furthermore, 8% of the population of 
England and Wales in 2001 was born out of the UK; half of this group classified themselves as 
non-white.(62)  
 
Table 2.1 Evolution of census ethnic categories for England and Wales, 1991–2011 
1991   2001  2011  
1 White White White 
 1 British 1 English/Welsh/Scottish/Northern 
Irish/British 
 2 Irish 2 Irish 
 3 Any  other White background 
(write in) 
3 Gypsy or Irish Traveller 
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  4 Any other white background (write in) 
 Mixed Mixed/Multiple Ethnic Groups 
 4 White and Black Caribbean 5 White and Black Caribbean 
 5 White and Black African 6 White and Black African 
 6 White and Asian 7 White and Asian 
 7 Any other mixed background 
(write in) 
8  Any other Mixed/multiple ethnic 
background  (write in) 
  Asian or Asian British Asian or Asian British 
2 Indian 8 Indian 9 Indian 
3 Pakistani 9 Pakistani 10 Pakistani 
4 Bangladeshi 10 Bangladeshi 11 Bangladeshi 
 11 Any other Asian background 
(write in) 
12 Chinese 
  13 Any other Asian background  (write in) 
 Black or Black British Black/African/Caribbean/Black British 
5 Black-Caribbean 12 Caribbean 14 African 
6 Black-African 13 African 15 Caribbean 
7 Black Other (write in) 14 Any other Black background 
(write in) 
16 Any other Black/African/Caribbean 
background 
 Chinese or other ethnic group Other ethnic group 
8 Chinese 15 Chinese 17 Arab 
9   Any other ethnic group (write in) 16 Any other ethnic group (write in) 18 Any other ethnic group  (write in) 
 
2.4.4 The 2011 Census  
In the 2011 Census, the White category was further expanded to incorporate Gypsy or Irish 
Traveller. Furthermore, Chinese ethnicity was reclassified from the ‘Other’ group to Asian, while 
a new category for Arab was added to the ‘Other’ group. In the 2001 Census, only people 
selecting “White” ethnicity could identify as “British”. This problem was addressed in the 2011 
Census by creating a distinct question for national identity; thus respondents could identify 
themselves as British (or any other nationality) independently of ethnicity.(63)   
 
 
2.4.5 The validity of ethnic categories used in official statistics 
The question on ethnicity has been refined over the past three waves of the census, making 
direct comparisons problematic. A reduced set of seven high-level categories has been found 
by Simpson and Akinwale to show stability over time (Table 2.2).(62)  
 
Table 2.2 Census ethnicity groups, 1991 and 2001 
1991 Categories 2001 Categories Harmonised Groups 
White  White + all subgroups White 
Black Caribbean Black or Black British- Caribbean Black Caribbean 
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Black African Black or Black British- African Black African 
Indian Asian or Asian British- Indian Indian 
Pakistani Asian or Asian British- Pakistani Pakistani 
Bangladeshi Asian or Asian British- Bangladeshi Bangladeshi 
Chinese Chinese or Other- Chinese Chinese 
Black - Other Black or Black British- Other Black Other (not comparable 
over time) 
Other- Asian Asian or Asian British- Other Asian  
Other Chinese or Other- Other  
Other Mixed + all subgroups  
*Simpson and Akinwale (2006)  
 
2.5 Challenges in classifying ethnicity 
One of the conceptual challenges of disaggregating populations by ethnicity is the way in 
which ethnic groups are defined and understood. Ethnic groups themselves should not be 
considered to be homogeneous, as it is well established that high-level groupings can conceal 
significant heterogeneity.(64–67)  
 
Senior & Bhopal have suggested that, when utilising ethnicity as an epidemiological variable, 
it should be defined so as to allow the differentiation of populations in a way that is relevant to 
health and facilitates the generation of hypotheses about the aetiology of disease or explains 
observed differences in healthcare usage and outcomes.(67) However, there is no way to 
create a classification scheme that is valid and meaningful across all settings, as the relevance 
and validity of ethnic categories depend entirely upon the context in which they are used. This 
provides a challenge when conducting epidemiological research into ethnicity, where 
categories for explanatory variables must be meaningful, discrete and fixed in order to be 
interpretable. In order to investigate ethnicity effectively, it must be operationalised into 
practical analytical categories which are understood to encompass the rich variety of 
concepts, but are however constrained by the time and socio-cultural context in which they 
were developed.(60)  
 
In both the US and the UK it has been acknowledged that the ethnic categories used in official 
statistics are, to some extent, arbitrary and have been selected primarily for pragmatic reasons. 
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A US directive for the collection of race and ethnicity data states “These classifications should 
not be interpreted as being scientific or anthropological in nature.”(65) Indeed, one of the 
concerns about the original ethnicity question for 1981 was that:  
“The question confused colour with ethnic and national origin and the category “white” in 
particular would be open to sensational and damaging treatment in the popular Press.” (68)   
 
Just as individuals can change their ethnic identity over time, so too does the classification of 
ethnicity evolve, with more categories being included in standard classifications, reflecting 
numerical growth in representation of certain groups on the one hand, and on the other more 
nuanced understanding of meaningful categories. This is of particular importance in countries 
such as the UK, where historic changes in migration patterns have increased the ethnic 
diversity of the country as well as created new ethnic categories for later generations born in 
the UK itself, with multiple and novel ethnic identities. Provided that researchers recognise the 
limitations of categories and approach them critically, the study of ethnic differences can 
nonetheless provide vital information about patterns of health and social indicators, and 
provide an essential foundation for tackling inequalities between different populations. As 
articulated by Mason,  
 
“We should not be afraid to use categories which are not embraced by actors themselves if 
these can illuminate patterns of disadvantage and domination. We must, however, be clear 
when we are doing so and not imply that these categories coincide with the identities of those 
to whom they refer.” (69) 
 
As the ethnic diversity of the UK continues to grow, health outcomes for some White, Black 
and South Asian ethnic minority groups remain far worse than for the White British 
majority.There have been concerns that research on ethnicity and health has been of poor 
quality, with some researchers failing to explicitly report how their ethnic categories have been 
derived, which concepts they are intended to represent and what role they expect ethnicity to 
play in the phenomenon under study.(67,70,71)  
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White ethnicity is typically used as the reference group in studies of ethnic differences. In the 
UK, where the majority of the population identifies as “White British, Scottish, or Irish”, this 
approach can be justified on the grounds that this ethnic group is the largest. However, this 
approach also implies that the experience of the White group represents the norm, to which 
other groups should aspire.(72)  
 
2.6 Conclusions 
From unscientific beginnings, the concept of ethnicity has evolved to encompass the 
spectrum of biological, social and cultural influences that are understood to form part of our 
individual identity. As the concept has evolved, so has the difficulty with which it can be 
operationalised into a single variable for research purposes. In the UK, and indeed worldwide, 
a pragmatic approach has been undertaken to create ethnic categories which are simple and 
meaningful, but still largely based on racial and geographic boundaries. Routinely collected 
national data are already widely used to examine health outcomes by gender, age, socio-
economic status and country of birth. The introduction of standardised ethnic categories 
across the government and the National Health Service (NHS) has massively increased the 
potential for these same data to be used to examine ethnicity in great detail both across 
representative population samples, as found in the Clinical Practice Research Datalink, and in 
selected population samples, such as the Hospital Episode Statistics.  
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Chapter 3  
Source electronic health databases  
 
3.1 Summary 
This chapter introduces the two primary electronic health databases used to conduct the three 
studies  reported in this thesis: the Clinical Practice Research Datalink (CPRD) and the Hospital 
Episode Statistics for England (HES). A brief history of ethnicity recording across the UK 
National Health Service and the way in which ethnicity data are coded in each source is 
described. 
 
3.2 The Clinical Practice Research Datalink 
Across the UK there are numerous primary care databases which bring together electronic 
patient records; however, most of these cover small geographical areas, or small numbers of 
general practices. The Clinical Practice Research Datalink (CPRD, formerly GPRD) is one of 
three clinical research databases which provide patient data from across practices in the UK, 
allowing for research to be undertaken on samples generalisable to the whole population. The 
other two databases like the CPRD are the Health Improvement Network Database (THIN) 
and the QRESEARCH database.  
 
The CPRD was initially set up in 1987 as a commercial databank by the company VAMP (Value 
Added Medical Products). Now run by the Medicines and Healthcare products Regulatory 
Agency (MHRA), the CPRD is the largest primary care database in the UK, covering just over 
8% of the UK population.(73–75) 
 
The UK has the advantage of near-universal registration with general practitioners, around 
98% of the entire population. As such, analyses of the registered patient population are widely 
representative of the UK population, though notable exceptions include asylum seekers, the 
homeless, prison populations and those in the armed services, who are less likely to access 
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GP services.(76–78) Additional linkages to secondary care data, disease registries, surveys and 
vital statistics give these databases unique value for observational studies and increasingly for 
pragmatic clinical trials.(79–82)  
 
The CPRD currently contains longitudinal primary care records for approximately 13.5 million 
patients, of whom 5.5 million are currently active. Continuous observational data have been 
collected in most practices for over six years, yielding over 30 million patient years of 
observation.78 Patients contributing to the CPRD have been shown to be representative of the 
UK population in terms of age and gender, though in terms of regional representation the north 
of England is slightly under-represented.(74) Importantly, the validity of a wide range of 
diagnostic and clinical measures has been established, with a 2010 systematic review 
demonstrating a mean positive predictive value of 88% across a range of  183 diagnoses.(83–
86) The distribution of general practices contributing to the CPRD compared with the 
distribution of all general practices in the UK in July 2012 is shown in table 3.1. 
 
Table 3.1 Regional distribution of practices contributing to the July 2012 CPRD compared with the 
UK distribution 
Region CPRD July 2012 % UK April 2012 % 
England 483 77% 8123 82% 
Scotland 69 11% 998 10% 
Wales 50 8% 474 5% 
NI 22 4% 354 4% 
Total 624 100% 9949 100% 
 
All patients contributing to the CPRD are registered with 624 practices which all use the Vision 
clinical software system. Vision is one of several clinical software systems recommended for 
use in primary care by the GP Systems of Choice (GPSoC) Initiative, which supplies 
information technology systems to general practices across the UK. Other software systems 
include Egton Medical Information Systems (EMIS) and TPP System One, amongst others.(87) 
Chapter 3: Source Electronic Health Databases 
 
40 
 
General practitioners and practice staff record data onto their clinical systems and send 
anonymised patient data every 6 weeks to the CPRD. These data are then appended to the 
continually growing database, which contains information on diagnoses, symptoms, referrals, 
test results, medications, consultations, demographics, and lifestyle factors. Fifty per cent of 
English practices contributing to the CPRD also allow linkage to other data sources, such as 
the Hospital Episode Statistics for England and the Office for National Statistics (ONS) 
Mortality Data. 
 
Quality of research data is audited at both the patient and practice level by the CPRD team. 
Individual patient data are defined as being of ‘Acceptable Research Quality’ (ARQ) if they are 
free of gaps or inconsistencies which cast doubt on the accuracy of the data recorded. 
Practices are required to record a minimum of 95% of prescribing and relevant patient 
encounter events. Data from practices are routinely validated by internal checks. Practice-level 
data are defined as being Up to Standard’ (UTS) if it conforms to set of 10 metrics, including 
having a high proportion of patients with ARQ data, and having rates of prescriptions, deaths, 
pregnancies and referrals comparable to other practices. The first practice to meet these 
quality criteria did so in 1987, with most other general practices reaching the same level of 
quality by 1991. 
 
For research purposes, individual patient data is anonymised, with identifying information 
such as NHS number, name, date of birth, address and postcode removed. Information such 
as gender and year of birth are retained in order to conduct stratified analyses. In addition to 
these demographic data, researchers can access coded data pertaining to diagnoses, 
symptoms and processes of care. Free text entered by the primary care team are not routinely 
available to researchers, as these may contain identifiable information. Coded data are 
entered according to the Read clinical coding system, a hierarchical system of medical coding 
used across UK primary care.(88,89)  
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The CPRD is organised into 10 file types, each of which contains a subset of the patient record. 
For research purposes, information from these files can be joined using the anonymised 
patient or practice identifier. The file types are described in table 3.2. 
 
Table 3.2 Description of Clinical Practice Research Datalink file types 
File type Contents Example fields 
Patient Basic demographics and 
registration details 
Anonymised identifier, year of birth, registration date, 
transfer out date, death date 
Practice Details for all participating practices Practice identifier, geographical region, date of 
becoming “up to standard”, date of last data 
collection 
Staff Practice staff details Staff identifier, gender, role 
Consultation Information about consultation type 
as entered by the GP 
Consultation identifier, consultation type, 
consultation date, staff identifier, consultation 
duration 
Clinical All medical history including 
symptoms signs and diagnoses 
Date of clinical event, date of data entry, clinical 
code, episode type, additional details identifier 
Additional Details relating to events coded in 
the clinical file 
Patient identifier, entity type, data fields (depends on 
entity type) 
Referral Information about referrals to 
external care centres 
Referral method, referral specialty, referral type, 
attendance type, referral urgency 
Immunisation Details of immunisation records Immunisation reason, type, stage, status, compound 
used, location, reason for immunisation, route of 
administration 
Test Test results linked to events coded 
in the clinical file 
Type of test, result, normal range for result, unit of 
measure 
Therapy All prescriptions issued by the GP CPRD product code, British National Formulary 
Code, product name, dosage, quantity, pack size, 
number of days prescribed 
 
3.3 The Hospital Episode Statistics for England 
Hospital Episode Statistics (HES) have been collected since 1989 on all patients in England 
receiving care in NHS or NHS-commissioned hospitals (such as private hospitals). Prior to the 
introduction of HES, only 10% of admitted patient data were recorded nationally. The primary 
purpose of HES is to monitor hospital workload and audit procedures undertaken across 
inpatient, outpatient and accident and emergency (A&E) settings. Data held in the HES 
database can be used to conduct research on the epidemiology of disease presenting in 
secondary care and also to examine differences in workload, waiting times and length of stay 
by socio-demographic factors and region. Data on inpatient episodes have been available 
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since 1989, while outpatient and accident and emergency data have been available since 
2003 and 2007 respectively.(90) 
 
HES data contain information falling into four main domains:  
I. socio-demographic information, such as age, gender, ethnic group and socio-
economic status 
II. clinical information including up to 20 diagnoses coded using the International 
Classification of Disease, Version 10 (ICD-10) and up to 24 procedures coded 
using the Office of Population Censuses and Surveys, Version 4 (OPCS).(91)  
III. administrative information, such as admission and discharge dates, time on 
waiting list, length of stay, and consultation information 
IV. geographic information, such as region of the patients’ residence, region of the 
hospital and NHS trust.  
 
HES data are input by hospital-based clinical coders at the end of each admission and curated 
by the NHS Information Centre for Health and Social Care (NHS IC) 
 
Overall completeness of HES data is high, with the number of admissions captured in the 
database closely reflecting the true number. Quality of HES data is audited against standards 
of completeness, duplication and consistency. Annual quality reports are produced detailing 
known problems and hospitals which are under-reporting admissions. 
 
For the purposes of this study, the HES will be examined in two ways: firstly, as a standalone 
dataset in which completeness and patterns of ethnicity recording will be assessed for 
inpatients, outpatients and A&E admissions; and secondly, as a linked dataset for patients 
registered with the 308 of the CPRD practices (approximately 50%), in order to examine 
discrepancies between linked patient ethnicity data.  
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The linkage between the CPRD, HES and ONS Mortality datasets at the start of the research 
project in July 2012 is displayed in figure 3.1. 
 
 
Figure 3.1 Schematic of data source linkage as of July 2012 
 
3.4 Ethnicity recording in UK primary care 
The capture of ethnic group information in routine health records is recognised in the UK as a 
pre-requisite to addressing inequalities in health service usage and health-related 
outcomes.(23,45,47,92,93)  In line with the broader UK government strategy to promote 
equality across all departments, the Department of Health mandated the recording of ethnicity 
data to ensure equity of health service provision throughout the National Health Service.(94)  
 
Although the facility to record ethnicity was introduced into primary care in 1991 and into the 
Hospital Episode Statistics for England in 1995, unsystematic implementation resulted in poor 
completeness and quality of the initial data, limiting their intended use for clinical care, 
commissioning and research.(52,95–97) 
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The 16 ethnic group categories defined by the 2001 Census  for England and Wales currently 
form the national standard for mandatory ethnicity data collection across the National Health 
Service.(23) The Read system contains 88 unique codes for ethnicity, all of which map to the 
16 categories for ethnic group based on the 2001 Census for England and Wales.(98) In 2011, 
Scotland became the first country in the world to record ethnicity on death certificates, 
however, ethnicity is still not routinely recorded on birth certificates anywhere in the 
UK.(99,100) 
 
Though ethnicity recording was mandated across the National Health Service in 1991 
alongside the Census, until recently, electronic health records have been of limited use for 
examining associations between ethnicity and health due to the poor completeness and 
quality of the data.(94,101) Instead, past studies exploring ethnicity have variously ascribed 
patient ethnicity indirectly, via name-recognition software or by estimating ethnic population 
size from Census data, both methods of questionable validity, particularly for individuals of 
mixed ethnicity and for descendants of migrants.(102–104)  
 
Individual-level ethnicity data is becoming increasingly available in both primary and 
secondary care, providing a novel opportunity to conduct research across the whole of the UK 
population into ethnic differences in the healthcare usage and outcomes. The computerisation 
of healthcare records across both primary care (general practice) and secondary care 
(hospital settings) has generated enormous potential for population-based research on 
morbidity and the use of health services. 
 
In order to improve the quality and completeness of ethnicity data available in primary care, 
the recording of ethnicity was incentivised under the Quality and Outcomes Framework (QOF) 
in 2004.(105,106) Under the scheme, general practices were awarded 1 QOF point per annum 
(equivalent to £125 for an average practice) for recording the ethnicity of 100% of all newly 
registered patients in each financial year.   
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In 2008 this scheme was replaced with a new enhanced service which remunerated practices 
5.6 pence for every new patient whose ethnicity was captured. The recording of ethnicity was 
removed from the programme in April 2011, as it is now expected that general practices will 
record ethnicity, along with first language, routinely in order to meet the needs of their 
registered populations.(107)  Data from the Quality and Outcomes Results database shows 
that 92% of general practices across the UK are now routinely recording ethnicity for 100% of 
their newly registered patients, up from 83% in 2007 (Figure 3.2).(106) 
 
 
Figure 3.2 Proportion of UK practices achieving 100% ethnicity recording for all new patients, 2007-
2011 
 
3.5 Ethnicity recording in UK secondary care 
Turning to hospital settings, a scheme was proposed in 1992 which required general 
practitioners to record patient ethnicity in all referral letters so that other NHS care providers 
need not repeatedly ask the patient.(108) This scheme was unsuccessful and recording of 
ethnic group data was later incorporated into the Hospital Episode Statistics in 1995.(96,109) 
In 2001, the ethnic codes first introduced in 1995 were updated to match the groupings of the 
2001 Census.(97) Ethnic group data has been available for outpatients since 2003 and for A&E 
since 2007.(110) Hospital Episode Statistics are available for England only and cover all NHS 
admissions, as well as private patients. In 2010, valid ethnicity was being recorded for over 
91% of all finished consultant episodes in England.(97) 
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3.6 How ethnicity data are captured 
In primary care it is expected that ethnicity will be recorded in one of two ways: either the 
patient will be asked to fill in a drop-down checklist of similar categories to those  of the 2001 
Census, or the patient will be asked face to face by the general practitioner or other practice 
staff.(23) This can take place during registration or consultation. In hospital settings, guidelines 
state that ethnicity should be self-reported by patients whenever possible, with assistance 
from relatives, interpreters and advocates where necessary.(111) Qualitative studies exploring 
patient and practitioner perspectives have reported that the collection of ethnicity data is 
widely accepted as being important, though concerns around the need for repeated collection 
of ethnicity, time burden on practitioners, limitations of the 16 standard categories and lack of 
coordination between primary and secondary care have been expressed.(112,113)   
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Chapter 4  
Current uses of routinely collected ethnicity data 
for population-based research in the UK: a 
literature review 
 
4.1 Aim 
The aim of the review was to ascertain how routinely available ethnicity data from electronic 
health databases in the UK is currently being used in observational studies.  
 
4.2 Summary 
This chapter summarises the current body of work that has made use of ethnicity data as 
routinely recorded in UK based primary and secondary care with the explicit purpose of 
examining health outcomes. The search strategy and inclusion and exclusion criteria are 
described. The results of the review and a discussion of the findings and rationale for the first 
of the three studies, of ethnicity recording (described in Chapter 5), conclude the chapter. 
 
4.3 Search strategy 
In February 2012, a keyword search in MEDLINE, EMBASE and Web of Knowledge was 
undertaken to identify all studies utilising data from four UK-based electronic health databases:  
the Clinical Practice Research Datalink (CPRD), The Health Improvement Network (THIN), the 
QRESEARCH database and the Hospital Episode Statistics (HES).  Only three literature 
databases were interrogated as saturation was reached,- with the majority of articles 
appearing in all three databases. As my main interest was in the four selected health 
databases rather than the topic of electronic health records as a whole, no Medical Subject 
Headings (MESH) were required in the search. Inclusion and exclusion criteria are detailed in 
table 4.1. 
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Duplicates were removed by Endnote X5 and by hand searching. Abstracts were scanned to 
remove articles that did not describe primary observational research using the electronic 
health databases of interest. The remaining abstracts were finally reviewed in detail to 
determine whether patient-level ethnicity was utilised in the study. 
 
Table 4.1  Search terms and inclusion and exclusion criteria for systematic review 
Database Text term                                                                                  
CPRD “General Practice Research Database” or “GPRD” or “Clinical Practice Research Datalink” or 
“CPRD” 
THIN “Health Improvement Network” 
QRESEARCH “QRESEARCH” 
HES “Hospital Episode Statistics” or “HES”                            
Study Type 
Included: Quantitative studies using the electronic health databases of interest   
Quantitative studies using patient-level ethnicity data as a variable in the analysis  
Excluded: Articles relating to other electronic health databases 
 Studies that did not utilize patient-level ethnicity data derived from  
The database of interest (i.e. / used area level measures of ethnicity,   
Attributed Census derived ethnic distributions to the data) 
 Studies which did not report patient level outcomes (i.e. / ecological  
Studies, reports about the technology of EHR, statistical methods,  
Data quality) 
Publication Type 
Included: Peer-reviewed articles published in journals 
Excluded: Review articles, opinion pieces, letters, editorials, summaries, conference abstracts, non-English 
publications 
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4.4 Results 
From a total of 1,232 observational studies using UK-wide electronic health databases, 15 
made use of the patient-level ethnicity data available (Figure 4.1).   
 
 
Figure 4.1 Systematic review search results  
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4.4.1 Study characteristics 
The key characteristics of the 15 included papers are summarized in table 4.2. Briefly, 10 
studies utilized the ethnicity data held within HES, 3 utilized the QRESEARCH database and 2 
utilized THIN. None of the included studies drew on the CPRD. Articles were published 
between 2004 and 2012 and covered a range of study designs, geographical regions and age 
ranges.  
 
Completeness of ethnicity data in secondary care was reported by eight studies as being 
between 65% and 95%. Missing ethnicity data was either considered as a distinct category for 
analysis, estimated using multiple imputation, collapsed together with the white ethnic groups 
or excluded from the analysis.  
 
All five studies set in primary care made use of patient data across the UK. Of the 10 studies 
set in secondary care, five included patients from the whole of England, while the remainder 
selected patients from various regions of the country.  In total, six studies incorporated ethnicity 
as a factor in the derivation and validation of risk prediction models,(114–119) three studies 
examined access to and use of secondary care services,(120,121) two examined in-patient 
procedures,(122,123) three studies focused on cancer,(124–126) and one on liver 
disease.(127)  
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Table 4.2 Key characteristics of studies included in literature review  
# Study Title Study population Source of 
ethnicity data 
% complete 
ethnicity 
Ethnic categories for 
comparison 
Treatment of  
Missing ethnicity  
1 Cooper, 
2009(124) 
The influence of deprivation and ethnicity on the 
incidence of oesophageal cancer in England 
4,252 oesophageal cancers in the 
West Midlands between 1977 and 
2004 
HES Up to 89%  White, Asian, Black, 
Other/Mixed, Not known, Not 
HES matched 
Treated as a category for 
analysis 
2 Bottle, 
2006(128) 
Identifying patients at high risk of emergency 
hospital admissions: a logistic regression analysis  
2,895,234 emergency admissions 
across England between 1999 and 
2004 
HES Not reported White, Black, Indian sub-
continent, Chinese, 
Unknown, other 
Treated as a category for 
analysis 
3 Bragg, 
2010(123) 
Variation in rates of caesarean section among 
English NHS trusts after accounting for maternal 
and clinical risk: cross sectional study 
620,604 women aged 15-44 with a 
singleton birth between January and 
December 2008 
HES 89% White, Afro-Caribbean, Asian, 
Other, Unknown  
Treated as a category for 
analysis 
4 Hacker, 
2004(121) 
Equity in waiting times for two surgical specialties: 
a case study at a hospital in the North West of 
England 
4,306 waiting list patients in NW 
England in 2000/2001 
HES  85% White, Non-white  Excluded from analysis 
5 Jack, 
2007(125) 
Testis and prostate cancer incidence in ethnic 
groups in South East England 
194,590 male inpatients in SE England 
with diagnosed or suspected 
testis/prostate cancer 
HES and 
Thames 
Cancer 
Registry 
63% HES + 
3% extra 
from TCR 
Categories from the 1991 and 
2001Census. White ethnic 
codes collapsed into a 
category for “All White”  
Treated as a category for 
analysis 
6 Mann, 
2008(127) 
Hepatitis C in ethnic minority populations in 
England 
6,339 patients with hepatitis C related 
liver disease between 1997 and 2005 
HES 65% White, Black African, Black 
Caribbean, Pakistani, 
Bangladeshi, Other, Mixed, 
Indian, Chinese, Unknown  
2 methods: 1. Unknown 
grouped with White 2. 
Unknown split between 
other ethnic groups 
7 Mindell, 
2008(122) 
Using routine data to measure ethnic differentials 
in access to coronary revascularization 
95,675 CHD and 19,282 coronary 
revascularization episodes for London 
residents between 2002 and 2004 
HES 70%-95% 
from 2002-
2004 
17 Categories from the 2001 
Census 
Treated as a category for 
analysis 
8 Billings, 
2006(118) 
Case finding for patients at risk of readmission to 
hospital: development of algorithm to identify 
high-risk patients 
24,276 patients in England admitted to 
hospital between 1999 and 2003 
HES Not reported White Black, Indian, 
Pakistani, Unknown/Not 
specified  
Not reported 
9 Shah, 
2011(120) 
Place of death and hospital care for children who 
died of cancer in England, 1999-2006 
Children (<15 years) who were 
diagnosed with cancer and who died 
under the age of 20 years in England 
1999–2006. 
HES+CCLG 84%  White, South Asian, Black, 
Other, Missing/Unknown 
Not reported 
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Table 4.2 Continued... 
# Study Title Study population Source of 
ethnicity data 
% complete 
ethnicity 
Ethnic categories for comparison Treatment of  
Missing ethnicity  
10 Downing, 
2011(126) 
Using routinely collected health data to 
investigate the association between ethnicity and 
breast cancer incidence and survival: what is the 
impact of missing data and multiple ethnicities? 
48,234 cases of female invasive breast 
cancer diagnosed in the 
Northern/Yorkshire and West 
Midlands cancer registries 
HES 83%   White, South Asian, Black, Other, 
unknown  
Filled in using 
multiple  
Imputation 
11 Hippisley-
Cox, 
2008(119) 
Predicting cardiovascular risk in England and 
Wales: prospective derivation and validation of 
QRISK2 
2.3 million Patients aged 35-74 in the 
QRESEARCH database between 1993 
and 2008 
QRESEARCH 27.1% 
women and 
23.8% men 
White/not recorded, South Asian, 
Black African, Black Caribbean, 
Chinese/Other 
Unknown 
ethnicity 
grouped with 
White 
12 Hippisley-
Cox, 
2010a(115) 
Derivation, validation, and evaluation of a new 
QRISK model to estimate lifetime risk of 
cardiovascular disease: Cohort study using the 
QRESEARCH database 
3,610,918 patients aged 30-80 from 563 
general practices contributing to 
QRESEARCH database free from CVD 
and not taking statins between 1994 
and 2010 
QRESEARCH  Not reported White/ not recorded, Indian, 
Pakistani, Bangladeshi, Other Asian, 
Black African, Black Caribbean, 
Chinese, Other/Mixed 
Unknown 
ethnicity 
grouped with 
White 
13 Hippisley-
Cox, 
2010b(114) 
Predicting the risk of Chronic Kidney Disease in 
Men and Women in England and Wales: 
prospective derivation and external validation of 
the qkidney scores 
2,363,069 patients aged 35-74 from 
general practices contributing to the 
QRESEARCH and THIN databases 
between 2002-2008  
QRESEARCH 
and THIN 
Not reported White/ not recorded, Indian, 
Pakistani, Bangladeshi, Other Asian, 
Black Caribbean, Black African, 
Chinese, Other 
Unknown 
ethnicity 
grouped with 
White 
14 Collins, 
2010(129) 
An independent and external validation of QRISK2 
cardiovascular disease risk score: A prospective 
open cohort study 
1.58 million Patients 35-74 in the THIN 
database free from cardiovascular 
events between 1993 and 2008 
THIN Not reported White/ not recorded, Indian, 
Pakistani, Bangladeshi, Other Asian, 
Black African, Black Caribbean, 
Chinese, other/mixed   
Unknown 
ethnicity 
grouped with 
White 
15 Collins, 
2011(116) 
External validation of QDSCORE (R) for predicting 
the 10-year risk of developing Type 2 diabetes 
2.4 million Patients 25-79 in the THIN 
database free from diabetes between 
1993 and 2008 
THIN Not reported White/ not recorded, Indian, 
Pakistani, Bangladeshi, Other Asian, 
Black African, Black Caribbean, 
Chinese, other /mixed 
Unknown 
ethnicity 
grouped with 
White 
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4.4.2 Study findings 
All of the studies, bar one, reported a relationship between ethnicity and at least one outcome 
of interest. Studies focusing on cancer found that the incidences of oesophageal and testis 
cancer were highest in the White population while the incidence of prostate cancer was 
highest for ethnic minority men.(125,130)  In a further study, the incidence of breast cancer 
was found to be lowest amongst South Asian women, though no ethnic differences in five-
year survival were evident.(126)  
 
Studies of secondary care usage found that ethnicity was a significant predictor of emergency 
hospital admission, or (any) readmission to hospital.(128) Patients of Black and South Asian 
ethnicity had lower use of coronary revascularisation surgery while Black and South Asian 
children with cancer were found to be less likely to die at home.(120,122)  Only Hacker et al. 
found no ethnic differences in their study of waiting times to surgery.(121)  
 
Studies of disease prevalence and risk uniformly reported increased risk in non-white groups, 
particularly South Asian groups for cardiovascular disease, chronic kidney disease and type 2 
diabetes mellitus. Full results tables presented in table 4.3. 
 
4.5 Discussion 
Fifteen of the 1,232 (1.3%) published observational studies on national electronic health 
databases retrieved by the literature search utilized the patient-level ethnicity data available. 
The fact that all 15 were published after the financial incentivisation of ethnicity recording in 
primary care in 2004 may reflect increased confidence in data quality and completeness 
brought about by this top-down initiative.   This is not to say that research into ethnicity using 
routine health records is not taking place at a local or regional level, but rather that for large-
scale studies at a national level, this resource has yet to be capitalized on. As evidenced in 
several studies throughout the UK, primary care records are widely used to examine ethnicity 
at a regional level, particularly in large cities with greater ethnic minority populations and 
higher levels of deprivation relative to the national average.(2,131–135)  
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Table 4.3 Key findings of studies included in literature review 
# Study Aims  What is known about ethnicity in this field Main ethnicity related findings Limitations of ethnicity data 
1 Cooper, 
2009(124) 
To examine the role of sex, ethnicity, 
affluence and deprivation on the incidence 
of oesophageal cancer and to determine 
changes in the incidence of its 
morphological subtypes (EAC and ESCC) 
over time.  
In the USA, ESCC is more common in the 
black population while EAC is most 
common among White males. 
A relationship between ethnicity and 
oesophageal cancer has not yet been 
studied in England. 
EAC strongly associated with White ethnicity. ESCC more common 
black men compared to white men, but not statistically significant.  
The incidence of EAC is rising rapidly due to its strong association 
with male gender and White ethnicity. The incidence of ESCC has 
not changed over time.  
None relating to ethnicity 
specified 
2 Bottle, 
2006(128) 
To incorporate ethnicity as an explanatory 
variable into a predictive model to identify 
patients at high risk of emergency hospital 
admissions 
Not stated Ethnicity was found to be significantly associated with the likelihood 
of being a of high-impact user (someone with three or more 
emergency admissions within a 12 month period) and was 
included in the final regression model  
None relating to ethnicity 
specified 
3 Bragg, 
2010(123) 
To determine whether ethnicity, other 
maternal factors and clinical risk factors can 
explain variation in rates of caesarean 
section in England.  
Not stated Odds of having a C-section were significantly increased for Black 
African/Caribbean women compared to White independent of all 
other risk factors. 
Incomplete and inaccurate 
coding of risk factors.  
4 Hacker, 
2004(121) 
To examine equity in waiting times for 
secondary care by age, gender, ethnicity 
and deprivation 
Patients from minority ethnic groups have 
been found to be less likely to receive the 
health services they require and are more 
likely to face discrimination in accessing 
services.  
No significant differences in waiting time by ethnicity were found:  
Univariate analysis showed a non-significant increase in waiting 
only  
Non-white ethnic group was 
small, even after combining 
ethnic minority groups 
5 Jack, 
2007(125) 
To compare the incidence of prostate and 
testis cancer in different ethnic groups. 
Studies in the US have shown that the 
incidence of testis cancer is five times 
higher in White compared to Black men 
and the incidence of prostate cancer is 
higher in Black men compared to White. 
Use of PSA testing is lower in Black men.  
Incidence of testis cancer was significantly lower in all South Asian, 
Black African/Caribbean, and Chinese sub groups compared to the 
“All White” group. Incidence of prostate cancer significantly higher 
in Black, Indian, Pakistani, and Mixed White/Black groups and 
significantly lower in Bangladeshi and Chinese groups compared 
to White.  
Residual confounding of 
deprivation may explain lower 
prostate cancer incidence in 
Bangladeshi men.  
 
6 Mann, 
2008(127) 
To investigate ethnic differences in the 
prevalence of hepatitis-C related end-stage 
liver disease.  
Ethnic minority groups may be less likely to 
be tested for Hepatitis C as they are not 
considered as being at high risk- they may 
be more likely to be admitted to hospital in 
end-stage disease or die without receiving 
successful treatment. 
Crude morbidity and mortality rates for end-stage liver disease were 
higher for Black African/Caribbean, Pakistani, Bangladeshi and 
Other groups compared to White and lower for Indian, Chinese and 
Mixed groups. After age standardisation, all non-white groups had 
significantly higher rates of end-stage liver disease, death, and 
hepatocellular carcinoma compared to the White group.  
Higher rates of liver disease in 
ethnic minority groups may be 
explained by higher 
prevalence of hepatitis C in 
host countries for new 
migrants.  
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Table 4.3 continued 
7 Mindell, 
2008(122) 
To examine ethnic differences in coronary 
revascularization. 
South Asian patients have been found to 
be less likely to received angioplasty or 
coronary bypass graft than White patients 
despite having equivalent levels of 
recommendations for revascularization. 
Proportional ratios showed that revascularizations were less 
common in Bangladeshi and Black African/Caribbean groups 
relative to need (number of CHD admissions) - particularly for 
those with emergency admissions. 
>20% of CHD patients did not 
have ethnicity coded in 
2003/4. 
Grouping of South Asian 
disguises known 
heterogeneity in 
morbidity/mortality. 
8 Billings, 
2006(118) 
To develop an algorithm to identify patients 
at high risk of readmission to hospital 
within 12 months. 
Not stated Ethnicity was found to be a significant predictor of readmission 
and was included in the final regression model.  
None relating to ethnicity 
specified 
9 Shah, 
2011(120) 
To describe patterns in hospital care and 
evaluate factors affecting place of death 
for children with cancer.  
Not stated Significant ethnic differences in place of death: 42% of White and 
70% of Asian and Black children died in hospital. 79% of children 
who died in hospice were White. Odds of dying at home 
significantly reduced for South Asian and Black children after 
adjustment. 
None relating to ethnicity 
specified 
10 Downing, 
2011(126) 
To examine the relationship between 
ethnicity and breast cancer 
incidence/survival and to assess the 
impact of missing data/multiple 
ethnicities 
In the UK, incidence of breast cancer has 
been found to be lower for ethnic minority 
groups than for White groups. Breast cancer 
survival has been found to be better for South 
Asian women, but worse for Black 
African/Caribbean women.   
Incidence of breast cancer was similar for White and Black 
groups and significantly lower for South Asian groups. After 
adjustment for age, gender and stage of diagnosis, no ethnic 
differences in 5-year survival were found.  
Study was unable to split 
ethnic groups into minor 
categories due to small 
numbers. Difficult to interpret 
results for “other” group due 
to heterogeneity.  
11 Hippisley-
Cox, 
2008(119) 
To revise an algorithm to predict the ten 
year risk of developing cardiovascular 
disease by incorporating ethnicity and 
relevant disease conditions (QRISK2).  
Rates of CVD are known to vary by between 
ethnic groups. Existing CVD risk scores which 
have been prospectively derived do not 
include a variable for self-assigned ethnicity. 
NICE guidance recommends multiplying 
Framingham risk score by 1.4 for men, but 
this does not take into account heterogeneity 
between South Asian populations.  
Incidence of CVD highest for South Asian groups and lowest 
for Black African/Caribbean and Chinese individuals. 
Prevalence of risk factors varied substantially between ethnic 
groups. The new risk model improves upon the older version 
and increases identification of ethnic minority groups at high 
risk.  
Only 25% of patients had 
self-assigned ethnicity. 
Misclassification of patients 
with missing ethnicity would 
result in an underestimate of 
the effect of ethnicity on CVD 
risk. 
12 Hippisley-
Cox, 
2010a(115) 
To further refine the QRISK2 score so that 
it may be used across all age groups.  
Not stated South Asian patients were most likely to have a high lifetime 
risk of CVD compared to White- this was highest for Pakistani, 
followed by Bangladeshi and Indian groups. The new score 
will increase identification of high CVD risk amongst younger 
patients, men, ethnic minority groups and people with a family 
history of premature CHD. 
None relating to ethnicity 
specified 
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Table 4.3 continued 
13 Hippisley-
Cox, 
2010b(11
4) 
To develop two risk scores to predict the 
5 year risk of developing moderate/severe 
kidney disease and the 5 year risk of End 
Stage Kidney Failure.   
Ethnicity is known to be associated with 
chronic kidney disease and thus relevant for 
inclusion in the risk scoring algorithm.  
Risk of moderate/severe CKD was significantly increased for 
South Asian patients compared to the White/not recorded 
group; Black African/Caribbean women had the lowest risk. 
Risk of End Stage Kidney Failure was significantly increased 
for Pakistani, other Asian and Chinese women relative to White 
women and for Pakistani, Other Asian and Black Caribbean 
men.  
None relating to ethnicity 
specified 
14 Collins, 
2010(129) 
To evaluate the QRISK2 score in an 
independent UK cohort and compare it to 
QRISK1 and the modified Framingham 
equation.  
Risk of CVD is known to vary between ethnic 
groups. To date, the choice of adjustment 
factor for the Framingham score has not been 
scientifically evaluated.  
Incidence of CVD was highest in South Asian groups- 
particularly Pakistani. The performance of QRISK was superior 
to the modified Framingham equation.  
None relating to ethnicity 
specified 
15 Collins, 
2011(116) 
To validate the QDSCORE which 
estimates 10 year risk of developing 
diagnosed Type 2 diabetes.  
Ethnic minority groups have an increased risk 
for type 2 diabetes. The prevalence of T2DM 
is 2-4x higher amongst South Asian groups 
and has an earlier onset than in the White 
European population.  
Incidence of T2DM was highest for South Asian groups- 
particularly Bangladeshi. Large proportions of South Asians 
had a predicted risk of 10% or higher of developing T2DM in 
the next 10 years.  
None relating to ethnicity 
specified 
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4.6 Rationale for study examining completeness and quality of ethnicity 
recording 
 
There have been concerns that research on ethnicity and health has been of poor quality, with 
some researchers failing to explicitly report how their ethnic categories have been derived, 
which concepts they are intended to represent and what role they expect ethnicity to play in 
the phenomenon under study.(136,137)  
 
The literature review identified several studies which both utilise datasets with high levels of 
ethnicity data completeness and also exemplify how electronic health records can be used to 
examine important ethnic differentials in usage of and access to healthcare services, 
prevalence and incidence of disease, and risk of outcomes, such as morbidity, mortality and 
hospital re-admission. Improving the quality and usability of the ethnicity data is therefore a 
necessary step towards increasing the use of these data for research into ethnic inequalities, 
and improving the validity and generalisability of the findings.  
 
The UK differs from the US in that there is no legal requirement for the inclusion of ethnic 
minority groups in publicly funded research which can provide the evidence base for guidance 
and policy tailored to ethnically diverse populations.(8) Furthermore, as demonstrated by the 
small number of papers identified in the systematic review, much of this research does not 
consider ethnicity as an explanatory variable of interest, and thus cannot investigate otherwise 
invisible inequalities which may exist.(138)  
 
One topic which is yet to be explored is the potential value of routinely collected healthcare 
data for examining ethnic disparities in healthcare usage and outcomes across whole 
populations. The computerisation of healthcare records across both primary care (general 
practice) and secondary care (hospital settings) has generated enormous potential for 
population-based research on morbidity and the use of health services.  
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Chapter 5  
Completeness and usability of ethnicity data in 
UK-based primary care and hospital databases  
 
5.1 Summary 
This chapter describes the first study of this thesis – an audit of the quality, completeness and 
generalisability of routinely recorded ethnicity data in the Clinical Practice Research Database 
(CPRD) and the Hospital Episode Statistics (HES). A modified version of this chapter was 
published as a peer-reviewed article in the Journal of Public Health in 2013.(139) 
 
5.2 Aims, objectives and research questions 
Although the validity of morbidity indicators in both the CPRD and HES has been explored in 
depth, to date, no comprehensive audit of ethnicity data has been conducted.(85,140–143)  
Furthermore, even though improvements in ethnicity recording have been demonstrated 
nationally, very few epidemiological studies using these databases have utilised the patient-
level ethnicity data held within.(139)  
 
Confirming that the ethnicity data recorded in routine health databases are of sufficient quality 
to explore ethnic differentials in health is an essential first step towards maximising their use 
for research and clinical purposes. The aim of this study was to ascertain the completeness 
and validity of routinely collected ethnicity data held in electronic health databases and to 
demonstrate the feasibility of using such data to investigate ethnic differences in disease 
patterning and outcomes across the UK. 
 
The objectives of this study were fourfold: 
1. to chart progress in the completeness of ethnicity recording in the CPRD and HES over time 
 2. to assess consistency of ethnicity coding for individuals whose ethnicity is recorded multiple 
times  
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3. to develop a simple and pragmatic method for choosing an ethnic category for patients with 
multiple discrepant ethnicity codes either within the CPRD alone or across linked CPRD and 
HES  
4. to determine whether the ethnic breakdown of the CPRD population is consistent with that 
of the 2011 UK Census.  
 
5.3 Methods 
5.3.1 Ethnicity data extraction 
The 16 categories used for ethnicity data collection across the NHS were standardised to the 
five high-level groups used in the 2001 Census for England and Wales, allowing the ethnicity 
data in CPRD and HES to be compared with each other and with other sources. The 16 
categories were not used in this analysis because the categorisation of ethnicity in the HES 
inpatient dataset prior to 2001 did not separate out the ‘White’ category into British, Irish and 
‘other White’. 
 
Table 5.1 Mapping of 2001 census categories to high-level groups 
16 groups 5 categories 
1 British 1.White 
2 Irish  
3 Any  other White background (write in)  
4 White and Black Caribbean 2. Mixed 
5 White and Black African  
6 White and Asian  
7 Any other mixed background (write in)  
8 Indian 3. Asian or Asian British 
9 Pakistani  
10 Bangladeshi  
11 Any other Asian background (write in)  
12 Caribbean 4. Black or Black British 
13 African  
14 Any other Black background (write in)  
15 Chinese 5. Chinese or Other Group 
16 Any other ethnic group (write in)  
  
Chapter 5: Completeness of ethnicity data in UK health databases 
60 
 
a) CPRD data 
Information in the CPRD was entered using the Read system of alphanumeric codes.(88) Read 
codes for ‘ethnic group’ falling under the 9i (2001 Census) and 9S (1991 Census) hierarchies 
were extracted for all currently registered and past patients contributing to the July 2012 build 
of the CPRD database. All ethnic codes were collapsed into the 16 categories used in the 2001 
Census (Table 5.1). Ethnicity codes were merged with the patient denominator file for July 
2012. All patients registered in CPRD practices up to and including 31 December 2011 were 
included in the analysis. Usable ethnicity was considered to be any 9i or 9S Read code which 
was not ‘unknown’ (9SD, 9SE, 9SZ, 9ig), at too high a level to be interpreted (9i, 9S), or missing. 
Identical ethnicity codes entered on the same system date for a single patient were removed, 
as these yield no additional information.  
 
b) HES data 
In August 2012, all ethnicity and demographic data for patients contributing to the Hospital 
Episode Statistics between the 1997/98 and 2011/12 financial years was extracted. The two 
coding hierarchies relating to the 1991 and 2001 Census were collapsed into the 16 ethnic 
categories of the 2001 Census. Usable ethnicity was considered to be any ethnic code which 
was not ‘unknown’ (ethnos variable: codes 9, X, Z, Zn), or missing. Since the unique patient 
identifier “hesid” has only been used since 1997 onwards, inpatient data for the financial years 
1997/98–2011/12 were included in the analysis. Outpatient data were available from 2003/04 
onwards and A&E data from 2007/08 onwards (Table 5.2). 
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Table 5.2 Categorisation of ethnicity in the Hospital Episode Statistics for England 
 
5.3.2 Statistical analysis 
 
a) Overall completeness of ethnicity recording 
For both the CPRD and HES, the proportion of patients with ethnicity ever recorded was 
calculated. For the CPRD, completeness was compared between a) all patients present in the 
CPRD including those who have left or died, b) currently registered patients (that is, all patients 
who have not died or transferred out of their general practice),  and c) patients registered after 
April 1st 2006 when incentivisation of ethnicity recording was introduced to primary care. For 
HES, completeness was assessed for all inpatients, outpatients and A&E attendees.  
 
In the CPRD, ethnicity recording was further broken down by year of first ever registration. For 
HES, ethnicity recording was further broken down by year of first ever admission (inpatients 
and A&E) or appointment (outpatients).  
 
  
Inpatient 1995-2000 Inpatient 2001 onwards  Outpatients 2003 onwards and A&E 
2008 onwards 
0 White A British (White) An = British (White) 
1 Black Caribbean B Irish (White) Bn = Irish (White) 
2 Black African C Any other White background Cn = Any other White background 
3 Black Other D White and Black Caribbean (Mixed) Dn = White and Black Caribbean (Mixed) 
4 Indian E White and Black African (Mixed) En = White and Black African (Mixed) 
5 Pakistani F White and Asian (Mixed) Fn = White and Asian (Mixed) 
6 Bangladeshi G Any other Mixed background Gn = Any other Mixed background 
7 Chinese H Indian (Asian or Asian British) Hn = Indian (Asian or Asian British) 
8 Any other ethnic group J Pakistani (Asian or Asian British) Jn = Pakistani (Asian or Asian British) 
9 Not given K Bangladeshi (Asian or Asian British) Kn = Bangladeshi (Asian or Asian British) 
X Not known L Any other Asian background Ln = Any other Asian background 
 M Caribbean (Black or Black British) Mn = Caribbean (Black or Black British) 
 N African (Black or Black British) Nn = African (Black or Black British) 
 P Any other Black background Pn = Any other Black background 
 R Chinese (other ethnic group) Rn = Chinese (other ethnic group) 
 S Any other ethnic group Sn = Any other ethnic group 
 Z Not stated Zn = Not stated 
 X Not known X = Not known 
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b) Multiple ethnicity recording within each source 
In both general practice and in hospital, patients can have their ethnicity recorded repeatedly 
over multiple consultations or visits.  Discrepancies may arise if there are: mistakes while 
entering the data onto the system, different responses from the patient when asked by the 
service provider, or different codings of ethnicity information without consulting the patient.  
 
In order to examine consistency of ethnicity coding, the proportion of patients with only one 
ethnicity code on their record was compared with the proportion of patients with multiple 
codes where these were: 
1. truly matched (multiple ethnic codes which are identical) 
2. categorically matched (multiple ethnic codes which are different but fall into the same 
five higher-level groups of ethnicity, namely White, Mixed, Asian/Asian British, 
Black/Black British, Chinese/Other) 
3. truly mismatched (multiple ethnicities which span different higher-level groups).   
 
5.3.3 Discrepant ethnicity recording between linked sources 
Of the 624 general practices contributing to the CPRD in August 2013, 357 consented to further 
linkage with HES. Linkage using deterministic matching on NHS number, date of birth and 
gender was undertaken by a Trusted Third Party. The completeness of ethnicity recording in 
each database alone was compared with the completeness of the databases combined. For 
the subset of patients registered from April 1st 2006 onwards with a valid ethnicity recorded in 
both CPRD and HES, the most commonly recorded ethnicity code in each database was 
determined separately, and compared them to determine the proportion of patients with 
matched or mismatched ethnicity across databases.  The degree of mismatch was further 
examined for each ethnic group in turn.  
 
5.3.4 Comparison of the CPRD population with the 2011 UK Census population 
The most recent census across the UK was undertaken on March 27th, 2011 with initial 
aggregate data released in September 2012. Ethnic breakdowns for the populations of 
England, Wales, Scotland and Northern Ireland were obtained from the relevant census 
Chapter 5: Completeness of ethnicity data in UK health databases 
63 
 
websites. Since the available categories for the ethnicity question vary slightly between the 
censuses for the constituent countries, categories were collapsed for comparison with the 
CPRD data.  
 
For comparison between the Census and the CPRD, two populations were derived from the 
January 2012 build of the CPRD. For the first population, the January 2012 database was 
reduced to include only patients who were actively registered on the date of the Census 
(March 27th, 2011). All patients who had left the CPRD before this date or who had joined the 
CPRD after this date were removed. For patients who were present in the CPRD on March 
27th, 2011, all ethnicity codes entered after this date were removed.  
 
The second population was restricted to patients who registered after April 1st 2006 and were 
present in the  CPRD March 27th 2011 population in order to examine distributions and 
consistency with other sources for a group for whom it is expected that ethnicity will have been 
recorded (and recording was incentivised). For both populations, the most recent ethnicity 
code prior to the census date was collapsed into the 16 categories and the 5 higher-level 
categories of the 2011 Census for analysis.  The proportions of patients belonging to each 
ethnic group in the CPRD were then directly standardised against the age distribution of the 
2011 Census. 
 
5.4 Results 
5.4.1 Overall completeness of ethnicity recording 
The first objective of this study was to chart progress in the completeness of ethnicity recording 
in the CPRD and HES over time. 
 
a) CPRD population 
From a total of 12,099,672 patients contributing to the July 2012 build of the CPRD, (including 
patients who have died or left the practice), 3,544,589 patients (29.3%) had at least one Read 
code for ethnicity, including unusable codes (not stated, not known, high level). The proportion 
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of patients with at least one usable ethnicity code recorded ranged from 27% (n=3,282,739) for 
the whole of CPRD to 78% for patients registered from 2006 onwards  (n=1,723,195) (Table 5.3). 
 
Figure 5.1 illustrates the low levels of ethnicity completeness for new patient registrations 
between 1995, when ethnicity recording was still new, and 2006, when ethnicity recording 
became financially incentivised under the Quality and Outcomes Framework. The 
completeness of ethnicity recording approaches 90% in 2010 across general practices in the 
CPRD. 
 
 
Figure 5.1 Proportion of patients with valid ethnicity recorded by financial year of registration 
(CPRD) or first attendance (HES) 
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Table 5.3 Overall completeness of ethnicity recording in CPRD (July 2012) 
 All acceptable patients Currently registered Registered April 1st 2006 
onwards 
 N % N % N % 
Total 12,099,672 100.0% 5,308,411 100.0% 2,201,065 100.0% 
Any ethnicity recorded (including not stated, not known) 3,544,589 29.3% 2,605,232 49.1% 1,874,916 85.2% 
% with usable ethnicity recorded (excluding not stated, not known) 3,282,739 27.1% 2,423,438 45.7% 1,723,195 78.3% 
% with only 1 ethnicity on their record 2,802,284 23.2% 2,038,097 38.4% 1,481,112 67.3% 
% with multiple ethnicities on their record 480,455 4.0% 385,341 7.3% 242,083 11.0% 
% with multiple ethnicities which are truly identical 379,591 3.1% 306,771 5.8% 180,455 8.2% 
% with multiple ethnicities which are categorically identical 62,413 0.5% 49,144 0.9% 35,208 1.6% 
% with truly discrepant ethnicity 38,523 0.3% 39,426 0.7% 26,420 1.2% 
% with no usable ethnicity on their record 8,816,933 72.9% 2,854,973 53.8% 486,870 22.1% 
 
Table 5.4 Overall completeness of ethnicity recording in HES (April 2012) 
  Inpatients Outpatients A&E 
 N % N % N % 
Total 51,965,028 100% 48,549,620 100% 31,860,530 100% 
Any ethnicity recorded (including not stated, not known) 51,965,028 100% 48,549,620 100% 31,860,530 100% 
% with usable ethnicity recorded (excluding not stated, not known) 41,281,350 79.4% 17,696,595 36.5% 8,531,890 26.8% 
% with only 1 ethnicity on their record 16,354,201 31.5% 4,608,411 9.5% 5,860,016 18.4% 
% with multiple ethnicities on their record 24,927,146 48.0% 13,088,173 27.0% 2,671,874 8.4% 
% with multiple ethnicities which are truly identical 22,883,676 44.0% 2,589,948 5.3% 2,620,117 8.2% 
% with multiple ethnicities which are categorically identical 652,246 1.3% 34,697 0.1% 7,740 0.2% 
% with truly discrepant ethnicity 1,391,227 2.7% 10,463,828 21.6% 44,287 0.1% 
% with no usable ethnicity on their record 10,683,678 20.6% 30,853,025 63.5% 23,328,640 73.2% 
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Considering differences in the completeness of ethnicity recording by gender and age, we find 
no notable differences by gender (Figure 5.2). By age, ethnicity recording is consistently highest 
for patients aged 40–79 in all years. Recording is markedly lower for patients aged 80 and over or 
19 and under, though this gap diminishes over time (Figure 5.3). 
 
 
Figure 5.2 Proportion of patients in CPRD with any ethnicity code recorded in the same financial year 
as first registration with the general practitioner by gender 
 
Figure 5.3 Proportion of patients in CPRD with any ethnicity code recorded in the same year as first 
registration with the general practitioner by age at registration  
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b) HES population 
All patients in the HES Inpatient, A&E, and Outpatient databases have an ethnicity code attached 
to every attendance or episode. As such, the completeness of ethnicity recording, including 
unusable codes, is 100% across HES, though the proportion of patients with usable ethnicity ever 
recorded varies significantly between the three sub-sets (Table 5.4). 
 
I. HES inpatient population 
A total of 51,965,028 patients contributing 223,451,171 inpatient episodes across 16 years were 
available for analysis. 79.4% (n=41,281,350) of patients had at least one code which was usable. 
The proportion of patients with usable ethnicity recorded improved from 41% for patients who 
were first admitted in 1997, to 86% for patients who were first admitted in 2011 (Figure 5.1). 
 
II. HES accident and emergency population 
A total of 31,860,530 patients contributed 73,085,977 A&E visits across five years. 26.8% 
(n=8,531,890) of these patients had a code which was usable. The proportion of patients with 
usable ethnicity recorded improved from 20% for patients who were first admitted in 2008 to 53% 
in for patients who were first admitted in 2011 (Figure 5.1). 
 
III. HES Outpatient Population 
In total, 48,549,620 patients contributed 574,625,389 outpatient appointments over nine years. 
36.5% (n=17,696,595) of patients had a code which was usable. The proportion of patients with 
usable ethnicity recorded did not improve over time, changing only from 46% in 2003 to 50% in 
2011, though in the intervening years completeness dropped to a low of 22% (Figure 5.1). 
 
5.4.2 Multiple ethnicity recording within each source 
The second objective of this study was to assess consistency of ethnicity coding for individuals 
whose ethnicity is recorded multiple times, both within individual databases and across linked 
databases.  
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a) CPRD Population 
Within the whole of CPRD (N=12,099,672), 4.3% of patients had had their ethnicity recorded 
multiple times. This increased to 7.3% for patients who were currently registered (n=5,308,411), 
and to 11.0% for patients registered from 2006 onwards (n=2,201,065). Amongst patients with 
multiple ethnicity codes on their record, the proportion of individuals whose ethnicity codes were 
either truly identical (at the 16-group level) or categorically identical (at the 5-category level) was 
consistently high, ranging from 89.1% for the 2006+ population, to 92.0% for the currently 
registered and total population (Table 5.3). Figure 5.4 illustrates the flow of data completeness 
and consistency in CPRD. Truly discrepant ethnicity is a problem for 24,253/11,801,879 patients 
(0.2%). Missing and not stated ethnicity is evident for 8,722,182 patients (73.9%). 
 
 Figure 5.4 Ethnicity recording for all patients in the CPRD  
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b) HES Population 
Multiple ethnicities were recorded for 48% of inpatients, 27% of outpatients and 8.4% of A&E 
patients. Amongst patients with multiple ethnicity codes on their record, ethnicity codes were 
either truly identical or categorically identical for 94.4% of inpatients and 98.4% of A&E patients. 
However, for outpatients, the comparable figure was only 20.1%, indicating that the majority 
of those with multiple ethnicity codes could not reliably be classified into a single ethnic group 
(Table 5.4). 
 
I. HES Inpatients 
Figure 5.5 illustrates the flow of data completeness and consistency in the HES inpatient 
database. Truly discrepant ethnicity is evident for 1,391,227 patients (2.7%). Missing and not 
stated ethnicity is evident for 10,683,687 patients (20.6%). 
  
Figure 5.5 Ethnicity recording for all HES Inpatients 
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II. HES Outpatients 
Figure 5.6 illustrates the flow of data completeness and consistency in the HES inpatients 
database. Truly discrepant ethnicity is evident for 10,463,828/48,549,620 (21.5%). Unknown 
ethnicity is evident for 30,853,025/48,549,620 patients (63.5%) 
 
 
 
Figure 5.6 Ethnicity recording for all HES Outpatients  
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II. HES Accident and Emergency 
Figure 5.7 illustrates the flow of data completeness and consistency in the HES A&E database. 
Truly discrepant ethnicity is evident for 44,287/31,860,530 patients (0.2%). Unknown ethnicity 
is a problem for 23,328,640 patients (7.0%). 
 
 
          Figure 5.7 Ethnicity recording for all HES A&E Patients 
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5.4.3 Missing and discrepant ethnicity in linked sources 
In the July 2012 build of the CPRD database, 3,899,648 patients also had linked HES data 
available. Completeness of valid ethnicity was 35.2% for CPRD, 86.4 for HES and 88.9% for the 
combined database. For the 827,753 patients registered from April 1st 2006 onwards, 
completeness was 78.7% for CPRD, 86.3% for HES and 97.1% for the combined database. 
 
To examine matched and mismatched ethnicity between linked CPRD and HES, the analysis was 
restricted to patients registered from 2006 onwards in order to maximise the proportion of 
patients with a valid ethnicity code in both databases. From the 827,753 patients registered from 
April 1st 2006 onwards, 561,502 (67.8%) met this criterion. 
 
When comparing the most commonly recorded ethnicity, 72.7% of patients (408,046/561,502) 
had a matching ethnicity code which belonged to the same 16-level category in both databases. 
This proportion increased to 85.0% (477,364/561,502) when collapsing the 16 categories into 5 
groups (Table 5.5). 
 
Table 5.5 Comparison of matched ethnicity between CPRD and HES using 16 vs. 5 categories 
(N=561,502) 
Most common ethnic group  
in CPRD and HES 
16 categories 5 categories 
  N % N % 
Mismatched 153,456 27.3 84,148 15.0 
Matched 408,046 72.7 477,364 85.0 
 
When using matrices to compare how individuals have had their ethnicity recoded in both 
datasets, the direction of mismatch was similar going from CPRD HES and from HESCPRD. 
Over 96% of individuals coded as White in one database were White in the linked database 
(453,244/470,535). Almost half of all individuals coded as South Asian in CPRD were South Asian 
in HES (17,636/35,708). Going in the other direction, 71% of South Asians in HES were coded the 
same in CPRD (17,636/25,011). Patients coded as Black in CPRD were most commonly coded as 
Mixed in HES. Individuals coded as Mixed in CPRD were most commonly White in HES; however, 
most individuals coded as Mixed in HES were coded as Black in CPRD.  Individuals coded as 
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Other in CPRD were most commonly coded as South Asian or Other in HES; most individuals 
coded as Other in HES were coded as White in CPRD (Table 5.6). 
 
Table 5.8 Proportion of patients with matching ethnicity in linked CPRD and HES (N=561,502) 
  Most common HES Ethnic Group 
Most common CPRD 
Ethnic Group White 
South 
Asian Black Other Mixed 
Equally 
common Total 
White 453,244 1,294 2,082 9,549 2,095 2,271 470,535 
Row % 96.33 0.28 0.44 2.03 0.45 0.48 100 
Column% 97.66 5.17 30.76 45.47 5.36 40.88 83.8 
South Asian 1,545 17,636 498 3,256 11,619 1,154 35,708 
Row % 4.33 49.39 1.39 9.12 32.54 3.23 100 
Column% 0.33 70.51 7.36 15.5 29.74 20.77 6.36 
Black 1,447 452 1,136 1,645 21,873 822 27,375 
Row % 5.29 1.65 4.15 6.01 79.9 3 100 
Column% 0.31 1.81 16.78 7.83 55.99 14.8 4.88 
Other 2,804 4,192 271 3,392 677 495 11,831 
Row % 23.7 35.43 2.29 28.67 5.72 4.18 100 
Column% 0.6 16.76 4 16.15 1.73 8.91 2.11 
Mixed 3,487 770 2,418 2,237 1,754 621 11,287 
Row % 30.89 6.82 21.42 19.82 15.54 5.5 100 
Column% 0.75 3.08 35.73 10.65 4.49 11.18 2.01 
Equally common 1,572 667 363 923 1,049 192 4,766 
Row % 32.98 13.99 7.62 19.37 22.01 4.03 100 
Column% 0.34 2.67 5.36 4.39 2.69 3.46 0.85 
Total 464,099 25,011 6,768 21,002 39,067 5,555 561,502 
Row % 82.65 4.45 1.21 3.74 6.96 0.99 100 
Column% 100 100 100 100 100 100 100 
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5.4.4 Developing a pragmatic method of identifying ethnicity in the CPRD 
The third objective of this study was to develop a simple and pragmatic method for assigning 
ethnicity for patients with multiple discrepant ethnicity codes either within the CPRD alone or 
across linked CPRD and HES.  
 
Based on the results preceding, an algorithm for assigning an individual a single ethnic category 
based on their CPRD record and utilising HES ethnicity when available has been developed. The 
details of the algorithm are displayed in figure 5.8.  
 
 
Figure 5.8 Pragmatic classification of ethnicity for patients in the CPRD 
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Estimates of the ethnic population in the CPRD using this method are shown in figure 5.9. 
Between 1995 and 2010, the proportion of patients with missing ethnicity in their first year of 
registration dropped from 66.15% to 10.93%. This was accompanied by a commensurate 
increase in all coded ethnicities, including “Not stated”, which increased three-fold, from 2.12% in 
1995 to 6.52% in 2010. The proportion of patients coded as being of White ethnicity doubled from 
30.14% in 1995 to 66.49% in 2010. The proportion of patients coded as being of South Asian 
ethnicity increased eight-fold, from 0.93% to 7.37%. The proportion of patients coded as being of 
Black African/Caribbean and Other ethnicity both increased 11-fold, from 0.36% to 3.99% and 
0.29% to 3.10% respectively. The proportion of patients coded as being of Mixed ethnicity 
increased 14-fold, from 0.12% to 1.69%. 
 
 
Figure 5.9 Ethnic makeup of the CPRD population, 1995–2010 
 
  
<1995 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Missing 66.15 67.79 67.89 67.64 68.60 67.61 70.78 70.11 66.58 66.34 65.87 64.56 26.61 12.52 11.82 10.48 10.93
Not Stated 2.12 2.28 3.02 3.93 2.17 2.33 2.31 2.22 3.76 2.45 2.58 2.48 9.21 9.41 8.08 7.35 6.52
Mixed 0.12 0.22 0.21 0.22 0.22 0.26 0.28 0.27 0.36 0.39 0.50 0.54 1.09 1.34 1.51 1.62 1.69
Other 0.28 0.40 0.47 0.48 0.51 0.49 0.52 0.59 0.67 0.90 0.9 1.04 1.82 2.12 2.57 3.14 3.1
Black 0.36 1.01 1.20 0.83 0.93 0.98 1.03 1.15 1.53 1.82 2.07 2.41 3.08 3.38 3.71 3.87 3.89
South Asian 0.83 1.08 0.96 1.14 1.44 1.35 1.56 1.59 1.95 2.12 2.36 2.85 4.62 5.45 6.18 6.61 7.37
White 30.14 27.23 26.25 25.75 26.14 26.99 23.50 24.07 25.14 25.98 25.73 26.13 53.57 65.78 66.13 66.93 66.49
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5.4.5 Comparison of the CPRD Population with the 2011 UK Census Population 
The final objective of this study was to determine whether the ethnic breakdown of the CPRD 
population is consistent with that of the 211 UK Census population.  From the 12,099,672 patients 
contributing to the July 2012 build of the CPRD database, 5,219,411 were active on census day, 
March 27th, 2011. Within this population, 1,446,254 had registered on or after April 1st, 2006.  
 
a) Regional comparison 
Compared with the 2011 Census, the CPRD census day population has a slightly higher 
proportion of individuals from Scotland, Wales and Northern Ireland, and a smaller proportion of 
individuals residing in England (Figure 5.8). 
 
Figure 5.10 Regional breakdown of patients contributing to CPRD and the 2011 UK Census on March 
27th 2011 
 
b) Age comparison 
The age structure of the active CPRD population on census day is virtually identical to that of the 
UK census population, indicating that patients contributing to CPRD are representative of the UK 
population in terms of age. Registrations from 2006 onwards relate to a much younger 
population, as would be expected as this population excludes some older individuals, but 
includes all children born from April 2006 onward. Figures 5.11 through 5.13 illustrate the 
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similarities between the age structures of the CPRD and Census populations by age group, 
gender and ethnic group. 
 
 
Figure 5.11 Comparison of age structure in the 2011 UK Census Population and 2011 CPRD 
Population on March 27th, 2011 
 
 
Figure 5.12 Age structure in the 2011 UK Census Population and 2011 CPRD Population by gender on 
March 27th, 2011 
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Figure 5.13 Age Structure of Census day CPRD population by ethnic group on March 27th, 2011 
 
c) Ethnicity Comparison 
Of the 5,219,411 patients in the CPRD who were active on March 27th, 2011, 42% had ever had 
their ethnicity recorded. The ethnic breakdown of the UK population in the 2011 census is very 
similar to the whole CPRD population on that date, both before and after age standardisation.  
Once restricted to registrations from 2006 onwards, the proportion of non-white individuals in the 
CPRD is slightly higher than in the Census (Figure 5.14).  
 
Figure 5.14 Ethnic breakdown of the CPRD and UK Populations on March 27th 2011 
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5.5 Discussion 
5.5.1 Main findings of this study 
This study compared the completeness of self-reported ethnicity recording in a sample of UK-
wide primary care patients (via the CPRD) and complete records from English secondary care 
via HES. It further investigated generalisability of the primary care data by comparing the ethnic 
breakdown in CPRD with that in the UK census, and explored issues of multiple and discrepant 
recording both within each resource and across linked databases. The study showed that, as of 
2012, valid ethnicity is now being recorded for 86% of newly registered patients in primary care, 
77% of HES inpatients, and 50% of both HES A&E patients and outpatients.  
 
Over 80% of patients in the CPRD and 90% of HES inpatients and A&E patients with multiple 
ethnicities had codes which were either truly identical or fell into the same five high-level groups. 
However, the comparable figure for HES outpatients was only 10%, indicating a high degree of 
instability, limiting the usefulness of this particular dataset.   
 
The ethnic breakdown of the CPRD, which has already been shown to be representative of the 
UK population in terms of age and gender, was found to be comparable to that of the combined 
censuses for England, Wales, Scotland and Northern Ireland.  
 
The overall completeness of ethnicity recording in the whole of CPRD shown here (29.3%) is 
comparable to that of other UK-based primary care databases such as QRESEARCH (33.5%) and 
The Health Improvement Network (33.5%)117, though the latter figure excludes patients with 
discrepant ethnicity. Furthermore, the completeness of usable ethnicity coding shown here for 
HES inpatients is comparable to that found by Jack et al. in 2002/3 (81.1%) and Mindell et al. in 
2003/4 (79%).(122,125) 
 
 
Linkage of the CPRD and HES inpatient data increased the proportion of complete records to 
88.9% overall and to 97.1% for those registered from 2006 onwards. The ability of routine health 
database linkage to reduce missing data has been detailed in a study linking the UK Renal 
Registry (UKRR) to HES inpatient data, and Office for National Statistics Mortality data. Similar to 
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the present study, the authors found completeness of ethnicity recording improved from 75.5% 
in the UKRR to 98.9% after linkage.(119) 
 
Finally, though agreement between HES and CPRD were found to be high overall, this was driven 
primarily by patients coded as being of White ethnicity. For patients of South Asian ethnicity, the 
correlation was only 50%, and it was weaker still for other ethnic groups. The findings here mirror 
those of a recent study which compared ethnicity recorded in HES to the “gold standard” of self-
reported ethnicity as captured in the  2010 Cancer Patient Experience Survey in England.(120) 
The study reported high accuracy of HES coding for patients of White British ethnicity, but far 
weaker agreement for all other ethnic groups. 
 
5.5.2 What is already known on this topic 
We know that routinely collected ethnicity data in UK-based healthcare databases is under-
utilised for observational epidemiological studies. Primary reasons for this include perceptions of 
poor completeness and quality of these data. National programmes targeting the improvement 
of this measure have been implemented, but the completeness and usability of these data are 
not currently audited. Completeness has been shown to be higher in regional databases such as 
the Wandsworth primary care database and the east London primary care database, which, as 
a result of local schemes targeting ethnicity recording, both have reported completeness of 
ethnicity recording over 90% for the past five years.(144,145) 
 
5.5.3 What this study adds 
This study has demonstrated that ethnicity data is being captured for the majority of the 
population in electronic healthcare databases, and that these data are largely complete and 
comparable to those for the general population. Linkage of datasets yields completeness of 
almost 100%, with high levels of agreement for patients of White and South Asian ethnicity. 
 
Previous studies have ascribed patient ethnicity indirectly, via name-recognition software or by 
estimating ethnic population size from census data. Both these methods are of questionable 
validity, particularly for individuals of mixed ethnicity and for descendants of migrants.(68-71)  
Chapter 5: Completeness of ethnicity data in UK health databases 
81 
 
Though these methods have been useful for certain situations in the past, they are increasingly 
less useful now, especially in countries such as the UK, where large proportions of current ethnic 
minority groups are UK born. Looking forward, there is little alternative to routine recording if we 
wish to study ethnicity in the long run. 
 
With respect to primary care, this study shows that the recording of valid ethnicity for new patients 
registering with general practice across the UK has improved dramatically following 
incentivisation under the Quality and Outcomes Framework. For secondary care, we have shown 
that the overall completeness of valid ethnicity for HES inpatients has been high for over a 
decade. As such, we recommend that the ethnicity data held in primary care databases, 
particularly for patients registered from 2006 onwards, and for hospital inpatients, can and should 
be more widely used for research, commissioning and audit purposes, particularly given the 
potential of linking to other resources, such as disease registries, birth and death registers, 
laboratory results and medication databases.  
 
5.5.4 Limitations 
The trade-off for maximising completeness of ethnicity is age selection. While the population from 
2006 onwards includes all children and is thus representative for studies examining ethnicity and 
care patterns in this group, for older patients the study population will be partially missing, though 
the level of bias this introduces will depend greatly on the research question and study design.  
 
Potential problems with the remaining HES datasets include poor completeness (particularly for 
A&E) and poor consistency of ethnic group coding (for outpatients). The trends shown in the 
analysis above suggest that completeness of valid coding in these sources is improving. It is 
possible that prioritising the recording of valid ethnicity in these settings, perhaps via financial 
incentivisation as in primary care, may facilitate this process. 
 
For researchers interested in using routinely recorded ethnicity data, it is important to be aware 
of the biases that may arise from using incomplete data. The likelihood of having missing 
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ethnicity may not be random, and instead be related to factors such as the circumstances in 
which patients are admitted, pressures on the available staff and lack of time or opportunity to 
ask the patient about their ethnicity. As none of these service-level factors are recorded in routine 
health databases, we cannot estimate the impact these may have on the completeness of 
ethnicity data.  
 
Turning to biases from inconsistent data, though patients with discrepant ethnicity accounted for 
a very small proportion of all those included in our analysis, utilising the most commonly recorded 
ethnic group for these patients proved a reasonable approach in our analysis. In our study of 
linked datasets, individuals with more than one ethnicity recorded equally commonly 
represented less than 1% of the sample. For this group, using the latest ethnicity recorded instead 
of excluding them entirely would maximize usable patient data. 
 
Further bias may have arisen from the possibility that the quality of ethnicity recording varies 
between general practices. The proportion of patients with usable ethnicity may have varied 
between the practices contributing to the study and will warrant future investigation. In general, 
the data quality of practices that choose to contribute to the CPRD is higher than the average 
nationally, and thus this variability may have been minimal.  
 
This study did not explore ethnicity beyond what was recorded in routine databases. Though the 
collection of self-reported ethnicity for all patients is the gold standard across the NHS, it is likely 
that data are collected in a range of non-standardised ways across a variety of non-standardised 
situations. This is a fundamental challenge of using routinely recorded health data for 
observational studies. Furthermore, due to the observational nature of this study, we are not in a 
position to explore the reasons why ethnicity is not recorded, or recorded inconsistently over time 
and between data sources. 
 
Relying on observational data meant that we were unable to “validate” whether the ethnicity data 
held in the databases was correct, according to how patients would actually classify themselves. 
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Furthermore, this study was unable to account for any actual changes in the self-perceived 
ethnicity that the patient may have experienced. Any differences in ethnicity were classified as 
discrepancies rather than true differences, as this would be impossible to ascertain without 
contacting the patient directly. 
 
5.6 Conclusions 
The importance of ethnicity in explaining differences in patterns of disease, healthcare usage and 
outcomes is widely recognised. Previous research has been hampered by deficits in the quality 
of routine data and insufficiency of estimation methods. This study has demonstrated that the 
completeness and consistency of routinely recorded ethnicity data in UK-based primary and 
secondary care have largely improved over time and, with certain caveats, can be usefully 
incorporated into health research.  We have highlighted dramatic improvements in the quality of 
primary care ethnicity data, particularly since the incentivisation of ethnicity recording in 2006.   
 
Completeness of ethnicity information also appears to have been consistently high over the last 
decade in hospital inpatient settings, but there is still much room for improvement in A&E and 
outpatient settings. The concept of ethnicity is a moving target, with the relevance and meaning 
of ethnic categories perpetually evolving over time. To maximise the value of routinely recorded 
ethnicity data, both researchers and healthcare professionals must work in tandem to 
continuously improve both the quality of these data and their impact via timely research. 
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Chapter 6  
Improving the identification of diabetes mellitus in 
electronic health records 
 
6.1 Summary 
This chapter describes the background and methods for the second study of the thesis, 
exploring methods of improving the classification of diabetes and identifying ethnic 
differences in incidence and prevalence. The chapter begins with a brief overview of the 
current literature on diabetes mellitus and ethnicity, outlining the most up to date definitions of 
diabetes subtypes, and describing the global burden of diabetes and known risk factors. 
Challenges of accurately classifying diabetes type from electronic health records and 
initiatives being undertaken by the UK Biobank study to tackle this, the methods pertaining to 
the execution of the diabetes classification algorithms and resulting analyses of prevalence 
and incidence are described. The results of the study and discussion of the findings are 
presented in chapter 7. 
 
6.2 Diabetes Mellitus Classification 
The term diabetes mellitus refers to a cluster of metabolic diseases characterized by chronic 
hyperglycaemia due to deficiency in either the production or action of the hormone insulin. 
The body uses insulin to regulate blood glucose levels and maintains normal levels by 
balancing the hormone’s production and secretion. The pathophysiology of diabetes is 
complex, with genetic, lifestyle, early life and environmental exposures all playing a role in its 
aetiology.(146–148) There are four main subtypes of diabetes, broadly classified according to 
aetiology: type 1 diabetes; type 2 diabetes; diabetes due to specific mechanisms, such as 
disease; and gestational diabetes.(149) 
 
Type 1 diabetes mellitus (T1DM, previously known as insulin-dependent or childhood-
onset/juvenile diabetes) is characterized by a complete lack of insulin production caused by 
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the autoimmune destruction of pancreatic β-cells. T1DM accounts for between 5% and 10% 
of all diabetic cases and onset typically occurs in childhood or young adulthood, though it can 
occur at any age.(149) Management of T1DM requires continuous insulin treatment in order 
to simulate the function of the β-cell.(150)   
 
Type 2 diabetes mellitus (T2DM, formerly referred to as non-insulin-dependent or adult-onset 
diabetes) accounts for 90–95% of the total diabetes burden worldwide. T2DM has a complex 
and multifactorial pathogenesis resulting in two main deficiencies, decreased insulin secretion 
and resistance to insulin action, resulting in inadequate removal of excess blood glucose. 
Primarily caused by excess body weight, particularly around the abdomen, T2DM tends to 
develop later in life. Recent studies have demonstrated increased incidence in teenagers and 
young adults, most commonly amongst those who are obese.(149) Most Individuals with 
T2DM do not require insulin to survive. Less severe forms of the disease can be treated with 
weight reduction, dietary modification and exercise, while therapeutic management with 
metformin and other antidiabetic drugs is used in more severe cases. At the most severe end 
of the treatment spectrum, surgery can be used to assist weight loss and metabolic 
regulation.(151)  
 
Further types of diabetes include gestational diabetes, maturity-onset diabetes of the young 
(MODY), drug- or chemical-induced diabetes, genetic diabetes and idiopathic diabetes (of 
unknown aetiology). Pre-diabetic states, where glucose levels are above normal but not high 
enough to be classified as diabetes, include impaired glucose tolerance (IGT) and impaired 
fasting glucose (IFG).(152) 
 
Chronic diabetes mellitus causes abnormalities in the metabolism of protein, fat and 
carbohydrates, resulting in long-term damage to the kidneys (nephropathy), eyes (retinopathy) 
and nerves (neuropathy), and increases the risk of cardiovascular disease and premature 
death by up to four-fold compared with individuals without diabetes.(153–158)  
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6.3 The global burden of type 2 diabetes 
Diabetes presents one of the largest public health concerns globally, with prevalence 
increasing rapidly, particularly in low- and middle-income countries, as a result of rapid 
urbanization and the adoption of western lifestyles and diets.(159–167) In 2014, the 
International Diabetes Federation reported that T2DM affects approximately 381.8 million 
people globally, with the number projected to increase to 592 million by 2035. Globally, 80% of 
people with diabetes live in developing countries.(168) Prevalence of diabetes is highest 
amongst individuals of originating from the Pacific Island regions of Melanesia, Micronesia 
and Polynesia, in both native and migrant populations. In 2010, the World Health Organization 
reported that the prevalence of obesity across 10 Pacific Island nations was over 30%, with 
prevalence of non-communicable disease at 40%.(169) Contemporary studies estimate the 
prevalence of diabetes to be 40% in Pacific Island communities and 18% in the North 
American diaspora community.(170,171) 
 
India and China host the largest number of diabetic cases worldwide. Given that these two 
countries are both experiencing both rapid population and economic growth, it is estimated 
that they will continue to do so through to 2035.(172,173)  
 
6.4 Risk factors for type 2 diabetes 
Obesity is the primary driver of the epidemic of type 2 diabetes worldwide. Over 80% of people 
with type 2 diabetes are overweight or obese.(174) Increased consumption of calorie-dense 
foods and the normalization of sedentary lifestyles resulting from rural to urban migration are 
largely responsible for increases in obesity. Obesity can trigger abnormalities in β-cell function, 
which increase the body’s resistance to the actions of insulin, resulting in hyperglycaemia and 
diabetes.(175) It is not generalized obesity, but centralized obesity, which has metabolic 
consequences.(175–178) Individuals who tend to store more fat in the abdominal area are 
considered to be at high risk of metabolic and cardiovascular disease, regardless of whether 
or not they are obese according to standard criteria.(152)  
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Epigenetic factors such as the intrauterine and postnatal environment have been shown to be 
strongly linked to future risk of type 2 diabetes via a mechanism known as fetal 
programming.(179) 
 
Family history of diabetes is associated with a two- to four-fold increase in type 2 diabetes risk, 
indicating a hereditary component to disease pathophysiology.(180,181)  Genome studies 
have identified over 50 genetic abnormalities associated with type 2 diabetes, which, even 
when combined, explain less than 15% of type 2 diabetes risk.(182,183) Though these 
abnormalities can be broadly correlated to ethnicity, currently there is no clear understanding 
of how they contribute to the pathophysiology of the disease, nor whether continued research 
into genetic markers will yield any benefit in terms of treatment or outcomes.(184)(185) 
Diabetes and cardiovascular disease interact synergistically, with the presence of one 
increasing the risk of the other.(148)   
 
The two primary goals of pharmacological treatment for diabetes are to control levels of blood 
glucose and prevent weight gain.(186–188) The glucose-lowering medications recommended 
for glycaemic control in type 2 diabetes can increase weight and negate the beneficial effects 
of reduced hyperglycaemia.(188,189) Weight loss can substantially reduce the incidence of 
type 2 diabetes and related complications.(190,191) 
 
6.5 Mechanisms of Increased Risk amongst South Asian Populations 
The prevalence of type 2 diabetes varies significantly by ethnic group, with the prevalence 
highest for individuals of South Asian ethnicity, both in native and migrant populations. Ethnic 
disparities in type 2 diabetes can be traced to differences in the underlying disease process; 
while insulin resistance is the primary driver of type 2 diabetes in South Asians populations, in 
other groups diabetes is predominantly caused by β-cell dysfunction.(192,193)  
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Amongst South Asian groups, onset of type 2 diabetes occurs, on average, a decade earlier 
than in White/European groups, and at lower levels of conventional risk factors such as age 
and body mass index (BMI).(192,194,195) Furthermore, South Asian populations have a higher 
incidence of adverse events and mortality than other ethnic groups. In particular, the age-
adjusted incidence of death from CHD amongst those with type 2 diabetes is increased by 
50% in South Asian groups.(196)   
 
Several mechanisms which put South Asian populations at increased risk of type 2 diabetes 
compared with other ethnic groups are discussed below.  
 
6.5.1 Greater insulin resistance 
Studies in India, the UK and the United States have demonstrated that South Asian populations 
exhibit higher levels of insulin resistance than the White population, regardless of age, gender 
or BMI.(197–201) The prevalence of insulin resistance is also increasing at a faster rate 
amongst children and adolescents of South Asian ethnicity compared with White ethnicity, 
resulting in young-onset type 2 diabetes.(202,203) 
 
6.5.2 Body composition 
Though South Asian people tend to have a lower BMI than other ethnic groups, they tend to 
store more fat in the abdominal region than other ethnic groups. As a result, the prevalence of 
type 2 diabetes in the South Asian population is higher than would be anticipated by the 
degree of obesity as measured by BMI.(204,205) In order to recognize that diabetes and 
cardiovascular risk is heightened at lower levels of BMI in this population, the World Health 
Organization has recommended revised cut-offs of 23 kg/m2 and 25 kg/m2 be used to delineate 
overweight and obesity respectively, revised down from the standard cut-offs of 25kg/m2 for 
overweight and 30 kg/m2 for obesity.(11,206) 
 
6.5.3 Thrifty Genotype and Thrifty Phenotype 
The thrifty genotype hypothesis posits that evolutionary traits which allowed individuals to 
survive in famine conditions by storing excess energy during historic periods of “feast or 
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famine” have now turned into an evolutionary disadvantage by predisposing individuals to 
diabetes in the current period of “continuous feasting”. According to Bhopal & Rafnsson, this 
may affect South Asian groups disproportionately, via the biological mechanism of 
‘mitochondrial efficiency’.(207) The hypothesis suggests that South Asian populations, and 
other groups adapted to living in warm climates, may be at increased susceptibility to diabetes 
and cardiovascular disease due the energy-conserving actions of mitochondria in response 
to environmental and nutritional pressures.  
 
The thrifty phenotype hypothesis suggests that diabetes risk may be increased amongst 
individuals who experience an unfavourable intrauterine environment as a result of maternal 
malnutrition or maternal hyperglycaemia. This nutritional scarcity may lead to changes in 
metabolism which protect the body from food shortages. While these changes may be 
beneficial in the neonatal and early life period, they may become detrimental in a nutrition-rich 
environment.(208)  
 
6.6 Type 2 Diabetes in the UK 
The combination of a genetic predisposition to diabetes, the stresses of migration and the 
immersion in western environment greatly increases the risk of diabetes amongst migrants to 
more affluent countries such as the UK, and serves to outweigh the benefits of the healthy-
migrant effect.(36,209–213) Currently in the UK, migrants comprise 13% of the UK population, 
the majority of whom are of South Asian origin, and at the highest risk of developing type 2 
diabetes and related complications.(214) 
 
In the UK 3.2 million people are currently diagnosed with diabetes mellitus, contributing to an 
overall prevalence of 6.0.%(215) Type 2 diabetes accounts for roughly 90% of all diagnosed 
cases, and has a prevalence of 5.4%. The prevalence of diabetes increases dramatically with 
age, ranging from 0.24% in those aged 0–9 to 26.3% in those aged 60–69. The prevalence is 
higher in men than women, with 56% of cases occurring in men and 44% in women in the 
UK.(216) 
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Compared with the White UK population, the prevalence of type 2 diabetes is 6 times higher 
in South Asian and 3 times higher in Black African/Caribbean populations.(26)(217)(218) Type 
2 diabetes is also increasingly prevalent amongst children in the UK, with girls of South Asian 
ethnicity being at highest risk. According to the National Paediatric Diabetes Audit, children of 
South Asian ethnicity are 8.7 times more likely to have type 2 diabetes than White children. 
Correspondingly, children of Black African/Caribbean ethnicity are 6.2 times more likely to 
have the condition than White children.(219) 
 
6.7 Identifying diabetes mellitus from electronic health records 
Accurate diagnostic coding of disease is an essential first step towards identifying patterns of 
disease and targeting interventions and resources appropriately. This is of particular 
importance for diabetes mellitus, which has a range of types and subtypes with differing 
aetiology but similar presentation.(152,220) Though diabetes subtypes are classified 
according to aetiological process, methods to identify the pathogenesis of diabetes are not 
yet satisfactory. As such, it is not always possible to accurately identify the correct diabetic type 
at initial presentation. 
 
Identifying diabetic disease and assigning diabetic type largely depend on the information 
available at the time of diagnosis. Because different diabetic types can often present in a 
similar fashion, further investigation over time can reveal mistakes in the initial diagnosis. In 
routine primary care records, where historical data cannot be removed, this can lead to the 
presence of multiple contradictory diagnostic codes, vague codes where the diabetic type 
cannot be determined, or incorrect diagnoses being carried forward.   
 
All of these problems fall under the three main types of diagnostic error: misclassification, 
miscoding and misdiagnosis. Misclassification is when the patient is coded as the wrong 
diabetic type; miscoding is when the diagnostic code is too vague or at too high a level to 
Chapter 6: Improving the identification of diabetes mellitus in electronic health records 
91 
 
allow identification of diabetes type; and misdiagnosis occurs when a patient who is not 
diabetic is coded as having the disease. 
 
In UK primary care, diagnostic codes for diabetes fall under the Read hierarchy of C10% (Table 
6.1). When electronic health records were introduced in primary care in the early 1990s, no 
guidelines on the coding of diabetes were available. Several studies have demonstrated great 
variation in coding of diabetes. These variations stem from the use of different clinical systems 
which utilize different modes of data entry and the evolution of terminology for diabetes – most 
importantly the move away from insulin-dependent/non-insulin-dependent to type 1 and type 
2 diabetes mellitus.(221)   
The Quality and Outcomes Framework has made the accurate coding of diabetes a payment 
trigger, and thus streamlined the coding of diabetes in primary care records. When first 
introduced in 2004, the use of any code under the C10% hierarchy was adequate to trigger 
payment. In 2006, this was restricted to the use of the codes under the C10E hierarchy for type 
1 diabetes and codes under the C10F hierarchy for type 2 diabetes. The rationale for this 
change was to make QOF indicators more comparable to the NICE guidance, which 
distinguishes between the type 1 and type 2 diabetes.(222) Miscoding stemming from the use 
of vague codes has also decreased because these patients will not appear on practice 
diabetic registers and thus practices cannot be paid for them. 
 
Table 6.1 High level classification of type 1 and type 2 diabetes mellitus 
Read code Description 
C10 Diabetes mellitus 
C100  Diabetes mellitus with no complications 
C108-1 Insulin dependent diabetes mellitus 
C109-1 Non-insulin dependent diabetes mellitus 
C108-2 Type 1 diabetes mellitus 
C109-2 Type 2 diabetes mellitus 
C108-3 Type I diabetes mellitus 
C109-3 Type II diabetes mellitus 
C1000 Diabetes mellitus of juvenile onset with no complications 
C1001 Diabetes mellitus of adult onset with no complications 
C10E Type 1 diabetes mellitus 
C10F Type 2 diabetes mellitus 
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The consequences of improper classification of diabetes have been summarised in a 2010 
systematic review of articles describing diabetic coding.(220)  These include inappropriate or 
delayed treatment, failure to identify correct risk factors, psychological effects on the individual 
and their family, unnecessary treatment resulting in resource wastage, and poor validity of 
primary care data for audit and research purposes.(220) 
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6.8 The UK Biobank Study 
The UK Biobank is a prospective cohort study established by the Medical Research Council 
and Wellcome Trust. Between 2006 and 2010, half a million men and women aged 40–69 were 
recruited for the purpose of investigating genetic, lifestyle and environmental risk factors for 
major chronic diseases such as cancer, diabetes, heart disease and stroke.(223) This study 
population will be followed up prospectively over the next several decades and all data 
collected as part of the study will be freely available for use by any researchers wishing to 
conduct health-related research that is of public benefit.(224) 
 
Linkage to national electronic health databases such as the Hospital Episode Statistics for 
England (HES) and the National Cancer Registry is being used to identify incident disease 
occurring after the baseline interview for all Biobank participants. Since improper or imprecise 
coding of disease can affect case ascertainment and subsequent attempts to characterise the 
relationships between risk factors and outcomes,  a key objective of the Biobank programme 
is to improve the identification and classification of diagnoses in routine medical records.(224) 
This is being piloted across several disease domains, including diabetes, via the use of 
outcomes adjudication groups, whose role it is to identify and validate disease events by 
cross-referencing reported outcomes with other sources of supporting data.(225)  It is 
envisaged that incident case identification for diabetes will occur via linkage to primary care 
records, a process which has been piloted using Welsh primary care data, and is described in 
section 6.9.   
 
Improving the ascertainment of diabetic type is of particular importance. In addition to the 
27,564 cases of diabetes present at baseline in the Biobank cohort, it was projected that 20,000 
further cases of diabetes would have been  identified by 2015.(226)(223) As such, the Biobank 
cohort is designed to provide great statistical power to studies looking to typify relationships 
between diabetes and its risk factors and outcomes.  
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The algorithms developed for the Biobank study are the most current iteration of a diagnostic 
toolkit designed to counteract the most common  
diagnostic errors as identified studies in London and the southeast of England. The algorithms 
for classification of diabetes follow the general principles for outcomes adjudication as defined 
by the Biobank study(225):         
1. to use a staged approach to ascertain, confirm and sub-classify disease 
2. to avoid false positive cases, but tolerate some false negative cases 
3. to be geographically generalizable, scalable, cost-effective and future proof. 
 
6.9 Rationale 
In November 2014, Medline was completed by myself to identify published articles utilizing the 
CPRD to examine ethnic differences in diabetes mellitus. The search showed that no study 
had been undertaken to quantify ethnic differences in the incidence and prevalence of 
diabetes mellitus in the CPRD. The following study set out to examine whether estimates of 
diabetes burden by ethnic group using the observational data held in the CPRD are 
comparable to those found in cohort and interventional studies undertaken throughout the 
UK. 
 
Diabetes mellitus is the largest public health problem facing the UK. Its increasing prevalence 
means that significant numbers of cases are available in the CPRD. Since the disease is 
predominantly managed in primary care we are likely to pick up the vast majority of cases in 
our database. Furthermore, findings from this research can be translated into action to address 
inequalities since the majority of diabetes risk is attributable to modifiable risk factors. Should 
the data in the CPRD be found usable to examine ethnic inequalities in outcome, the scope 
for research into ethnicity and diabetes and opportunities for timely and high-impact research 
at a low cost are expanded. 
 
The purpose of adjudicating disease outcomes is two-fold: firstly, to enhance power by 
improving identification of disease cases; and secondly, to increase specificity of classification 
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by differentiating between conditions of similar presentation but different aetiology.(225) 
Though linkage of primary care records for a proportion of Biobank participants has been 
achieved in Wales and Scotland, no linkage to English, Scottish or Irish primary care yet exists.  
 
The algorithms designed to adjudicate diabetes cases were developed by a team at the 
University of Surrey led by Simon de Lusignan using the Welsh data held in the Secure 
Anonymised Information Linkage Databank (SAIL) at the University of Swansea. Though the 
algorithms as designed required the use of ethnicity data to help adjudicate diabetes type, no 
ethnicity data were available at the time of development and thus the results from the initial 
derivation cohort may underestimate the prevalence of type 2 diabetes in ethnic minority 
subgroups in the SAIL database population.  
 
The present study sought to improve on the original implementation by utilizing the patient-
level ethnicity data available in the CPRD. Additionally, the performance of these algorithms in 
the CPRD was examined, as improving classification of diabetes by ethnic group is a critical 
first step towards validating these algorithms for use in other, more diverse settings. The 
increased specificity of diabetes diagnoses across the CPRD population will greatly improve 
power to identify ethnic differences in patterns of diabetes prevalence and incidence in large-
scale epidemiological studies using this resource.   
 
6.10 Study objectives and hypotheses 
The objectives of this study were to: 
1. Implement three algorithms designed to improve the classification of type 1 and type 
2 diabetes mellitus and develop a simplified version of the algorithms which does not 
require the use of linked HES data. 
2. Compare the performance of the algorithms with respect to improving the coding and 
classification of diabetes type between the Welsh SAIL database, where the algorithm 
was derived, and the CPRD. 
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3. Determine ethnic differences in the prevalence and incidence of type 1 and type 2 
diabetes over time using populations derived from the algorithms.  
4. Examine ethnic differences age at onset of type 1 and type 2 diabetes, and BMI value 
at diagnosis. 
5. Quantify differences in the incidence of type 1 and type 2 diabetes for South Asian and 
Black/Caribbean subgroups. 
 
The hypotheses of this study were: 
a) The use of algorithms incorporating routinely recorded information on prescribing, 
clinical measures and competing diagnoses will improve the classification of diabetic 
type over the use of diagnostic Read codes alone. 
b) The prevalence and incidence of type 2 diabetes will increase over time, with 
incidence highest for South Asian followed by Black African/Caribbean and White 
groups. 
c) Onset of type 2 diabetes will be earlier in South Asian groups compared with White 
and Black African/Caribbean groups. 
d) The BMI value closest to the date of diabetes diagnosis will not vary by ethnicity for 
T1DM, but be lower for the South Asian in comparison with the White group for T2DM. 
 
6.11 Methods 
All clinical and therapeutic data were extracted from the August 2013 build of the CPRD for all 
patients with at least one diagnostic Read code for diabetes mellitus (see Appendix).   
 
6.11.1 Data Extraction 
a) Diagnostic Read codes for diabetes mellitus 
Each individual Read code was assigned to one of seven categories (type 1 
definite/probable/possible, type 2 definite/probable/possible, or other). If a patient had 
multiple Read codes falling into any one category, the earliest recorded code of each type was 
retained for analysis (Table 7.1).  
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Table 6.2 Categorization of Read codes for diabetes mellitus 
 Type 1 Diabetes Type 2 Diabetes Other 
Definite Type 1 DM: C10E 
Not 
contradicted/ceased/superseded 
Type 2 DM: C10F 
Not 
contradicted/ceased/superseded 
Gestational L180 
Genetic C10c-
C10D 
Other/Secondary  
C10G-J, L-N, 
C11y0 
Insulin resistance: 
C10K, C1098, 
C10F8 
Ceased: 21263, 
212H 
Probable IDDM: C108 
Adult onset: C1073 
Gestational: L1805 
Not 
contradicted/ceased/superseded 
NIDDM: C109 
Gestational: L1806 
Gestational: L180X 
Not 
contradicted/ceased/superseded 
Possible Diabetes mellitus, adult onset: 
C10z1 C10y0 C110 
Not 
contradicted/ceased/superseded 
Diabetes mellitus, adult onset: 
C10%, C112 (z), L180x  
Not 
contradicted/ceased/superseded 
 
b) Clinical Measures 
For each clinical measure, the value closest to the date of diabetes diagnosis was retained for 
analysis.  
 
III. Body Mass Index 
Body mass index values were either taken directly from the value associated with the clinical 
Read code for BMI (22K) or calculated using height and weight values recorded in the CPRD 
additional file using the equation (weight/height2).  Implausible values for height (below 1.37 
m and over 2.3m) were removed. Values over 100 which could reasonably be considered to 
have been measured in centimetres were converted to metres. Similarly, implausible values 
for weight (<25.4kg or >254kg) were removed. If a patient had multiple height or weight values 
recorded on the same day, the difference between the smallest and largest values was 
calculated; if the difference was less than or equal to 5 cm for height or 2 kg for weight, the 
average of the values was taken. If the difference was any larger, the records were dropped. 
BMI values were collapsed in a dichotomous variable for obesity, defined as a BMI >30 kg/m2. 
 
For the purposes of examining BMI at disease onset, the BMI value closest to the date of 
diagnosis for both type 1 diabetes and type 2 diabetes was selected. This value could have 
been before or after the diagnosis date. 
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IV. Hyperglycaemia 
Glycated haemoglobin (HbA1c) and blood glucose values were obtained from the test results 
file of the CPRD. Hba1c values were converted to % if recorded as mmol/mol and. HbA1c 
values greater than 20% and blood glucose values greater than 50 were removed due to being 
outside of the plausible value range. A dichotomous variable was constructed for analysis, 
where patients were considered to have hyperglycaemia if they had an HbA1c value over 6.5% 
or a blood glucose value of greater than 11.1 mmol/L at the date of diabetes diagnosis. 
 
c) Medications 
All medications falling under the British National Formulary (BNF) headings of “6.1.1 Insulins” 
and “6.1.2 Antidiabetic drugs” were extracted from the Therapy file of the CPRD. The 
antidiabetic drugs were split into two groups of “Metformin” and “Other antidiabetic drugs” to 
create three drug categories in total. Insulin was considered to be “non-continuous” if there 
was a gap of 6 months or more between any two prescriptions between the date of diabetes 
diagnosis and August 2013. 
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6.11.2 Description of the algorithms 
 
a) Flowchart 1: Assigning initial diabetic classification  
The first of the three Biobank algorithms provided an initial diabetes classification for each 
patient, based on diagnostic Read codes alone. Patients with type 1 or type 2 diabetes were 
classified using a hierarchical method starting with definite codes and stepping down to 
probable codes and then possible codes. Patients whose only diabetes codes were subtype 
specific were classified separately (Figure 6.1). 
 
 
Figure 6.1 Flowchart 1: Initial Sort and Classification of diabetes type  
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b) Flowchart 2: Improving classification of type 1 diabetes 
The second algorithm further refined the classification of patients initially identified as having 
type 1 diabetes by utilizing supporting information which allowed patients to retain their 
classification as type 1 diabetics, or to be reclassified as having either type 2 diabetes or 
gestational diabetes. Supporting information – including prescriptions of diabetic medications 
(insulin, metformin and other antidiabetic drugs), pregnancy, hospitalizations, body mass 
index, age, gender and ethnicity –  was used to detect potential errors in the classification of 
type 1 diabetics.  
 
The RCGP algorithm at step 2.8 classified patients as probable type 2 diabetics if they were: 
aged 35 or over at date of diagnosis if White; aged 30 or over at date of diagnosis if non-White; 
obese at date of diagnosis (BMI >30) (Figure 6.2). In the original derivation cohort, the RCGP 
algorithm considered only age and obesity, as ethnicity data were not available.  
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Figure 6.2 Flowchart 2: Detecting errors in T1DM  
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c) Flowchart 3: Improving classification of type 2 diabetes 
The third algorithm further refined the classification of patients initially identified as having type 
2 diabetes by utilizing supporting information which allowed patients to retain their 
classification as type 2 diabetics, or to be reclassified as having type 1 diabetes, polycystic 
ovary syndrome, gestational diabetes, or not diabetes (Figure 6.3). In addition to the supporting 
information used in flowchart 2, diabetic hyperglycaemia defined as HbA1c >6.5% or raised 
blood sugar of >11.1 mmol/L was used in step 3.5. 
 
 
Figure 6.3 Flowchart 3 Detecting errors in T2DM  
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6.11.3 Description of the simplified algorithms 
 
a) Flowchart 2: Improving classification of type 1 diabetes 
In the full Biobank algorithm for detecting errors in T1DM (Flowchart 2), information on hospital 
admissions is required at step 2.5 as a possible explanation for a gap of 6 months or more in 
insulin prescription in the GP record. Though hospital data were available for all participants 
in the original derivation cohort in the SAIL database, hospital admission data were available 
for only half of the practices contributing to the CPRD that consented to additional linkages. In 
order to tailor the algorithms for use in the CPRD, a simplified version of the algorithm removing 
this step was tested, and results were compared between the two versions.  
 
b) Flowchart 3: Improving classification of type 2 diabetes 
In the full Biobank algorithm for detecting errors in T2DM (Flowchart 3), women with a 
pregnancy recorded within 12 months of hyperglycaemia are categorized as having 
gestational diabetes at step 3.8. After discussion with the Biobank team, it was agreed that this 
combination does not rule out the possibility that the individual could have type 2 diabetes. In 
the simplified version of Flowchart 3, step 3.8 was removed and results between the two 
versions were compared. 
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6.11.4 Calculating prevalence and incidence of T1DM and T2DM 
A prospective cohort study was conducted to examine the prevalence and incidence of type 
1 and type 2 diabetes in the CPRD.  
 
a) Participants 
All patients identified as having type 1 diabetes at the end of Flowcharts 2 and 3 were included 
in the analysis of the prevalence and incidence of type 1 diabetes if they had a diagnosis code 
for T1DM with a date attached.  Similarly, all patients identified as having type 2 diabetes at 
the end of Flowcharts 2 and 3 were included in the analysis of incidence and prevalence of 
type 2 diabetes if they had a diagnosis code for T2DM with a date attached.  
 
b) Prevalence analysis 
For the study of disease prevalence, the outcome was all individuals with a diagnosis of 
diabetes at the midpoint of each calendar year from 1990 to 2013. Point prevalence was 
calculated by dividing the number of individuals with diabetes by the number of acceptable 
patients in the CPRD on July 1st of each year. Prevalence of both type 1 and type 2 diabetes 
was presented both as an overall proportion and broken down by calendar year, five-year age 
band, gender and ethnic group. Indirect standardisation against the European standard 
population was used for the 2012 population in order to compare crude and standardised 
prevalences for the whole study population, and by ethnic group and gender for 2012, the 
latest full calendar year of data available.(227) 
 
c) Incidence analysis 
For the study of disease incidence, the outcome was first diagnosis of type 1 or type 2 diabetes 
between January 1990 and August 2013. Individuals with a first diagnosis prior to 1990 were 
excluded from the analysis. Incidence was calculated by dividing the number of newly 
diagnosed patients by the number of person-years of follow-up of all eligible patients 
contributing to the CPRD.  
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Crude incidence rates of diabetes per 10,000 person years of follow-up time were calculated 
for patients with either T1DM or T2DM. For the analysis, the start of follow-up was defined as 
the date at which the practice became up to standard or 6 months after the registration date, 
whichever was the later. 
 
Follow-up time ended at the date of first diagnosis of type 1 or type 2 diabetes. For patients not 
diagnosed with diabetes, follow-up time was censored at the earliest of date of transferring 
out of the practice, date of latest data collection, death, or August 1st 2013.  
 
To examine trends by calendar year, Cox proportional hazards regression with time since 
study entry as the timescale was used to evaluate the risk of diabetes in all patients between 
January 1990 and August 2013, broken down by five-year age band, gender and ethnic group. 
To evaluate trends by age group, Cox proportional hazards using age as the timescale was 
used. 
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Chapter 7  
Quantifying ethnic differences in incidence and 
prevalence of diabetes mellitus 
 
7.1 Summary 
This chapter outlines the implementation of the series of three algorithms described in chapter 
6, designed to improve the classification and reduce misdiagnosis of patients diagnosed with 
type 1 and type 2 diabetes mellitus using routinely recorded diagnostic, therapeutic and 
clinical data. The resulting estimates of the incidence and prevalence of type 1 and type 2 
diabetes according to calendar period, ethnic group, age and gender are then reported and 
the utility of the CPRD for examining ethnic differences in diabetes is discussed. 
 
7.2 Results of the diabetes adjudication algorithms 
The first objective of this study was to implement the three algorithms and to develop a 
simplified version of the algorithms which doesn’t require the use of linked HES data. 
 
7.2.1 Numbers of patient identified by algorithms  
From a total of 15,000,986 patients contributing to the August 2013 build of the CPRD, 
10,641,428 were registered for a minimum follow-up period of 6 months and had data that was 
of acceptable research quality (Figure 7.1).  
 
a) Flowchart 1: Assigning initial diabetic classification 
From the total of 10,641,428 acceptable patients, 391,994 had at least one diagnostic Read 
code for diabetes. At the end of Flowchart 1, which assigns each patient an initial diabetic type 
based on Read codes alone (page 95), 33,575 patients were classified as having type 1 
diabetes (8.6%), 343,047 were classified as having type 2 diabetes (87.5%) and 15,002 patients 
were classified as having any other sub-group of diabetes (3.8%) (Figure 7.2).  
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Figure 7.1 Cleaning of the CPRD Denominator 
 
Figure 7.2 Initial Sort and Classification Results 
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b) Flowchart 2: Improving the classification of type 1 diabetes 
Flowchart 2 was used to refine the classification of type 1 diabetes using supporting 
information such as medications, hospital admissions and clinical measures (page 96). The 
results of the second algorithm are displayed in Figure 7.3. A total of 33,575 patients initially 
classified as type 1 diabetics were entered into Flowchart 2. Using the full version of the 
algorithm, 68.2% of the initial cohort remained as type 1 diabetics at the end (n=22,907). Using 
the simplified version of the algorithm, 83.6% of type 1 diabetics remained so at the end 
(n=28,075). In the full algorithm, 28.7% of patients were re-classified as having probable type 2 
diabetes (n=9,644), compared with 16.4% in the simplified algorithm (n=5,500). 
 
Of the 2,725 patients eligible to enter the RCGP algorithm in the main algorithm, 146 (5.4%) 
were of non-White ethnicity (South Asian, Black African/Caribbean, Other, or Mixed). 
Employing an age cut-off of 30 instead of 35 for date of first diabetes diagnosis in the non-
white group resulted in an additional 20 individuals initially classified as having type 1 diabetes 
being re-classified as having probable type 2 diabetes. In the simplified analysis, 5.4% of 
patients eligible to enter the RCGP algorithm were of non-White ethnicity (185/3,417), of whom 
22 were classified as probable T2DM by using the lower age cut-off.  
 
c) Flowchart 3: Improving the classification of type 2 diabetes 
Flowchart 3 was used to refine the classification of type 2 diabetes by utilising information on 
medications, clinical measures, and diagnostic codes pregnancy and PCOS (page 97). The 
results of the third algorithm detecting errors in type 2 diabetes are displayed in Figure 7.4.  A 
total of 343,047 patients initially classified as type 2 diabetics were entered into Flowchart 3.  
Using the full version of the algorithm, 95.1% of the initial cohort remained as type 2 diabetics 
at the end (n=326,135). In the simplified algorithm, an additional 201 women classified as 
having gestational diabetes previously  were included in the  group of type 2 diabetics, 
increasing the proportion marginally.   
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Of the 2,193 patients eligible to enter the RCGP algorithm in both the main and simplified 
algorithms, 12.3% were of non-White ethnicity (n=269), of whom 20 retained their classification 
as having type 2 diabetes as a result of the lower age cut-off. 
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Figure 7.3 Detecting errors in type 1 diabetes: Results for full and simplified algorithms 
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Figure 7.4 Detecting errors in type 2 diabetes: Results for the full and simplified algorithms 
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7.2.2 Comparison with derivation cohort 
The second objective of this study was to compare the performance of the algorithms with 
respect to improving the coding and classification of diabetes type between the Welsh SAIL 
database, where the algorithm was derived, and the CPRD. 
 
The comparison of the results from the full and simplified algorithms applied to the CPRD with 
those of the SAIL database is summarized in Table 7.1. The number of patients comprising the 
initial cohort of type 1 and type 2 diabetics was 4.5 times larger in the CPRD than in the SAIL 
database (376,622 vs. 34,596). After initial classification, the CPRD cohort had a greater 
proportion of patients classified as having type 1 diabetes (8.9% vs. 7.1%) and a smaller 
proportion of patients classified as having type 2 diabetes (91.1% vs. 92.9%) than the SAIL 
database.  
 
Table 7.1 Proportion of patients classified as having type 1 or type 2 diabetes in the CPRD and SAIL 
databases 
 CPRD (N=376,622) SAIL (N=84,596) 
 T1DM T2DM T1DM T2DM 
 N Row % N Row % N Row % N Row % 
Initial Classification (Flowchart 1) 33,575 8.9 343,047 91.1 5,965 7.1 78,631 92.9 
         
Full Algorithms         
T1DM Verification (Flowchart 2) 22,907  9,644      
T2DM Verification (Flowchart 3) 2,870  326,135      
Total 25,777 6.8 335,779 89.1 3,855 4.6 74,628 88.2 
% retaining initial classification 77.0  97.9  64.6  94.9  
Simplified Algorithms         
T1DM Verification (Flowchart 2) 28,075  5,500      
T2DM Verification (Flowchart 3) 2,870  326,336      
Total 30,945 8.2 331,836 88.1     
% retaining initial classification 92.2  96.7      
 
After both the full and simplified versions of the algorithms were run, the proportion of patients 
retaining their initial classification was higher in the CPRD than in the SAIL database. 
Comparing the results from applying the full algorithms in the CPRD and SAIL databases, 77% 
of those initially classified as having type 1 diabetes (25,777/33,575) and 97.9% of those initially 
classified as type 2 diabetes retained their classification in CPRD (335,779/343,047). In SAIL, 
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the equivalent figures were 64.6% for type 1 diabetes (3,955/5,695) and 94.9% for type 2 
diabetes (74,628/79,631).  
 
Using the simplified algorithms in the CPRD increased the proportion retaining their type 1 
classification from 77% in the full algorithm to 92.2% in the simplified algorithm (30,945/33,575). 
In comparison, the proportion retaining their type 2 classification reduced slightly, from 97.9% 
in the full algorithm to 96.7% in the simplified algorithm (331,936/343,047). 
 
7.3 Prevalence of type 1 and type 2 diabetes 
The third objective of this study was to determine ethnic differences in the prevalence and 
incidence of type 1 and type 2 diabetes over time using populations derived from the 
algorithms.  
 
7.3.1 Study population 
Patients with type 1 diabetes identified from the simplified versions of the adjudication 
algorithms were used to calculate the prevalence and incidence of diabetes in the CPRD. From 
a cohort of 30,945 patients classified as having type 1 diabetes, 28,938 (93.5%) had a date 
associated with their diagnostic Read code and were included in the analysis. From a cohort 
of 331,836 patients classified as having type 2 diabetes from the simplified adjudication 
algorithms, 305,916 (92.2%) had a date associated with their diagnostic Read code and were 
included in the analysis.  
 
In order to determine whether patients without a diabetes date recorded differed from those 
with a date recorded, the breakdown of diabetes type, ethnic group and gender in both 
populations was compared. Table7.2 compares the gender and ethnic breakdown of patients 
with and without a date for diabetes recorded. Diabetic patients without a diagnosis date 
recorded had a greater proportion of individuals without ethnicity recorded (58.7% vs 37.3%), 
a higher proportion of individuals classified as having type 2 diabetes and a higher proportion 
of females.   
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Table 7.2 Comparison of patients with and without date of diabetes diagnosis recorded 
 No diagnosis date (N=27,927) Diagnosis date (n=334,854) 
 N Col % N Col % 
Diabetes type     
Type 1 2,007 7.2 28,938 8.6 
Type 2 25,920 92.8 305,916 91.4 
Ethnic Group     
White 10,392 37.2 189,835 56.7 
South Asian 545 2.0 11,031 3.3 
Black 351 1.3 5,005 1.5 
Other 189 0.7 3,091 0.9 
Mixed 49 0.2 951 0.3 
Unknown 16,401 58.7 124,941 37.3 
Gender     
Male 14,938 53.5 185,053 55.3 
Female 12,989 46.5 149,801 44.7 
 
7.3.2 Overall Prevalence 
The demographic characteristics of the study populations are described in table 7.3. During 
the study period there were a total of 334,584 cases of diabetes, giving an overall prevalence 
of 0.26% for type 1 diabetes (28,938/10,641,428) and 2.87% for type 2 diabetes 
(305,916/10,641,428) across all age groups. Indirectly age standardising the overall prevalence 
figures for 2012 against the EU standard population did not alter the overall prevalence of type 
1 diabetes (0.30% CI95% 0.29, 0.30) but did increase the overall prevalence of type 2 diabetes, 
from 3.73% to 3.88% (CI95% 3.86, 3.90). 
 
The overall prevalence of type 1 diabetes was highest for White groups (0.36%) and lowest for 
South Asian groups (0.15%). The prevalence for all other ethnic groups was 0.20%. The overall 
prevalence of type 1 diabetes was 0.32% for males and 0.23% for females. The most recent 
prevalence figures (for 2012) are comparable to the overall prevalence for all years. Indirectly 
age standardising these figures against the EU standard population did not change the overall 
prevalence of 0.30% but did increase the prevalence slightly in each ethnic group except 
‘unknown’. 
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The overall prevalence of type 2 diabetes was highest for South Asian groups (4.7%) followed 
by White (3.9%) and Black African/Caribbean groups (3.2%). The overall prevalence of type 2 
diabetes higher for males than for females. The prevalence of type 2 diabetes in 2012 was 
higher in all ethnic and gender groups. Age standardisation results in a doubling of the 
prevalence in South Asian and Black African/Caribbean groups, to 10.32% and 7.42%, 
respectively. 
 
. 
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Table 7.3 Gender and ethnic breakdown the study population 
 Type 1 
Diabetes 
Type 2 
Diabetes 
 
 
Denominator 
population 
T1DM 
prevalence 
crude all 
years 
T1DM 
prevalence 
crude 2012 
T1DM 
prevalence age 
standardized 
2012* 
T2DM 
prevalence 
crude all 
years 
T2DM 
prevalence 
crude 2012 
T2DM prevalence 
age standardized 
2012* 
 N Col 
% 
N Col 
% 
N % % % % % % % 
Total 28,938 100 305,916 100 10,641,428 100 0.26 0.30 0.30 (0.29, 0.30) 2.87 3.73 3.88 (3.86, 3.90) 
Ethnic Group             
White 16,143 55.8 173,692 59.8 4,504,565 42.3 0.36 0.36 0.37 (0.37, 0.38) 3.86 4.20 4.08 (4.06, 4.11) 
South Asian 347 1.2 10,684 3.5 226,570 2.1 0.15 0.14 0.17 (0.15, 0.20) 4.72 5.48 10.32 (10.08, 10.56) 
Black 298 1.0 4,707 1.5 148,320 1.4 0.20 0.18 0.21 (0.17, 0.24) 3.17 3.65 7.42 (7.14, 7.69) 
Other 210 0.7 2,881 0.9 11,803 1.1 0.18 0.17 0.19 (0.15, 0.22) 2.44 3.15 5.40 (5.15, 5.65) 
Mixed 118 0.4 833 0.3 59,959 0.6 0.20 0.19 0.24 (0.18, 0.31) 1.39 1.55 5.88 (5.35, 6.41) 
Unknown 11,822 40.9 113,119 37.0 5,583,971 52.5 0.21 0.24 0.23 (0.22, 0.23) 2.03 3.04 3.23 (3.21, 3.26) 
Gender             
Male 16,456 56.9 168,597 55.1 5,179,187 48.7 0.32 0.35 0.34 (0.34, 0.35) 3.26 4.21 4.61 (4.58, 4.64) 
Female 12,482 43.1 137,319 44.9 5,462,241 51.3 0.23 0.25 0.25 (0.25, 0.26) 2.51 3.27 3.23 (3.21, 3.25) 
*Prevalence figures standardized against the EU standard population(227) 
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7.3.3 Ethnic differences in age and body mass index at diabetes onset 
The fourth objective of this study was to examine ethnic differences age at onset of type 1 and 
type 2 diabetes and BMI at diagnosis. The mean and median age and BMI values at onset by 
ethnic group are displayed in table 7.4  
 
Table 7.4 Age and BMI at onset of type 1 and type 2 diabetes 
 Type 1 diabetes Type 2 diabetes Denominator population 
 N Col % N Col % N % 
Age at diabetes diagnosis/study entry   
0-9 39, 77 13.7 168 0.1 2,008,865 18.9 
10-19 6,856 23.7 471 0.2 1,013,174 9.5 
20-29 5,480 18.9 3,156 1.0 1,989,653 18.7 
30-39 4,518 15.6 14,818 4.8 1,812,336 17.0 
40-49 2,830 9.8 41,380 13.5 1,263,129 11.9 
50-59 2,084 7.2 71,006 23.2 951,273 8.9 
60-69 1,519 5.3 83,059 27.2 719,843 6.7 
70-79 1,155 4.0 63,662 20.8 518,147 4.9 
80+ 519 1.8 28,196 9.2 365,008 3.4 
Median age at DM diagnosis (SD)  
Total 26 (20.3) 62 (13.7)   
White 25 (16.7) 63 (13.5)   
South Asian 27 (19.2) 52 (13.1)   
Black 28 (18.7) 53 (13.5)   
Other 28 (17.8) 55 (13.3)   
Mixed 17 (15.3) 53 (13.6)   
Unknown 27 (21.2) 62 (13.7)   
Mean age at DM diagnosis (CI95)  
Total 30.2 (29.9, 30.4) 61.5 (61.4, 61.5)   
White 29.1 (28.7, 29.3) 62.1 (62.1, 62.2)   
South Asian 29.9 (27.8, 31.9) 52.0 (51.8, 52.3)   
Black 29.8 (27.7, 32.0) 54.2 (51.8, 52.3)   
Other 29.4 (27.0, 31.8) 56.1 (55.6, 56.6)   
Mixed 20.8 (18.0, 23.6) 53.5 (52.6, 54.5)   
Unknown 31.9 (31.5, 32.3) 61.9 (61.9, 62.0)   
Median BMI value closest to DM diagnosis date in  kg/m2 (SD)  
Total 24.1 (4.8) 29.1 (5.55)   
White 24.1 (4.8) 29.4 (5.6)   
South Asian 23.5 (4.3) 27.1 (4.8)   
Black 24.8 (5.3) 29.1 (5.5)   
Other 23.3 (4.8) 27.7 (5.3)   
Mixed 23.2 (5.0) 28.3 (5.8)   
Unknown 24.2 (4.7) 29.1 (5.4)   
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The median age of T1DM diagnosis was 26 (SD 20.3). When stratified by ethnic group, median 
age of T1DM diagnosis was similar for White, South Asian and Black African/Caribbean 
groups. The mean age of T1DM diagnosis was higher than the median, at 30.2 (CI95% 29.9, 
30.4). The mean age of T1DM diagnosis was similar for all ethnic groups except for the Mixed 
group, whose mean age of onset was nine years lower than that for the whole population, at 
20.8 years of age (CI95% 18.0, 23.6). The mean and median age of T1DM onset for patients 
with unknown ethnicity were both higher than for the White population. 
 
The median age of T2DM diagnosis was 62 (SD 13.7). When stratified by ethnic group, South 
Asian, Black African/Caribbean and Mixed groups were diagnosed with T2DM a decade 
earlier than the White group (Table 7.3). Ethnic differences in the mean age of T2DM onset 
mirror those of the median, with onset in ethnic minority groups 8–10 years earlier than in the 
White population.  
 
The mean age of T2DM onset stratified by ethnic group is shown for each calendar year 
between 1990 and 2013 in figure 7.5. The graph highlights large differences between ethnic 
groups in 1990, which diminish over time. Though a reduction in mean age at onset was 
observed in all ethnic groups, the decline was greatest in the Black African/Caribbean 
population, for whom the mean age reduced from 59.6 in 1990 to 53.3 in 2013. The difference 
in mean age of onset over the study period was 3.9 years for the White population and 1.0 
years for the South Asian population. 
 
Turning to BMI value closest to date of diagnosis, the mean value for the whole T1DM 
population was 24.1 kg/m2, and highest for the Black African/Caribbean population, at 24.8 
kg/m2, and lowest for the South Asian population, at 23.5 kg/m2. Mean BMI in the T2DM 
population was higher, at 29.1 kg/m2. Mean BMI was higher and equivalent in the White and 
Black African/Caribbean populations, at 29.4 kg/m2 and 29.1 kg/m2, respectively, and lower in 
the South Asian, and Other ethnic groups, at 27.1 kg/m2 and 27.7 kg/m2, respectively. 
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Figure 7.5 Mean age of type 2 diabetes diagnosis by calendar year and ethnic group 
 
7.3.4 Prevalence by calendar year 
Figure 7.6 illustrates the crude prevalence of type 1 and type 2 diabetes at the midpoint of each 
calendar year between 1990 and 2012 in the CPRD. The prevalence of type 1 diabetes rose 
slightly over the study period, from 0.2% in 1990 to 0.3% in 2012. Standardisation against the 
EU population did not alter the crude prevalence of type 1 diabetes in 2012 
 
The prevalence of type 2 diabetes rose six-fold over the study period, from 0.6% in 1990 to 3.7% 
in 2012. The prevalence of type 2 diabetes in 2012 increased after standardisation against the 
EU standard population to 3.88% (CI95 3.86, 3.90). When stratified by gender, the prevalence 
both type 1 and type 2 diabetes was higher for males than for females in all years. Amongst 
type 2 diabetics, prevalence increased over time, slightly more so in males than in females.  
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Ethnic differences in diabetes prevalence over time are illustrated in Figure 7.7. The prevalence 
of type 1 diabetes remains consistently highest in the White group across all study years; it 
was lower prevalence for the South Asian group and for the Black African/Caribbean group it 
was similar to that of the White group. The prevalence of type 2 diabetes is consistently highest 
in the South Asian group in all calendar years.  
 
Between 1990 and 2007, prevalence was lowest for the White population. From 2008 onwards, 
the prevalence in the White population overtook that in the Black African/Caribbean 
population.  In the non-White ethnic groups, prevalence peaked in the year 2005, with a 
midyear prevalence of 4.4% in the Black African/Caribbean group and 6.7% in the South Asian 
group.  In the White ethnic group, prevalence increased annually, to peak in 2012, at 4.2%.  
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Figure 7.6 Prevalence of type 1 and type 2 diabetes by calendar year 
and gender  
 
 
Figure 7.7 Prevalence of type 1 and type 2 diabetes by calendar year 
and ethnic group 
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7.3.5 Prevalence by Age group 
The most recent prevalence estimates for the mid-2012 CPRD population were used to 
examine age and gender differences in diabetes prevalence within ethnic groups. The overall 
and gender specific prevalence of type 1 and type 2 diabetes by five-year age band is shown 
in figure 7.8. While the prevalence of type 1 diabetes remained constant across all age groups, 
the prevalence of type 2 diabetes increased rapidly from age 30 onwards and peaked in the 
age group 75–79 with a prevalence of 14.3%.  
 
When stratified by gender, the prevalence of type 1 diabetes was raised slightly in men 
compared with women in all age groups. The prevalence of type 2 diabetes was equivalent 
between males and females until age 35, after which the prevalence was higher in males. 
Prevalence of type 2 diabetes peaked at in the age group 75–79, with a prevalence of 16.6% in 
males and 12.4% in females. 
 
The age-specific prevalence of type 1 and type 2 diabetes by ethnic group is shown in figure 
7.9. The prevalence of type 1 diabetes was highest in the White group at all ages until age 85, 
after which the prevalence was highest in the Black African/Caribbean group. No clear 
differences between South Asian and Black African/Caribbean groups were apparent.  
 
The prevalence of type 2 diabetes was highest in the South Asian population at all ages. 
Prevalence peaked earlier for South Asian groups than for Black African/Caribbean and White 
groups. Peak prevalence occurred at age 75–79 in the South Asian group at 31.6% and at age 
80–84 in the other groups with a prevalence of 14.7% in White and 29.4% in Black 
African/Caribbean patients. The decline in prevalence observed amongst in the oldest age 
groups was related to deaths in the diagnosed population. 
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Figure 7.8 Prevalence of type 1 and type 2 diabetes by age at diagnosis and gender in 2012 
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Figure 7.9 Prevalence of type 1 and type 2 diabetes by age at diagnosis and ethnic group in 2012 
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7.4 Incidence of type 1 and type 2 diabetes 
 
7.4.1 Overall incidence 
The analysis presented below describes the crude incidence and crude risk of type 1 and type 
2 diabetes for all patients in the CPRD. A total of 11,972 incident type 1 diabetes events 
occurred between January 1990 and August 2013, giving a crude incidence rate of 1.58 per 
10,000 person-years (CI95% 1.56, 1.61). A total of 227,483 incident type 2 diabetes events 
occurred over the study period, giving an overall crude incidence rate of 30.75 per 10,000 
person years (CI95% 30.63, 30.88). 
 
Table 7.5 presents the crude incidence rates per 10,000 person-years, and age- and gender-
adjusted hazard ratios for type 1 and type 2 diabetes by ethnic group, gender and age group.  
 
For type 1 diabetes, the overall rate was highest in the White population, followed by Black 
African/Caribbean and South Asian groups. In comparison with the White population, the risk 
of T1DM was reduced by 27% in the Black African/Caribbean population (HR 0.73, CI95% 0.60, 
0.89) and by 45% in the South Asian population (HR 0.55, CI95% 0.46, 0.63). The incidence rate 
was lower in women than in men, with a relative hazard of 0.74 for women (CI95% 1.29, 1.37).  
Incidence peaked in the 10–19 age group, with a crude rate of 2.96 per 10,000 person-years. 
Relative to the 0–9 age group, the risk of T1DM was increased by 43% in this group (HR 1.43, 
CI95% 1.34, 1.52).  
 
For type 2 diabetes, relative to the White group, the incidence was raised two-fold in the Black 
African/Caribbean group (HR 2.05, CI95% 1.97, 2.13) and three-fold in the South Asian group 
(HR3.04, CI95% 3.00, 3.11). The incidence was reduced by 29% in women compared with men 
(HR 0.71, CI95% 0.71, 0.72). The incidence peaked in the 70–79 age group, with a crude rate of 
95.47 per 10,000 person-years. Relative to those aged 30–39, the risk of T2DM was increased 
11-fold in this group (HR 11.37, CI95% 11.12, 11.62).  
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Table 7.5 Crude incidence rates and adjusted hazard ratios for type 1 and type 2 diabetes by ethnic group, gender and age 
 Type 1 diabetes Type 2 diabetes 
 Events Crude rate [CI95%] Adjusted HR [CI95%] Events Crude rate [CI95%] Adjusted HR [CI95%] 
Overall 11,972 1.58 [1.56, 1.61]   227,483 30.75 [30.63, 30.88]   
           
Ethnic Group           
White 6,469 1.92 [1.87, 1.96] 1 -- 129,770 39.56 [39.35, 39.78] 1 -- 
South Asian 126 1.18 [0.99, 1.41] 0.58 [0.48, 0.69] 6,148 61.13 [59.62, 62.68] 3.05 [2.97, 3.13] 
Black 102 1.59 [1.32, 1.94] 0.78 [0.64, 0.95] 2,589 42.08 [40.49, 43.74] 2.10 [2.01, 2.18] 
Other 68 1.29 [1.02, 1.64] 0.64 [0.51, 0.82] 1,784 34.89 33.30, 36.54] 1.38 [132, 1.45] 
Mixed 47 1.97 [1.48, 2.62] 0.87 0.65, 1.16] 485 20.60 [18.85, 22.52] 1.59 [1.46, 1.75] 
Unknown 5,158 1.31 [1.27, 1.34] 0.60 [0.57, 0.62] 86,707 22.35 [22.20, 22.50] 0.69 [0.68, 0.70] 
           
Gender           
Male 6,902 1.84 [1.80, 1.88] 1 -- 125,472 34.31 [34.13, 34.50] 1 -- 
Female 5,067 1.33 [1.29, 1.37] 0.72 [0.769 0.75] 102,011 27.27 [27.11, 27.44] 0.70 [0.69, 0.71] 
           
Age group           
0-9 1,703 2.06 [1.96, 2.16] 1 -- 78 0.09 [0.08, 0.11] 0.01 [0.09, 0.014] 
10-19 2,546 2.96 [2.85, 3.08] 1.46 [1.37, 1.55] 261 0.30 [0.27, 0.35] 0.04 [0.03, 0.05] 
20-29 1,614 1.79 [1.71, 1.88] 0.89 [0.83, 0.95] 1,852 2.05 [1.96, 2.15] 0.25 [0.23, 0.26] 
30-39 1,835 1.65 [1.58, 1.73] 0.79 [0.74, 0.85] 9,416 8.47 [8.30, 8.64] 1 -- 
40-49 1,427 1.25 [1.19, 1.32] 0.60 [0.56, 0.64] 29,053 25.73 [25.44, 26.03] 2.99 [2.92, 3.06] 
50-59 1,055 1.06 [1.00, 1.13] 0.49 [0.46, 0.53] 51,399 53.42 [52.96, 83.88] 6.16 [6.03, 6.30] 
60-69 822 1.03 [0.96, 1.10] 0.47 [0.44, 0.52] 63,374 84.33 [83.67, 84.99] 9.66 [9.45, 9.88] 
70-79 687 1.19 [1.11, 1.29] 0.55 [0.51, 0.60] 50,298 95.47 [94.64, 96.31] 11.16 [10.91, 11.41] 
80+ 280 0.80 [0.72, 0.90] 0.39 [0.35, 0.44] 21,752 67.32 [66.43, 68.22] 8.35 [8.15, 8.55] 
*Rates per 10,000 person years, hazard ratios adjusted for age and gender 
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7.4.2 Incidence by calendar year 
Figure 7.10 illustrates the crude incidence of type 1 and type 2 diabetes in each calendar year 
between 1990 and 2013 in the CPRD. The incidence of type 1 remained largely constant over 
time, with a slight increase in 2006 only. The incidence of type 2 diabetes rose 2.5-fold between 
1990 and 2003. Apart from a potentially artefactual increase in 2006, likely resulting from 
increased ascertainment associated with changes in the Quality and Outcomes Framework 
scheme, the incidence decreased between 2003 and 2013, from  39.29 per 10,000 person-
years in 2003 (CI95%  38.69, 39.89) to 32.67 per 10,000 person-years in 2013 (CI95%  31.92, 
33.43). 
  
 
 
Figure 7.10 Incidence of type 1 and type 2 diabetes by calendar year and gender  
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The crude cumulative incidence curves for type 1 and type 2 diabetes by years of follow-up 
are shown in figure 7.11. For type 1 diabetics, the incidence was highest in the White 
population over the entire duration of follow-up for males. For females, the cumulative 
incidence in the Black African/Caribbean group overtook that of the White group after 15 years 
of follow-up. Amongst type 2 diabetics, cumulative incidence was consistently highest for the 
South Asian group and lowest for the White groups throughout the duration of follow-up.  
 
7.4.3 Incidence by age group 
The crude cumulative incidence curves for type 1 and type 2 diabetes by age are shown in 
figure 7.12. In the T1DM population, cumulative incidence was higher in the White population 
in both males and females at all ages. The difference between the White and non-White 
populations was more pronounced amongst females. In the T2DM population, cumulative 
incidence was highest for the South Asian population, followed by Black African/Caribbean 
and White populations for both genders.  Disparities between ethnic groups increased with 
age, with incidence rising fastest in the South Asian population and slowest in the White 
population.  
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Figure 7.11 Cumulative incidence of type 1 and type 2 diabetes by calendar year and ethnic group 
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Figure 7.12 Cumulative incidence of type 1 and type 2 diabetes by age and ethnic group 
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7.5  Incidence in ethnic minority subgroups 
The final objective of this study was to examine differences in the incidence of type 1 and type 
2 diabetes for South Asian and Black/Caribbean subgroups. In order to identify heterogeneity 
in the risk of type 1 and type 2 diabetes between ethnic minority subgroups, crude rates and 
adjusted hazard ratios exploring risk in Indian, Pakistani, Bangladeshi, African and Caribbean 
groups were calculated and compared with the White population. The results are presented in 
table 7.6. Compared with the White population, the risk of type 1 diabetes was reduced in the 
Indian group by 40% (HR 0.60, CI95% 0.46, 0.78) and in the Pakistani groups by half (HR 0.52 
CI95% 0.36, 0.75) after adjusting for age and gender. No differences in T1DM incidence between 
the White and Black African/Caribbean subgroups were evident. 
 
For type 2 diabetes, risk was increased in all ethnic minority subgroups relative to the White 
population. Relative risk was highest in the Bangladeshi population, who were found to have an 
almost 6-fold increase in T2DM risk relative to the White population (CI95% 5.61, 6.28). This was 
followed by the Pakistani group, who had a 4-fold increase in risk relative to the White population 
(CI95% 3.84, 4.43), and the Indian group, who had a 2.6-fold increase in risk (CI95% 2.46, 2.66). 
Risk of T2DM was doubled in the African and Caribbean groups relative to the White population 
(African HR 2.00, CI95% 1.88, 2.13; Caribbean HR 2.15, CI95% 2.03, 2.27).  
 
Table 7.6 Crude incidence rates and adjusted hazard ratios by ethnic minority subgroup 
 Type 1 diabetes Type 2 diabetes 
 Events 
Crude 
rate [CI95%] 
Adj. 
HR [CI95%] Events 
Crude 
rate [CI95%] 
Adj. 
HR [CI95%] 
Ethnic Group          
White 6,469 1.92 [1.87, 1.96] 1 -- 129,770 39.56 [39.35, 39.78] 1 -- 
Indian 54 1.18 [0.90, 1.54] 0.60 [0.46, 0.78] 2.709 62.98 [60.65, 65.39] 2.56 [2.46, 2.66] 
Pakistani 29 1.15 [0.80, 1.66] 0.52 [0.36, 0.75] 1.442 60.40 [57.36, 63.60] 4.05 [3.84, 4.43] 
Bangladeshi 10 1.28 [0.69, 2.38] 0.59 [0.32, 1.10] 544 74.45 [68.49, 81.02] 5.77 [5.31, 6.28] 
African 50 1.64 [1.24, 2.16] 0.79 [0.60, 1.04] 984 33.01 [31.01, 35.14] 2.00 [1.88, 2.13] 
Caribbean 34 1.64 [1.18, 2.29] 0.84 [0.60, 1.17] 1194 61.42 [58.04, 65.01] 2.15 [2.03, 2.27] 
*Rates per 10,000 person years, hazard ratios adjusted for age and gender 
 
The cumulative incidence of type 1 and type 2 diabetes for ethnic minority subgroups by age is 
shown in figure 7.13. In the T1DM population, cumulative incidence was highest in the Indian 
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population, followed by Pakistani and then Bangladeshi populations until age 70, after which 
point rates were highest in the Bangladeshi group. The pattern was reversed amongst women 
with type 1 diabetes, with rates highest in the Bangladeshi population and lowest in the Indian 
population. In the T2DM population, cumulative incidence was highest in the Bangladeshi 
population, followed by the Pakistani and Indian populations for both genders.  Disparities 
between South Asian groups increase with age, with incidence rising fastest in the Bangladeshi 
population and slowest in the Indian population.  
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Figure 7.13 Cumulative incidence of type 1 and type 2 diabetes for ethnic minority subgroups 
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7.6 Discussion 
The aim of this study was to explore how algorithms improving the classification of diabetes 
type perform in the CPRD and to quantify ethnic differences in the incidence and prevalence 
of type 1 and type 2 diabetes using these algorithms. This study represents the first 
implementation of these algorithms in a large database representative of the UK population 
as a whole, and also the first assessment of ethnic differences in diabetes burden for the entire 
cohort of patients contributing to the CPRD. The results show that it is feasible to implement 
the algorithms and that the resulting estimates of diabetes prevalence and incidence are 
comparable to those found in other UK-based studies.  
 
7.6.1  Improving the coding and classification of diabetes mellitus 
This study improved upon the original implementation of the algorithms in the Welsh SAIL 
database by utilizing the patient-level ethnicity data available in the CPRD to improve the 
identification of patients with type 2 diabetes. Were ethnicity data to be available in the SAIL 
database, it is possible that ethnic differences in diabetes prevalence would still be 
underestimated, as the Welsh database covers a much smaller and less ethnically diverse 
population than the CPRD. According to the 2011 Census, 14.5% of the English population 
identified themselves as non-white, compared with 4.4% of the Welsh population. 
 
Compared with the original derivation cohort, a higher proportion of diabetics retained their 
initial classification. This difference may be attributable to the lack of full HES linkage in CPRD. 
In Flowchart 2, HES linked data is used to determine whether type 1 diabetics with a 6-month 
gap in their insulin prescription dates could have plausibly received their prescription during 
a visit to hospital. Individuals without a hospital visit should be reclassified as having T2DM. 
Since 50% of CPRD patients have no hospital data, they all retain their T1DM classification, as 
we cannot definitively say whether or not they attended hospital. Were HES linkage available 
for 100% of the CPRD population, we would identify a greater proportion of patients initially 
classified as T1DM who should be reclassified as T2DM due to having a gap of 6 months or 
more in their insulin prescription.    
Chapter 7: Ethnic differences in the prevalence and incidence of diabetes mellitus 
  
135 
 
Since the completion of this analysis, a similar study of diagnostic coding error has been 
published regarding a cross-sectional on five general practices in Leicester.(228) Compared 
with our study sample of 391,994 patients diagnosed with diabetes between 1990 and 2013, 
the Leicester study identified 2,324 adults aged 17 and over diagnosed with diabetes in 
2009/10. The overall prevalence of diabetes was 6.9% in 2011 in Leicester compared with 4.0% 
in 2012 in the CPRD, potentially reflecting the greater ethnic diversity of the study area in 
relation to the UK as a whole.  
 
7.6.2 Type 1 diabetes 
The study demonstrated a stable prevalence and incidence of type 1 diabetes over time, with 
a slight increase in 2006. Notable differences by ethnicity were evident, with prevalence in the 
White group more than double that in all other ethnic groups. Ethnic differences in incidence 
continued in the same direction, with the adjusted risk of T1DM reduced significantly in both 
the South Asian and Black African/Caribbean groups relative to the White group.  
 
The UK has the fifth highest incidence of T1DM amongst children under 14 globally. A report 
by the International Diabetes Federation found that in 2013 the incidence of T1DM in this age 
group was 2.5 per 10,000 person years.(229) This is comparable to the findings of this study, 
where the incidence of T1DM was 2.06 per 10,000 person-years in the age group 0–9 and 2.96 
per 10,000 person-years in the age group 10–19, average a rate of 2.51 across the two age 
groups. 
 
7.6.3 Type 2 diabetes 
The study identified substantial differences in the incidence and prevalence of type 2 diabetes 
by ethnic group, and considerable heterogeneity in risk between ethnic minority subgroups. 
Our findings of a 3-fold risk increase in the South Asian population and a 2-fold increase in the 
Black African/Caribbean population echo the results of several other UK-based studies, 
confirming that the CPRD population provides a substantial cohort to explore a range of 
research questions relating to population-wide trends in the differential burden of diabetes by 
ethnicity.(194,230,231)  
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The incidence of type 2 diabetes in the CPRD has been examined previously. In 2010 Holden 
et al. reported an overall incidence rate of 51.5 per 10,000 person-years, with significant 
increases over time. The study confirmed a higher incidence in males in all calendar years. 
Their study did not explore ethnic differences, but did report a secular increase in the 
proportion of patients being diagnosed with T2DM under the age of 40, likely attributable in 
part to the increasing proportion of South Asian and Black African/Caribbean individuals 
amongst diabetic cases.(232)  
 
Our study has identified significant differences in the age of diabetes onset, confirming the 
hypothesis that onset will be earliest in the South Asian population and latest in the White 
population. The 10-year difference in median age at onset is comparable to that found in non-
database studies of diabetes in the UK. 
 
The study has confirmed that significant differences in diabetes risk exist between ethnic 
minority subgroups. If numbers allow, using a higher level of granularity to explore ethnic 
differences can reveal hidden heterogeneity between ethnic groups and contribute to a more 
nuanced understanding of the pathways linking ethnicity and health. Reasons for differences 
between South Asian subgroups are manifold. Indian, Pakistani and Bangladeshi groups 
migrated to the UK in different waves; as such, their current level of acculturation and 
subsequent health risk may differ.(37) Because the Indian population came to the UK first, on 
average, this group has a higher level of education and tends to live in more affluent areas. In 
contrast, because the Bangladeshi population is largely made up of much more recent 
migrants, this group tends to have a lower educational and professional level, and clusters in 
more deprived areas, such as inner east London.(28,233)  
 
Furthermore, religious and cultural factors may play a role; Pakistani and Bangladeshi 
populations are largely Muslim, and this has an impact on dietary practices and acceptance 
of smoking and alcohol use.(40,234–236) As discussed earlier,  the Health Survey for England 
has shown that while rates of smoking are higher in Bangladeshi men compared with other 
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men in England, over 90% of all Bangladeshi adults are non-drinkers.(237) Turning to alcohol 
use, a large proportion of Muslim adults report abstaining from alcohol use, though those who 
do drink alcohol tend to have higher consumption than other groups.(40)  
 
7.6.4 Reasons for observed increases in incidence and prevalence in type 2 diabetes 
Firstly, the apparent rise in incidence may be due to an actual increase in the number of people 
developing diabetes in the UK population. This in turn could be due to rising BMI in the 
population and a growth of ethnic minority populations who are contributing 
disproportionately to the diabetes burden. This study has demonstrated that the incidence of 
type 2 diabetes is higher in ethnic minority groups than in the White population. Additionally, 
the incidence may have increased due to changes in the diagnostic criteria for identifying type 
2 diabetes adopted in the UK, which have lowered the threshold for fasting plasma glucose, 
resulting a larger cohort of T2DM patients based on a broader inclusion criteria, reflecting 
newer evidence that diabetic complications occur at lower levels of glucose impairment.(238–
240) 
 
Secondly, the increasing prevalence and incidence of type 2 diabetes may stem from the 
combined influences of the lowering in age at first diagnosis, as demonstrated in this study, 
and improved survival after diagnosis. Metformin, which is recommended as the first-line 
pharmacological treatment for type 2 diabetes, has been shown to improve survival for 
patients with type 2 diabetes, primarily by reducing the risk of cardiovascular outcomes.(241–
243) 
 
Thirdly, improved case ascertainment via initiatives such as the NHS health checks 
programme, local enhanced services and the Quality & Outcomes Framework may have 
contributed to the increase in the reported prevalence and incidence rates of type 2 diabetes. 
Such initiatives improve opportunities to detect disease by increasing the number of patient–
GP encounters  and by increasing the amount of targeted activity by practice staff.(244–247)  
This increase in ascertainment serves to reduce the number of people with undiagnosed 
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diabetes in the population. The combined influence of these concurrent initiatives may have 
contributed to the smaller ethnic differences reported here compared with earlier UK-based 
studies due to improving equity of care for all patients across the UK. 
 
Finally, temporal changes in the diagnostic coding of diabetes mellitus in primary care may 
also contribute to the increase. Though the recording of any diabetes mellitus was incentivised 
under the Quality and Outcomes Framework in 2004, this was changed in 2006 to reward only 
the coding of type 1 and type 2 diabetes mellitus. More specific diagnostic coding, as 
evidenced by the spike in the incidence of both type 1 and type 2 diabetes observed in 2006.  
 
7.6.5 Limitations 
The primary limitation of this study is the reliance on date of first recorded diagnostic code to 
approximate the date of diabetes onset. It has been shown that approximately 7 years can 
elapse between the onset of disease and its identification by health professionals; thus 
duration of disease and number of incident events is likely underestimated in our sample, due 
to the presence of undiagnosed diabetes in our study population.(248) In the UK it is estimated 
that 1% of the population, or one in three diabetics, has disease that is either undiagnosed or 
unrecorded in primary care.(249,250) The prevalence of undiagnosed diabetes in the UK has 
reduced in recent years, likely via the dual actions of increased awareness and concentrated 
efforts by GPs to create registers of diabetic patients to ensure appropriate access to care and 
treatment. (251) 
 
Secondly, this study did not attempt to identify patients in the CPRD without diagnostic codes 
for diabetes. It is possible that patients may have evidence on their primary care record which 
supports a diagnosis of diabetes, such as prescriptions, raised blood glucose or ‘process of 
care’ codes, but do not have an appropriate diagnostic code which would identify them as 
being on a general practice’s diabetic register. A study in the QRESEARCH database found 
that it is possible to identify undiagnosed diabetes using routine primary care databases via 
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the recording of blood glucose data, and it reported that 30% of all people aged 40 and over 
had a blood glucose value recorded in the preceding two years.(252) 
Thirdly, secular improvements in the recording of ethnicity and covariate information such as 
glycaemia and BMI mean that individuals registered more recently are more likely to have 
their diabetes diagnosed in a timelier manner. Furthermore, ascertainment of correct diabetic 
type may be more accurate in these individuals due to the greater completeness of supporting 
information required to adjudicate diabetic outcomes. Historic patients contributing to the 
study may be more likely to have errors or missing data, particularly if diagnosed prior to the 
incentivisation of diabetes coding.  
 
Finally, the lack of HES linkage for all patients registered with the CPRD means that we are 
able to determine whether gaps in insulin prescriptions are plausible, thus limiting our ability 
to appropriately retain T1DM classification or reassign those with non-continuous insulin to 
T2DM.   
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Chapter 8  
Ethnic and gender differences in risk of coronary 
heart disease amongst patients with and without 
type 2 diabetes: Methods 
 
8.1 Summary 
This chapter describes the methods and background of the third and final study reported in 
the thesis, that examining differences in the incidence of first non-fatal coronary heart disease 
(CHD) by ethnic group, gender, deprivation and diabetic status.  All patients with type 2 
diabetes identified in the previous chapter free from CHD at diagnosis were eligible for 
inclusion. A random sample of CPRD patients free from both CHD and type 2 diabetes aged 
30 and above was selected as the comparison group. Ethnic and gender differences in 
incidence of CHD and cardiac death were estimated for individuals with and without diabetes 
using multivariable Cox regression. The results for non-fatal CHD are presented in chapter 9. 
The results for fatal and non-fatal CHD combined are presented in chapter 10. A discussion of 
both chapters is presented in chapter 11. 
 
8.2 Study objectives and hypotheses 
The main objectives were to: 
1. Identify how much excess CHD risk is conferred by having diabetes and whether there 
is an interaction with age, gender, deprivation and ethnic group. 
2. Quantify ethnic and gender differences in crude incidence of fatal and non-fatal CHD 
amongst patients with and without type 2 diabetes 
3. Quantify ethnic and gender differences in the adjusted risk of fatal and non-fatal CHD 
amongst patients with and  without type 2 diabetes 
4. Break down estimates of adjusted risk further by South Asian subgroup (Indian, 
Pakistani and Bangladeshi) and Black subgroup (African, Caribbean) in comparison 
with the White population as a whole. 
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The hypotheses of this study were: 
1. That the South Asian group will have a higher risk of incident fatal and non-fatal CHD 
and the Black African/Caribbean group a lower risk than the White group 
2. That the excess risk for the South Asian group will be greater in the diabetic population 
than in the non-diabetic population. 
3. The risk of CHD will be higher in diabetics compared with non-diabetics both overall 
and by age, gender, ethnic group and deprivation. 
4. In the ethnic subgroup analysis, CHD risk will be raised for all South Asian subgroups, 
and, in particular, be highest for the Pakistani group in comparison with the White 
group. 
 
8.3 Background  
The term coronary heart disease (CHD) refers to diseases of the arteries which supply 
oxygenated blood to the heart. CHD develops via the process of atherosclerosis, whereby 
plaques composed primarily of fat and calcium build up in the blood vessels. As these harden 
over time, they can narrow the arteries and restrict blood flow to the heart, resulting in angina 
or myocardial infarction.(253)  
 
The causal pathway towards coronary heart disease is multifactorial. The majority of CHD risk 
stems from modifiable risk factors.(254) The key risk factors for atherosclerosis are 
dyslipidaemia, type 2 diabetes mellitus, hypertension and obesity.(255,256) 
 
CHD and stroke combined form the largest grouping of cardiovascular disease (CVD), which 
is the leading cause of death in the UK and worldwide. CVD contributes to over half of the 
entire global burden of non-communicable disease and in 2010 accounted for 29.6% of all 
deaths globally.(257),(258) Data from 2012 show that 46% of all deaths in Europe were CVD 
related, 20% of which were attributable to CHD.(259) 
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Coronary heart disease was first described by Scottish clinicians Heberden, in 1772, and 
Jenner in 1788.(260)  Throughout the late 1800s and early 1900s, clinical evidence of 
myocardial infarction and arterial occlusion contributed to the understanding of the 
atherosclerotic process resulting in CHD,  and in 1930 CHD was added to the International 
Classification of Diseases (ICD).(261),(262)  
 
The study of CHD heralded the beginnings of modern non-communicable disease 
epidemiology, which recognised that chronic disease risk is mediated by the interplay of 
multiple risk factors rather than a single aetiological element.(263) To this end, longitudinal 
cohort studies and epidemiological surveillance programmes were set up to monitor global 
changes in CHD prevalence and the contributions of prevention and treatment to risk factor 
reduction. Prominent examples of these include the Monitoring Trends and Determinants in 
Cardiovascular Disease (MONICA) Project, which was established by the World Health 
Organization in 1979, and the Framingham Heart Study, which was established in 
1948.(263,264) 
 
By the mid-20th century, the prevalence of CHD had risen to epidemic proportions, primarily 
across the United States and northern Europe, quickly overtaking infectious diseases such as 
tuberculosis.(265) In the United States, the epidemic peaked in the 1960’s, at which time 1 in 3 
deaths was caused by CHD.(265) In the UK, the epidemic reached its zenith ten years later; 
Mortality rates increased exponentially between 1921 and 1970, peaking at 730 deaths/100,000 
in England and Wales, and 960/100,000 in Scotland for men aged 55-64.(261)  
 
Since 1970, CHD mortality rates have declined dramatically across the developed world. 
Between 1980 and 2006, the UK had a 41% reduction in mortality rates from myocardial 
infarction, the largest across all of Europe. In 2010, the age standardized mortality rate for CHD 
was 111.1/100,000 in men and 49.4/100,000 in women and is predicted to continue to decline 
through 2016.(259,266)  
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Since the 1980’s a substantial epidemiological transition has taken place. As CHD mortality 
has declined in developed countries, it has increased rapidly in low- and middle-income 
countries, where now 80% of all CHD-related deaths occur.(257,258) CHD death in these 
regions occur approximately 10 years earlier than in Europe and north America, due in part to 
earlier onset of disease and poorer healthcare infrastructure.(254)  
 
This shift has been driven concurrently by increasing life expectancy and the adoption of 
western life styles, increasing the prevalence cardiovascular risk factors, and the lack of 
adequate population-based strategies to reduce the impact of these risk factors on incidence 
and mortality.(258) In 2012 the World Health Assembly introduced a target to reduce global 
mortality from non-communicable diseases by 25% by the year 2025, with the prevention of 
cardiovascular disease at the heart of the programme.(258) The proposed strategy focuses 
on the key risk factors of obesity, hypertension, hypercholesterolaemia, tobacco smoking, 
alcohol consumption and dietary fat and salt intake.(258) 
 
8.3.1 Coronary heart disease and diabetes mellitus 
A key driver of the global rise in CHD is diabetes mellitus. 75% of the global burden of diabetes 
stems from low- and middle-income countries.  Diabetes and CHD share many of the core 
risk factors, and are suspected to have a common genetic basis.(267) Diabetes mellitus 
triggers changes in endothelial function and energy metabolism which promote 
atherosclerosis; The atherosclerotic process tends to initiate earlier in diabetic individuals and 
progress faster, resulting in a 2- to 4-fold increase in CHD events and CHD-related mortality in 
this group.(268–271) CHD is responsible for 80% of all deaths amongst individuals with 
diabetes and is the leading cause of morbidity in this population. Individuals with 
hyperglycaemia, diabetes or metabolic syndrome have up to three times the risk of 
cardiovascular mortality compared with those without metabolic abnormalities.(268,269)  
Correspondingly, diabetes is considered to be a CHD equivalent and thought to confer a 
cardiovascular risk equal to that of having established CHD.(272)  
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8.3.2 Coronary heart disease and ethnicity 
It has been established that traditional risk factors for heart disease such as smoking, 
hypertension, diabetes and obesity increase risk in all populations, but that the magnitude of 
effect and interactions between the risk factors differ according to ethnic group.(273) Both 
prevalence and severity of CHD are known to vary by ethnicity, with marked differences in 
incidence and mortality demonstrated globally. In the UK, incidence and mortality from CHD 
are increased amongst South Asians but decreased amongst the Black African/Caribbean 
population compared with the White population. 
 
Broadly speaking, South Asian groups as a whole carry a higher burden of cardiovascular risk 
factors and benefit from fewer protective factors.(192,193,236,274) Incidence of CHD is higher 
in South Asian populations, both in the host countries and in the diaspora.(275) In India, CHD 
is the leading cause of death. A meta-analysis of 9 studies conducted in 2013 demonstrated 
an increase in CHD incidence of 35% in South Asian populations compared with White 
populations (HR 1.35, CI95%  1.30,1.40).(276,277)  
 
a) Mechanisms by which diabetes increases CHD risk amongst South Asians 
Ethnic differences in CHD are exacerbated by diabetes, which has been shown to have a 
greater impact on CHD risk amongst South Asians compared to White populations. Though 
conventional risk factors account for over 80% of all CHD risk in all ethnic groups, they do not 
explain the 40% excess of CHD observed amongst South Asians.(278)  
 
Insulin resistance is well established as the underlying mechanism responsible for the 
increased rates of CHD amongst South Asians globally, and has been found to account for 
70% of the excess risk of CHD in South Asians compared to Europeans.(269) Two prospective 
studies of CHD mortality based in London (SABRE and LOLIPOP) have confirmed that the 
prevalence and incidence of CHD are doubled in South Asian groups, even after accounting 
for cardiovascular risk factors, further supporting the independent effect of diabetes and 
metabolic disturbances on CHD risk.(279) 
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Though South Asian groups have a higher CHD incidence, they have been found to have 
better survival. As such, increased mortality amongst South Asians has been attributed to a 
greater burden of modifiable risk factors rather than poor management after a coronary event, 
suggesting that the most effective way to reduce ethnic inequalities in coronary disease 
outcomes is to focus public health efforts on primary care.(276,280) 
 
Despite having higher rates of stroke, Black African/Caribbean groups in the UK have lower 
rates of CHD and CHD-related mortality than White and South Asian groups.(281)  Though 
both South Asian and Black African/Caribbean populations have higher levels of insulin 
resistance than the White majority population, lipid profiles and levels of obesity and central 
adiposity are more favourable in Black African/Caribbean groups compared to South 
Asians.(282) 
 
Amongst South Asian groups, CHD tends to develop earlier and at lower levels of risk 
compared to White populations. In India, 50% of CHD-related deaths occur before age 70, 
compared to 6% in high-income countries.(283) Furthermore, as a result of higher levels of 
central adiposity, South Asian groups tend to develop CHD at lower levels of BMI and smaller 
waist circumference; thus, CHD events are increasing amongst people without obesity as 
defined by BMI.(284)  
 
b) Differences between South Asian subgroups 
Combining data for South Asian groups can be misleading – ethnic and racial differences are 
almost never demonstrably genetic and therefore genetic and social environment are likely to 
be crucial. As highlighted in the introduction of this thesis, ethnicity serves as a useful concept 
which encompasses a range of factors which cannot be reduced simplistically to genetic 
differences. In the UK context, it has been demonstrated that Pakistani populations are at high 
risk of CVD compared with other South Asian ethnic groups, with studies demonstrating up to 
60% increased risk of first myocardial infarction (MI).(281,285) 
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CHD prevalence and incidence  have both been found to be higher in Pakistani and 
Bangladeshi groups and lower in Indians.(26,286,287) A study by Bhopal et al. found that 
Bangladeshi groups have the highest risk profile for CHD compared to the other South Asian 
subgroups, and that South Asians as a whole have a higher risk profile for CHD compared to 
Europeans.(236) A Scottish study of  acute MI demonstrated that incidence was highest for 
Pakistani men and lower other South Asian subgroups, White and Chinese groups. These 
differences were not present amongst women.(280) 
 
While smoking and lack of exercise are more common amongst  Bangladeshi and Pakistani 
men, alcohol use is highest amongst Indians.(236,280,288) Beneficially, Pakistani and Indian 
groups are more likely to eat fruits and vegetables daily. Obesity is less common in the 
Bangladeshi subgroup than in the other two subgroups. There are no significant differences 
between South Asian subgroups with respect to hypertension.(236) 
 
8.3.3 Coronary heart disease and gender 
The incidence of CHD has been shown to be lower in women than in men, with onset on 
average 10 years later.(289–291) CHD mortality in women is reduced 5-fold, though gender 
differences diminish after age 70.(292) As with ethnicity, the relationship between gender and 
CHD is also modified by the presence of diabetes mellitus; the increase in CHD risk associated 
with diabetes has been shown to be higher for women than men, cancelling out any 
cardioprotection evident amongst non-diabetics.(293),(294)  
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8.4 Study Design 
A prospective cohort study was undertaken to examine: 
 a) Incidence of non-fatal CHD in: 
   i) All patients with T2DM  
  ii) A random sample of patients without T2DM 
  iii) A sample of age matched patients without T2DM 
 b) Incidence of fatal and non-fatal CHD in 
i) All patients with T2DM whose records were linked to ONS data, enabling 
ascertainment of date and cause of death 
ii) A random sample of patients without T2DM whose records were linked to 
ONS data. 
 
8.5 Participants 
8.5.1 Patients with Type 2 diabetes 
From the total cohort of patients defined as having type 2 diabetes in chapter 6, a subset 
meeting the following criteria were retained for analysis: 
a) Aged ≥30 at date of T2DM diagnosis 
b) Diagnosed between January 1st 1990 and August 1st 2013 
c) Free from CHD at time of T2DM diagnosis 
d) Registered for a minimum of 12 months prior to T2DM diagnosis in order to capture 
incident diabetics diagnosed during registration with the CPRD, for whom onset date 
and classification of diabetes type is likely to be more accurate and to exclude 
prevalent diabetics with unknown type and duration of diabetes.(295) 
 
8.5.2 Patients without Type 2 diabetes 
a) Random sample 
A random sample of 1 million patients aged 30 or over in August 2013 was extracted from the 
CPRD. From this sample, all patients with a diagnosis of T2DM were removed. A subset of 
patients free from CHD at age of 30 was retained. Information on the day and month of birth 
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was not provided. Therefore, each patient’s date of birth was estimated as 1st July of their year 
of birth, allowing a maximum error margin of six months for age. 
 
b) Age matched sample 
A second sample of age matched patients without type 2 diabetes was extracted from the 
CPRD. Up to four controls for each case were identified in the database. A maximum difference 
in age of 1 year was tolerated in order to maximize the number of successful matches. As 
previously, each patient’s date of birth was estimated as 1st July of their year of birth, allowing 
a maximum error margin of six months for age. The start of follow-up for the non-diabetic 
sample was matched to that of the diabetic population.  
 
The matched sample of patients without type 2 diabetes was used for in the primary analysis 
examining the incidence of non-fatal CHD in the whole CPRD population, and not for the 
secondary analysis of combined fatal and non-fatal CHD in the subset of patients with linked 
ONS mortality data. 
 
8.6 Outcome definition 
The outcome of the primary study was incidence of first non-fatal coronary heart disease 
between January 1990 and August 2013, defined using the Quality and Outcomes Framework 
definition of a clinical diagnosis of ischaemic heart disease, myocardial infarction or angina 
pectoris (Table 8.1). The first incident non-fatal CHD during the study period was identified 
from the patient’s CPRD clinical file. Individuals with a CHD event prior to January 1990 were 
excluded from the analysis. 
 
For the secondary analysis, the outcome of the study was combined fatal and non-fatal CHD 
for the subset of CPRD patients with linkage to ONS mortality data. Codes for fatal CHD were 
identified from the ONS record using the ICD-9 and ICD-10 classification systems (Table 8.1). 
The code list was based on those used by the CALIBER study group and modified to add 
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several additional codes identified in recent studies.(296) In this population the date of first 
fatal or non-fatal CHD event during the study period was identified.   
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Table 8.1 Medical codes for non-fatal CHD from CPRD and fatal CHD from ONS Mortality data 
Read Codes for non-fatal CHD found in the CPRD 
G3...00 Ischaemic heart disease 
G30..00 Acute myocardial infarction 
G31..00 Other acute and subacute ischaemic heart disease 
G32..00 Old myocardial infarction 
G33..00 Angina pectoris 
G34..00 Other chronic ischaemic heart disease 
G35..00 Subsequent myocardial infarction 
G38..00 Postoperative myocardial infarction 
G39..00 Coronary microvascular disease 
G3y..00 Other specified ischaemic heart disease 
G3z..00 Ischaemic heart disease NOS 
Gyu3.00 [X]Ischaemic heart diseases 
ICD Codes for Fatal CHD found in ONS Mortality data 
I20 Angina pectoris 
I21 Acute myocardial infarction 
I22 Subsequent myocardial infarction 
I23 Certain current complications following acute myocardial infarction 
I24 Other acute ischaemic heart diseases 
I25 Chronic ischaemic heart disease 
I46 Sudden cardiac death 
I49 Death due to ventricular fibrillation 
410 Acute myocardial infarction 
411 Other acute and subacute forms of ischemic heart disease 
412 Old myocardial infarction 
413 Angina pectoris 
414 Other forms of chronic ischaemic heart disease 
4292 Ill-defined descriptions and complications of heart disease; Cardiovascular disease, 
unspecified 
4295 Ill-defined descriptions and complications of heart disease; Rupture of chordae tendineae 
4296 Ill-defined descriptions and complications of heart disease; Rupture of papillary muscle 
4297 Ill-defined descriptions and complications of heart disease; Certain sequelae of MI 
 
8.7 Covariate definition 
Both time-constant and time-varying covariates were extracted for all subjects meeting the 
inclusion criteria. 
 
8.7.1 Time constant covariates 
Ethnicity, gender and deprivation were constant for each patient. For the main analysis 
ethnicity was categorized using the high-level Census groupings of White, South Asian, Black, 
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Mixed, Other and Not Stated. In this chapter, results for White, South Asian and Black groups 
only are reported. 
 
For the secondary analysis South Asian and Black groups were further subdivided into Indian, 
Pakistani, Bangladeshi, African and Caribbean, with rates and risk of CHD compared to the 
White population as a whole. 
 
Practice-level Index of Multiple Deprivation (IMD) data were available for all patients and used 
in the primary analysis of non-fatal CHD. Individual-level IMD was available for the subset of 
patients belonging to practices with linkage to deprivation data and used only in the analysis 
of fatal and non-fatal CHD for patients with linked ONS Mortality data.  
 
8.7.2 Time-varying covariates 
 
a) Medications 
For both diabetic and non-diabetic cohorts, the first ever prescription of antihypertensives, 
lipid-lowering medications and aspirin were extracted. For diabetic patients, first prescription 
of insulin, metformin or other antidiabetic drugs were additionally extracted. Exposure status 
was denoted by “0” for unexposed and “1” for exposed. Follow-up time prior to first prescription 
of each drug was denoted using “0”. This value switched to “1” on the date of first prescription. 
Patients whose first prescription occurred before the start of follow-up were classified as “1” 
throughout.  
 
b) Clinical measures 
V. Body mass index 
Body mass index values were either taken directly from the value associated with the clinical 
Read code for BMI (22K) or calculated using height and weight values recorded in the CPRD 
additional file using the equation (weight/height2).  Implausible values for height (below 1.37 
m and over 2.3m) were removed. Values over 100 which could reasonably be considered to 
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have been measured in centimetres were converted to metres. Similarly, implausible values 
for weight (<25.4kg or >254kg) and duplicate values recorded on the same day were removed. 
If a patient had multiple height or weight values recorded on the same day, the difference 
between the smallest and largest values was calculated; if the difference was less than or 
equal to 5 cm for height or 2 kg for weight, the average of the values was taken. If the difference 
was any larger, the records were dropped. 
 
BMI was calculated for all dates when both height and weight values were available. For dates 
when BMI could not be calculated, BMI values as recorded directly into the CPRD were 
substituted, resulting in a longitudinal record for each patient indicating all BMI values 
recorded during their time in the CPRD. BMI values below 15 or over 50 and duplicate values 
recorded on the same day were dropped.  
 
For analysis, the latest BMI recorded prior to follow-up and all values during follow-up were 
retained. BMI values were grouped into four categories of underweight, normal weight, 
overweight and obese, as defined by the World Health Organization:(297)  
I. Underweight (15–18.4 kg/m2) 
II. Normal weight (18.5–24.9 kg/m2) 
III. Overweight (25–29.9 kg/m2) 
IV. Obese (≥30 kg/m2) 
 
VI. Glycated haemoglobin 
Glycated haemoglobin (HbA1c) values were obtained from the Test results file of the CPRD 
and converted to % if recorded as mmol/mol. All HbA1c values greater than 20% and duplicate 
values recorded on the same day were removed. For analysis, the latest HbA1c recorded prior 
to follow-up and all values during follow-up were retained. HbA1c values were grouped into 
three categories of <5.4%, 5.5-6.4% and 6.5-20%. According to the UK National Institute for 
Health and Care Excellence (NICE), the target value for blood glucose control is 6.5%.(298) 
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VII. Total Serum Cholesterol 
Total serum cholesterol values were obtained from the Test results file of the CPRD. 
Implausible values (<2 mmol/L or >10 mmol/L) and duplicate values recorded on the same 
day were removed.  For analysis, the latest cholesterol value recorded prior to follow-up and 
all values during follow-up were retained. Cholesterol values were dichotomized into two 
groups indicated by “0” for values ≤5mmol/L and “1” for values >5mmol/L. 
   
VIII. Hypertension 
All values for systolic and diastolic blood pressure were obtained from the additional file of the 
CPRD. Implausible values for systolic blood pressure (<50 mmHg or >250 mmHg) and diastolic 
blood pressure (<35 mmHg or >140 mmHg) and duplicate values recorded on the same day 
were removed. For each date of blood pressure recording, an indicator for clinical 
hypertension was created to equal “0” if blood pressure was ≤140/90mmHg  and “1” if blood 
pressure was >140/90 mmHg, as defined by the NICE guidelines.(299) 
 
c) Lifestyle measures 
IX. Tobacco Consumption 
Clinical codes for tobacco consumption falling under the Read code hierarchy of 137% were 
categorized into three groups of “Non-smoker”, “Current smoker” and “Ex-smoker”. Patient’s 
smoking status changed over follow-up each time their category changed. For example, 
several patients with smoking status recorded alternated between smoker and non-smoker 
over the course of follow-up. 
 
X. Alcohol consumption 
Alcohol usage was derived either from the Read codes for alcohol intake or values for “Alcohol 
units per day” from the additional file of the CPRD. Values over 1,000 and duplicate values 
recorded on the same date were removed. Read codes and alcohol values were organised 
into three categories of “Non-drinker”, “Moderate drinker” and “Heavy drinker”, as used by the 
CALIBER study group.(300)   
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8.8 Statistical Analysis 
All analyses were performed using Stata MP, release 13.(301) 
 
8.8.1 Descriptive analyses 
Characteristics of patients, including demographics and clinical characteristics, at baseline 
and ‘ever usage of medications’ was summarised for patients with and without type 2 diabetes 
separately. For categorical variables, proportions were calculated; for continuous variables, 
means and standard deviations were calculated. Medians were calculated for continuous 
variables with a skewed distribution.  
 
8.8.2 Multivariable survival analysis  
a) Differences in CHD risk by diabetic status 
In order to quantify differences in the risk of first non-fatal CHD between patients with and 
without type 2 diabetes, the diabetic and non-diabetic denominator populations were 
combined. Interactions between diabetic status and age, gender, deprivation quintile and 
ethnic group were explored.  
 
b) Differences in CHD risk by ethnic group 
In order to compare the incidence of first CHD event by ethnic group, follow-up time was 
limited to each patient’s period of “Up to standard” (UTS) observation, as described in chapter 
3. For the diabetic cohort, the start of observation time was defined as being the latest of: 
i) date of T2DM diagnosis 
ii) 1 year after registration date 
iii) ‘practice up to standard’ date.   
 
For the non-diabetic random sample, the start of observation time was defined as being the 
latest of: 
i) turning age 30 
ii) registration date 
iii) ‘practice up to standard’ date.  
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For the non-diabetic matched sample, the start of observation time was equal to that of the 
matched individual with type two diabetes. 
 
In all cohorts, follow-up time ended at the date of first CHD event. In the secondary analysis of 
fatal and non-fatal CHD in patients with linked data, follow-up time ended at the date of first 
CHD event or cardiac death. For patients not experiencing a CHD event, follow-up time was 
censored at the earliest of transfer out date, last collection date and death from all causes or 
August 1st 2013. Follow-up time for those not experiencing the event of interest was censored 
at the earliest of transfer out date, last collection date, death from other causes, or August 1st 
2013. 
 
c) Analysis of crude incidence 
Crude incidence rates of first CHD per 10,000 person years of follow-up time were calculated 
for patients with and without T2DM. All analyses were stratified by gender and ethnic group. 
Cox proportional hazards regression using time since study entry as the timescale was used 
to evaluate the risk of developing a first CHD event in: 
I. all patients with T2DM diagnosed between January 1990 and August 2013 
II. a random sample of patients free from T2DM who were aged 30 or older between 
January 1990 and August 2013. 
 
d) Analysis of adjusted risk 
Multivariable Cox proportional hazards regression was used to examine the relative risk of fatal 
and non-fatal CHD in all ethnic groups relative to the White reference population. Four pre-
specified survival models with increasing levels of covariate adjustment were compared for 
each population of interest: 
 
1) Crude model for risk of CHD by ethnic group 
2)  Additionally adjusted for age 
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3) Additionally adjusted for component factors of the Framingham Risk Score(302) (Blood 
pressure, smoking status, and total cholesterol). Component measures from the 
Framingham Risk score were selected because they were well recorded in the 
database. More current risk models such as the QRISK score for ten year 
cardiovascular risk were not used due to poorer completeness of key variables such 
as family history of cardiovascular disease, and cholesterol:HDL ratio. 
 
4) Additionally adjusted for index of multiple deprivation, medication use and additional 
confounders well characterized in the CPRD.  Models for both diabetic and non-
diabetic cohorts included adjustment for BMI, alcohol consumption and first ever 
prescription of antihypertensives, lipid lowering medications or aspirin. Models for 
patients in the diabetic cohort further adjusted for HbA1c category and first prescription 
of insulin, metformin and other antidiabetic drugs. Models for the primary analysis of 
non-fatal CHD in the full CPRD cohort adjust for practice level IMD score, while those 
for the analysis of fatal and non-fatal CHD in the subset of patients with linked data 
adjust for patient-level IMD score. 
 
8.8.3 Clustering by practice  
In order to improve the accuracy of the statistical inference, regression analyses for all three 
study populations accounted for the effects of clustering by practice by using cluster robust 
standard errors. This accounts for the fact that the individuals contributing to the analysis are 
not independent of one another, but rather share some variation related to the practice that 
they attend. For example, health care delivery may differ between practices depending on 
local population needs, local financial incentives, and local care delivery schemes. Therefore 
patients within a single practice may share experiences which differ from patients attending 
different practices.  
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Failure to account for clustering can result in biased estimates of standard error and narrow 
confidence intervals. Accounting for clustering increase the standard errors and widens the 
95% confidence intervals to better reflect the non-independence of observations.(303)  
Clustering of the errors does not change the estimate of the hazard ratios, but allows for the 
errors to be correlated within clusters of practice and uncorrelated across practices.  
 
The use of hierarchical, or multilevel modelling methods using a random effects term allowing 
for patients to be clustered within practices was not suitable for this study as the shared frailty 
model (which models random effects In survival analyses) is not allowed when patients enter 
the study at different times (delayed study entry), as is the case with this analysis. Furthermore, 
adjusting for practice as a categorical, time independent variable in the regression models 
was not possible due to computational limits on matrix size in Stata, which would not allow 
for the addition of 640 indicators to the analyses.  
 
8.8.4 Approaches to handling missing data 
Apart from the demographic variables of year of birth and gender, all other Read-coded 
variables are missing to some degree in the CPRD. Missing data compromise the ability to 
make causal inferences by creating bias, causing a loss of statistical power, or by reducing 
the precision of estimates of effect size when restricting analyses to include patients with 
complete data (complete case analysis).  
 
In routine electronic health records, the input of information onto the patient record is 
dependent on a combination of factors relating to the patient, practitioner and service 
provision infrastructure. In databases such as the CPRD, where large patient populations are 
available for study, the missing data can potentially lead to information bias. The impact of 
information loss and bias depends both on the research question of interest and the ways in 
which the observed data are selected – known as missing data mechanisms.  In 1976, Rubin 
identified three main missing data mechanisms:(304)  
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1. Missing completely at random: The missing values and observed values do not differ 
systematically and the reason for the data being missing is unrelated to the outcome 
of interest. 
2. Missing at random: Missing values differ systematically from observed values, but the 
reasons for this difference can be explained by the other variables. 
3. Missing not at random: Missing values differ systematically from observed values and 
the reason is related to the outcome of interest.  
 
Two methods for dealing with missing data include using complete case analysis or replacing 
missing values with imputed values. Multiple imputation methods are appropriate for 
situations in which the mechanism is missing at random, or approaching missing at random. 
For the purposes of this study, multiple imputation was found to be inappropriate because 
several of the variables included in the study are likely to be missing not at random, and 
because reasons for ‘missingness’ are likely to differ depending on the covariate of interest. 
While measures such blood pressure and BMI are likely to be measured regularly as part of a 
health check, such health checks may occur more frequently for groups such as older adults 
and pregnant women.  
 
Measures such as HbA1c and cholesterol are likely to be measured more frequently in 
individuals with established or suspected health conditions, limiting the ability to make 
accurate comparisons between those with and without disease. Furthermore, variables such 
as tobacco consumption and alcohol use are subject to reporting bias which may affect an 
individual’s propensity to visit the GP or to report habits candidly, most often leading to an 
underestimate of the true exposure.(305) Finally, ethnicity may be better recorded for patients 
who are perceived to be at high risk, or have established disease conditions.  
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a) Sensitivity analyses 
For each of the regression models included in the study, sensitivity analysis using complete 
cases only was undertaken to examine the robustness of estimates of ethnic differences when 
restricting the analysis to individuals with complete covariate recording. 
 
For the main models describing differences between White, South Asian, and Black 
African/Caribbean ethnic groups, an additional sensitivity analysis was conducted using the 
non-diabetic population who were also free of type 1 diabetes at the time of the study.  
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Chapter 9  
Ethnic and gender differences in CHD risk 
amongst patients with and without type 2 
diabetes: Results for non-fatal CHD 
 
9.1 Summary 
This chapter reports the findings of the prospective cohort study identifying ethnic and gender 
differences in the risk of first non-fatal CHD for patients with and without type 2 diabetes. 
Section 9.2 describes the derivation of the study populations and section 9.3 their 
demographic and baseline clinical characteristics. The next section presents the findings of: 
the primary analyses, which identified ethnic differences in CHD risk amongst patients with 
T2DM and compared CHD risk to those without T2DM. The third section presents the results 
from secondary analyses which explored heterogeneity of risk between ethnic minority 
subgroups. The final section explores differences in risk of non-fatal CHD by diabetic status. 
 
9.2 Study Populations 
A total of 862,184 patients were included in the study. Participants were separated into two 
denominator populations: one of patients with T2DM diagnosed between 1990 and 2013, and 
one of patients free from T2DM over the same period. The diabetic cohort was derived from 
the 331,836 patients with T2DM identified in chapter 7. After applying inclusion criteria and 
logic checks, 196,254 were included in the main analysis of incident non-fatal CHD. Forty-four 
per cent of this population had linked ONS mortality data and were included in the secondary 
analysis of incident fatal and non-fatal CHD combined, presented in chapter 10. 
 
The first non-diabetic cohort was derived from a random sample of 1 million patients aged 30 
and over on January 1st 1990. From this sample, 967,810 were found to be free from diabetes 
as of August 1st 2013, and after applying the inclusion criteria and logic checks, 665,930 
individuals were included in the main analysis of incident non-fatal CHD.  
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The second non-diabetic cohort was derived from an age matched sample of 915,305 
individuals. The requirement that study entry date precede study exit date was incorporated 
into the matching program syntax. After removing patients with prevalent CHD, 858,054 
individuals were included in the main analysis of incident non-fatal CHD (Figure 9.1).  
 
Figure 9.1 Derivation of study cohorts 
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The gender and ethnic breakdown of the study populations is illustrated in figure 9.2. 
 
Figure 9.2 Breakdown of study populations by diabetic status, gender and ethnic group 
 
 
9.3 Demographic and baseline characteristics for main analysis of 
incident non-fatal CHD in the whole CPRD 
 
9.3.1 Demographic characteristics 
Table 9.1 shows the demographic and clinical characteristics of the subjects according to 
diabetic status. The two denominator populations for the main analysis of incident non-fatal 
CHD were 196,254 patients with type 2 diabetes free from CHD at the time of study entry and  
665,930 non-diabetic patients free from CHD at the age of 30. Ethnicity was recorded for 61.3% 
of the diabetic population and 47.8% of the non-diabetic population. The diabetic population 
comprised 56.1% White, 2.8% South Asian, 1.2% Black African/Caribbean and 39.8% of other 
or unknown ethnicity.   
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The non-diabetic random sample comprised 43.4% White, 1.8% South Asian, 1.2% Black 
African/Caribbean and 53.5% of other or unknown ethnicity. The non-diabetic matched 
sample comprised 46.4% White, 1.2% South Asian, 0.8% Black African/Caribbean and 51.6% 
of other or unknown ethnicity.  
 
In the diabetic population, 13,331 patients (6.8%) experienced a non-fatal CHD event over a 
total of 1,052,717 person-years of follow-up. Median follow-up time was 4.6 years in the diabetic 
cohort (SD 4.0)  
 
In the non-diabetic random sample, 23,248 patients (3.5%) experienced a non-fatal CHD event 
over a total of 4,731,546 person-years of follow-up. Median follow-up time was 5.5 years in the 
non-diabetic random sample (SD 6.0). 
 
In the non-diabetic matched sample, 62,976 patients (7.3%) experienced a non-fatal CHD 
event over a total of 7,435,005 person-years of follow-up. Median follow-up time was 7.8 years 
in the non-diabetic matched sample (SD 6.5). 
 
In the diabetic cohort, the proportion of patients experiencing a non-fatal CHD event was 
highest in the White population (7.2%) followed by South Asian (7.0%) and Black 
African/Caribbean (3.3%). In the non-diabetic population, events were most common in the 
White group (6.2%) followed by South Asian (4.5%) and Black African/Caribbean (4.4%). 
 
The median age at baseline was 62.5 for diabetic participants (SD 13.0) and 42.0 for the non-
diabetic random sample (SD 16.4) and 56 for the non-diabetic matched sample (SD 14.1).  In 
both the diabetic and non-diabetic cohorts, the median age at study entry was over 10 years 
lower for South Asian than for White patients. Compared with the non-diabetic population, the 
diabetic population had a greater proportion of males (53.5% vs. 48.3%).  
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9.3.2 Medications 
Recording of medication usage can be thought of as being 100% complete, as a code is added 
to the medical record only when a prescription is issued; thus, the absence of a code indicates 
that no prescription was made. Over the course of follow-up, insulin was prescribed for 13.2% 
of those with diabetes, metformin for 70.9% and other antidiabetic drugs for 50.2%. Prescription 
of insulin and other antidiabetic drugs (OAD) was comparable between ethnic groups while 
metformin prescription was 10% higher for the South Asian group (82.8%) compared with the 
White group (72.3%). The prescription of cardiovascular medications was 3–6 times higher in 
the diabetic compared with the non-diabetic cohort. In both cohorts, the prescribing of 
cardiovascular medication was highest in the White group.  
 
9.3.3 Clinical covariates 
Completeness of covariate recording was consistently higher in the diabetic cohort than in the 
non-diabetic cohort. A baseline blood pressure value was available for 99.8% of diabetics and 
86.0% of non-diabetics, with hypertension recorded in 42% of diabetics and 19.6% of non-
diabetics. Hypertension was most prevalent in the White group, followed by Black and South 
Asian groups in both diabetic and non-diabetic cohorts. 
 
Total cholesterol values were available for 97.5% of diabetics and 40.7% of non-diabetics, with 
raised cholesterol at baseline evident in 31% of diabetics and 26% of non-diabetics. The 
proportion of patients with raised baseline cholesterol did not vary by ethnic group amongst 
diabetics, but was raised in the White group compared with South Asian and Black groups in 
the non-diabetic cohort.  
 
Smoking status was recorded for 97.8% of diabetics and 88.2% of non-diabetics. At baseline, 
fewer diabetics had their latest smoking status recorded as “current smoker” compared with 
non-diabetics (15.6% vs. 26.1%). In both the diabetic and non-diabetic cohorts, the proportion 
of current and ex-smokers was highest in the White group and lowest in the South Asian 
group.  
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Alcohol usage was recorded for 94.9% of diabetics and 76.4% of non-diabetics.  The majority 
of South Asians in both diabetic and non-diabetics had their baseline alcohol status recorded 
as “non-drinker” (66.5% diabetic, 54.4% non-diabetic). In both diabetic cohorts, heavy drinking 
was 4–8 times more prevalent in the White group than in the South Asian and Black groups. 
 
Body mass index was recorded for 97.9% of diabetics and 77.1% of non-diabetics. While 37.8% 
of non-diabetics were overweight or obese, 81.8% of diabetics were in that weight category. 
In the diabetic cohort, the majority of White and Black groups were obese, while the majority 
of South Asian patients fell into the overweight category. In the non-diabetic cohort, the 
majority of patients of all ethnic groups fell into the normal weight category. 
 
Amongst the 97.5% of diabetics with HbA1c values recorded, 69.2% had a baseline value 
greater than 6.5%. The proportion of patients with raised HbA1c was highest for South Asian 
patients (78.8%) followed by Black (72.4%) and White (68.8%) patients. 
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Table 9.1  Demographic, clinical, and therapeutic characteristics of CPRD patients with and without T2DM 
 T2DM N=196,254 Non diabetic random sample N=665,930 
 White South Asian Black All other Total White South Asian Black All other Total 
 N % N % N % N % N % N % N % N % N % N % 
Total 110,180 100 5,520 100 2,412 100 78142 100 196,254 100 289,128 100 12,147 100 8,134 100 356,521 100 665,930 100 
Incident CHD 7,928 7.2 385 7.0 80 3.3 4,938 6.3 13,331 6.8 11,553 4.0 208 1.7 51 0.6 11,436 3.2 23,248 3.5 
Median follow-
up (SD) 
4.9 ±4.1 4.3 ±4.2 4.0 ±4.1 4.2 ±4.0 4.6 ±4.0 6.0 ±6.2 3.0 ±4.5 3.1 ±4.4 5.2 ±5.9 5.5 ±6.0 
Gender                     
Male 58,045 52.7 2,877 52.1 1,160 48.1 42,943 55.0 105,025 53.5 129,776 44.9 5,841 48.1 3,577 44 182,628 51.2 321,822 48.3 
Female 52,135 47.3 2,643 47.9 1,252 51.9 35,199 45.0 91,229 46.5 159,352 55.1 6,306 51.9 4,557 56 173,893 48.8 344,108 51.7 
Age at study entry                    
30-39 4,183 3.8 763 13.8 206 8.5 3,379 4.3 8,531 4.3 122,295 42.3 7,907 65.1 4,808 59.1 162,349 45.5 297,359 44.7 
40-49 14,023 12.7 1,519 27.5 603 25.0 10,985 14.1 27,130 13.8 57,129 19.8 2,166 17.8 1,977 24.3 69,485 19.5 130,757 19.6 
50-59 25,684 23.3 1,628 29.5 639 26.5 19,027 24.3 46,978 23.9 43,883 15.2 1,079 8.9 710 8.7 46,097 12.9 91,769 13.8 
60-69 31,482 28.6 1,020 18.5 564 23.4 21,104 27.0 54,170 27.6 31,444 10.9 600 4.9 365 4.5 31,788 8.9 64,197 9.6 
70+ 34,808 31.6 590 10.7 400 16.6 23,647 30.3 59,445 30.3 34,377 11.9 395 3.3 274 3.4 46,802 13.1 81,848 12.3 
Median age (SD) 63.2 ±12.7 52.3 ±12.0 55.5 ±12.5 62.3 ±13.1 62.5 ±13.0 43 ±16.2 35 ±11.6 37 ±11.3 41 ±16.8 42 ±16.4 
Median age male 
(SD) 
61.7 ±12.2 51.4 ±11.9 54.9 ±12.6 60.4 ±12.5 60.8 ±12.4 43 ±15.0 36 ±11.4 38 ±11.0 40 ±15.2 41 ±15.1 
Median age fem. 
(SD) 
65.1 ±13.2 53.4 ±121 56.1 ±12.4 64.9 ±13.5 64.6 ±13.4 43 ±17.1 35 ±11.8 36 ±11.5 44 ±18.1 43 ±17.5 
Practice level IMD score                    
1 14,880 13.5 511 9.3 116 4.8 15,826 20.3 31,333 16.0 46,217 16 1,590 13.1 449 5.5 69,780 19.6 118,036 17.7 
2 23,760 21.6 779 14.1 265 11.0 10,911 14.0 35,715 18.2 64,394 22.3 1,903 15.7 925 11.4 62,836 17.6 130,058 19.5 
3 22,734 20.6 1,180 21.4 501 20.8 18,062 23.1 42,477 21.6 62,274 21.5 2,818 23.2 1,538 18.9 75,596 21.2 142,226 21.4 
4 24,636 22.4 1,394 25.3 874 36.2 17,597 22.5 44,501 22.7 62,093 21.5 2,813 23.2 2,815 34.6 82,026 23 149,747 22.5 
5 24,170 21.9 1,656 30.0 656 27.2 15,746 20.2 42,228 21.5 54,150 18.7 3,023 24.9 2,407 29.6 66,283 18.6 125,863 18.9 
Medications ever prescribed+                   
Insulin 15,412 14 684 12.4 373 15.5 9,477 12.1 25,946 13.2           
Metformin 79,629 72.3 4,571 82.8 1,921 79.6 53,102 68 139,223 70.9           
OAD 55,426 50.3 2,833 51.3 1,195 49.5 39,076 50 98,530 50.2           
Antihypertensives 90,985 82.6 3,811 69 1,783 73.9 60,994 78.1 157,573 80.3 96,912 33.5 2,093 17.2 1,755 21.6 89,449 25.1 190,209 28.6 
Lipid lowering 87,817 79.7 4,225 76.5 1,659 68.8 56,446 72.2 150,147 76.5 47,351 16.4 1,281 10.5 646 7.9 32,024 9 81,302 12.2 
Aspirin 58,665 53.2 2,511 45.5 1,000 41.5 37,646 48.2 99,822 50.9 43,303 15 842 6.9 495 6.1 37,047 10.4 81,687 12.3 
With linked ONS mortality data                   
 71,405 64.8 3,120 56.5 1,500 62.2 10,755 13.8 86,780 44.2 165,794 57.3 4,872 40.1 3,833 47.1 35,063 9.8 209,562 31.5 
+ Medications for diabetes extracted only for patients with diagnosed type 2 diabetes  
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Table 9.1 Continued… 
  T2DM N=196,254 Non diabetic random sample N=665,930 
 White South Asian Black All other Total White South Asian Black All other Total 
 N % N % N % N % N % N % N % N % N % N % 
Baseline clinical measures                    
Blood Pressure                     
≤140/90 mmHg 63,040 57.2 3,495 63.3 1,450 60.1 44,805 57.3 112,790 57.5 204944 70.9 9423 77.6 5976 73.5 221907 62.2 442250 66.4 
>140/90 mmHg 47,058 42.7 2,018 36.6 958 39.7 32,962 42.2 82,996 42.3 61913 21.4 1338 11 1428 17.6 66064 18.5 130743 19.6 
Unknown 82 0.1 7.0 0.1 4.0 0.2 375 0.5 468 0.2 22271 7.7 1386 11.4 730 9 68550 19.2 92937 14 
Cholesterol                     
≤5 mmol/L 75,420 68.5 3,839 69.5 1,629 67.5 49,924 63.9 130,812 66.7 52485 18.2 2765 22.8 1913 23.5 42359 11.9 99522 14.9 
>5 mmol/L 33,347 30.3 1,649 29.9 754 31.3 24,690 31.6 60,440 30.8 94132 32.6 2763 22.7 1575 19.4 72768 20.4 171238 25.7 
Unknown 1,413 1.3 32 0.6 29 1.2 3528 4.5 5002 2.5 142511 49.3 6619 54.5 4646 57.1 241394 67.7 395170 59.3 
Smoking Status                     
Non 56,626 51.4 4,255 77.1 1,705 70.7 42,709 54.7 105,295 53.7 154150 53.3 9229 76 5858 72 177154 49.7 346391 52 
Current 17,812 16.2 561 10.2 255 10.6 11,961 15.3 30,589 15.6 84645 29.3 1716 14.1 1454 17.9 86231 24.2 174046 26.1 
Ex 35,075 31.8 685 12.4 441 18.3 21,745 27.8 57,946 29.5 37919 13.1 769 6.3 539 6.6 29384 8.2 68611 10.3 
Unknown 667 0.6 19 0.3 11 0.5 1727 2.2 2424 1.2 12414 4.3 433 3.6 283 3.5 63752 17.9 76882 11.5 
Alcohol consumption                    
Non 26,412 24 3,671 66.5 1,037 43 20,091 25.7 51,211 26.1 43833 15.2 6610 54.4 3329 40.9 51955 14.6 105727 15.9 
Moderate 70,304 63.8 1,495 27.1 1,221 50.6 46,855 60 119,875 61.1 173676 60.1 3287 27.1 3331 41 175163 49.1 355457 53.4 
High 9,056 8.2 120 2.2 55 2.3 5,854 7.5 15,085 7.7 24414 8.4 140 1.2 152 1.9 22725 6.4 47431 7.1 
Unknown 4,408 4.0 234 4.2 99 4.1 5,342 6.8 10,083 5.1 47205 16.3 2110 17.4 1322 16.3 106678 29.9 157315 23.6 
Body Mass Index                     
Underweight 908 0.8 33 0.6 6 0.2 580 0.7 1527 0.8 6095 2.1 479 3.9 147 1.8 6499 1.8 13220 2 
Normal 16,163 14.7 1,301 23.6 340 14.1 12,181 15.6 29,985 15.3 117111 40.5 5386 44.3 2669 32.8 124740 35 249906 37.5 
Overweight 35,638 32.3 2,297 41.6 886 36.7 25,932 33.2 64,753 33 83120 28.7 3388 27.9 2552 31.4 83110 23.3 172170 25.9 
Obese 55,915 50.7 1,853 33.6 1,156 47.9 36,919 47.2 95,843 48.8 40420 14 1210 10 1703 20.9 35608 10 78941 11.9 
Unknown 1,556 1.4 36.0 0.7 24 1.0 2,530 3.2 4,146 2.1 42382 14.7 1684 13.9 1063 13.1 106564 29.9 151693 22.8 
HbA1c+                     
<5.5% 7,708 7.0 286 5.2 181 7.5 5037 6.4 13,212 6.7           
5.5-6.4% 24,952 22.6 831 15.1 433 18 16,068 20.6 42,284 21.5           
≥5.5% 75,845 68.8 4,348 78.8 1,746 72.4 53,936 69.0 135,875 69.2           
Unknown 1,675 1.5 55.0 1.0 52 2.2 3,101 4.0 4,883 2.5           
+Hba1C values collected and analysed for patients with diagnosed type 2 diabetes only          
 
  
Chapter 9: Ethnic differences in non-fatal CHD 
168 
 
Table 9.1 continued... 
 Non diabetic matched sample N=858,054 
 White South Asian Black All other Total 
 N % N % N % N % N % 
Total    100.0 9,974 100.0 6,535 100.0 443,009 100.0 858,054 100.0 
Incident CHD 34,332 8.6 691 6.9 188 2.9 27,765 6.3 62,976 7.3 
Median follow-up (SD) 9.1 ±6.6 4.8 ±5.7 4.5 ±5.5 6.9 ±6.4 7.8 ±6.5 
Gender           
Male 181,564 45.6 4,754 47.7 2,900 44.4 217,766 49.2 406,984 47.4 
Female 216,972 54.4 5,220 52.3 3,635 55.6 225,226 50.8 451,053 52.6 
Age at study entry           
30-39 42,877 10.8 2,136 21.4 1,420 21.7 69,072 15.6 115,505 13.5 
40-49 72,320 18.1 2,356 23.6 1,771 27.1 93,360 21.1 169,807 19.8 
50-59 105,680 26.5 2,419 24.3 1,373 21.0 109,040 24.6 218,512 25.5 
60-69 98,319 24.7 1,947 19.5 1,219 18.7 93,550 21.1 195,035 22.7 
70+ 79,340 19.9 1,116 11.2 752 11.5 77,987 17.6 159,195 18.6 
Median age (SD) 58 ±13.8 52 ±13.5 50 ±13.5 55 ±14.3 56 ±14.1 
Median age male (SD) 56 ±13.0 51 ±13.4      50 ±13.2 53 ±13.7 55 ±13.5 
Median age fem. (SD) 58 ±14.3 52 ±13.8 50 ±13.8 57 ±14.7 57 ±14.5 
Practice level IMD score           
1 55,904 14.0 923 9.3 280 4.3 84,203 19.0 141,310 16.5 
2 85,607 21.5 1,199 12.0 694 10.6 69,185 15.6 156,685 18.3 
3 83,666 21.0 2,266 22.7 1,376 21.1 95,544 21.6 182,852 21.3 
4 87,975 22.1 2,514 25.2 2,152 32.9 100,538 22.7 193,179 22.5 
5 85,384 21.4 3,072 30.8 2,033 31.1 93,539 21.1 184,028 21.4 
Medications ever prescribed+           
Antihypertensives 213,996 53.7 4,437 44.5 2,993 45.8 174,709 39.4 396,135 46.2 
Lipid lowering 135,652 34.0 3,524 35.3 1,715 26.2 84,866 19.2 225,757 26.3 
Aspirin 118,087 29.6 2,522 25.3 1,243 19.0 86,084 19.4 207,936 24.2 
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Table 9.1 continued... 
 
 Non diabetic matched sample N=858,054 
 White South Asian Black All other Total 
 N % N % N % N % N % 
Baseline clinical measures          
Blood Pressure           
≤140/90 mmHg      245,240       61.5                 6,907                   69.3     4,162       63.7    241,376       54.5    497,685      58.0  
>140/90 mmHg      135,967       34.1                 2,478                   24.8     2,031       31.1    127,171       28.7    267,647      31.2  
Unknown        17,329         4.3                   589                     5.9        342         5.2      74,462       16.8      92,722      10.8  
Cholesterol           
≤5 mmol/L        83,847       21.0                 3,082                   30.9     1,896       29.0      56,144       12.7    144,969      16.9  
>5 mmol/L      192,220       48.2                 4,129                   41.4     2,422       37.1    132,598       29.9    331,369      38.6  
Unknown      122,469       30.7                 2,763                   27.7     2,217       33.9    254,267       57.4    381,716      44.5  
Smoking Status           
Non      217,998       54.7                 7,729                   77.5     4,631       70.9    218,052       49.2    448,410      52.3  
Current      106,023       26.6                 1,295                   13.0     1,079       16.5    103,026       23.3    211,423      24.6  
Ex        58,582       14.7                   621                     6.2        566         8.7      42,510         9.6    102,279      11.9  
Unknown        15,933         4.0                   329                     3.3        259         4.0      79,421       17.9      95,942      11.2  
Alcohol consumption          
Non        70,649       17.7                 5,961                   59.8     2,630       40.2      72,766       16.4    152,006      17.7  
Moderate      240,433       60.3                 2,517                   25.2     2,862       43.8    215,097       48.6    460,909      53.7  
High        34,163         8.6                   183                     1.8        162         2.5      29,913         6.8      64,421        7.5  
Unknown        53,291       13.4                 1,313                   13.2        881       13.5    125,233       28.3    180,718      21.1  
Body Mass Index           
Underweight          5,822         1.5                   241                     2.4          76         1.2        5,822         1.3      11,961        1.4  
Normal      139,959       35.1                 3,831                   38.4     1,749       26.8    136,896       30.9    282,435      32.9  
Overweight      134,607       33.8                 3,328                   33.4     2,274       34.8    119,091       26.9    259,300      30.2  
Obese        69,414       17.4                 1,489                   14.9     1,685       25.8      55,971       12.6    128,559      15.0  
Unknown        48,734       12.2                 1,085                   10.9        751       11.5    125,229       28.3    175,799      20.5  
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9.4 Comparison of incident non-fatal CHD risk according to diabetic 
status  
The first objective of this study was to compare the risk of incident CHD between patients with 
and without type 2 diabetes and explore interactions between diabetic status and ethnic 
group, age, gender and deprivation 
 
9.4.1 Comparison with random sample of non-diabetics 
The combined study population of 862,184 patients was used to compare the incidence of 
non-fatal CHD between individuals with type 2 diabetes and the random sample without type 
2 diabetes. Table 9.2 displays the crude and adjusted hazard ratios for the entire study 
population as a whole and stratified by ethnic group. Within the whole study population, 36,579 
incident events of non-fatal CHD were recorded. The crude risk of non-fatal CHD was 39% 
higher in the diabetic population compared with the non-diabetic reference population (HR 
1.39, CI 95 1.36, 1.42). After adjustment for age, gender and practice-level deprivation, the 
excess risk in the diabetic population was reduced to 22% (HR 1.22, CI95% 1.20, 1.25).  By 
ethnic group, the adjusted risk of non-fatal CHD was increased in the Black population by 75% 
(HR 1.75, CI95% 1.18, 2.58), in the South Asian population by 60% (HR 1.60, CI95% 1.34, 1.91) 
and in the White population by 28% (HR 1.28, CI95% 1.24, 1.31).  
 
Table 9.2 Incidence of non-fatal CHD according to diabetic status: random sample of non-diabetics 
 White South Asian Black Other/unknown Total 
N 399,308  17,667  10,546  434,663 862,184  
Incident CHD 19,481  593  131  16,374  36,579  
 HR [CI 95] HR [CI 95] HR [CI 95] HR [CI 95] HR [CI 95] 
Non T2DM (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM crude 1.44 [1.40, 1.48] 1.67 [1.40, 1.99] 1.75 [1.19, 2.58] 1.32 [1.27, 1.36] 1.39 [1.36, 1.42] 
T2DM adjusted 1.28 [1.24, 1.31] 1.60 [1.34, 1.91] 1.75 [1.18, 2.58] 1.15 [1.11, 1.19] 1.22 [1.20, 1.25] 
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The results from the Cox regression examining interactions between diabetic status 
demographic factors are displayed in table 9.3. Tests for effect modification by gender, age 
and deprivation were found to be statistically significant. No significant interaction between 
diabetic status and ethnic group was found. The interaction between diabetic status and 
gender indicates that the relative risk of CHD for females compared with males differs between 
diabetic and non-diabetic patients. The reduction in CHD risk for females was greater for non-
diabetics than diabetics (HR 0.58, CI95% 0.57, 0.59 vs. HR 0.67, CI95% 0.64, 0.69).  
 
Similarly, the increase in CHD risk by ten-year age band was significantly greater for non-
diabetic patients than for diabetic patients. In the diabetic cohort, CHD risk increased by 46% 
in the oldest group compared with the youngest group (CI95%  1.16, 1.84); In the non-diabetic 
cohort, CHD risk increased by almost 6 times in the oldest group compared with the youngest 
(HR 5.81, CI95%  5.19, 6.52).  
 
The increase in CHD risk for those in the least affluent deprivation quintile compared with 
those in the most affluent quintile was larger for non-diabetics than for diabetics (HR 1.48, 
CI95% 1.42, 1.55 vs. HR 1.16, CI95% 1.10, 1.23). The test for interaction between ethnic group 
and diabetic status was non-significant, as exemplified by the overlapping confidence 
intervals for diabetic/non-diabetic South Asian patients and diabetic/non-diabetic Black 
patients. Thus, the difference in CHD risk for ethnic minority groups compared with White does 
not depend on diabetic status.  
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Table 9.3 Incidence of non-fatal CHD: Interactions between diabetic status and demographic 
factors 
 NON T2DM 
random sample 
T2DM  P value for interaction with diabetic 
status 
 HR [CI 95] HR [CI 95]  
Ethnic Group      
White (ref) 1 -- 1 --  
South Asian 1.52 [0.33, 1.75] 1.32 [1.19, 1.47] 0.297 
Black 0.56 [0.43, 0.75] 0.58 [0.47, 0.72] 0.370 
Gender      
Male (ref) 1 -- 1 --  
Female 0.58 [0.57, 0.59] 0.67 [0.64, 0.69] 0.007 
Age Group      
30–39 (ref) 1 -- 1 --  
40–49 1.48 [1.37, 1.62] 1.04 [0.86, 1.27] <0.001 
50–59 2.21 [2.01, 2.43] 1.19 [0.96, 1.47] <0.001 
60–69 3.56 [3.21, 3.96] 1.26 [1.01, 1.58] <0.001 
70+ 5.81 [5.19, 6.52] 1.46 [1.16, 1.84] <0.001 
Deprivation Quintile      
IMD 1 (most affluent) (ref) 1 -- 1 --  
IMD 5 (least affluent) 1.48 [1.42, 1.55] 1.16 [1.10, 1.23] <0.001 
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9.4.2 Comparison with non-diabetic matched sample 
The combined study population of 1,054,308 patients was used to compare the incidence of 
non-fatal CHD between individuals with type 2 diabetes and the matched sample without type 
2 diabetes. Table 9.4 displays the crude and adjusted hazard ratios for the entire study 
population as a whole and stratified by ethnic group. Within the whole study population, 76,307 
incident events of non-fatal CHD were recorded.  
 
The influence of type 2 diabetes on the risk of incident non-fatal CHD was more modest in this 
analysis compared to the previous analysis utilizing the random sample of non-diabetics.  
 
The crude risk of non-fatal CHD was 23% higher in the diabetic population compared with the 
non-diabetic reference population (HR 1.23, CI 95 1.21, 1.26). After adjustment for age, gender 
and practice-level deprivation, the excess risk in the diabetic population was reduced to 7% 
(HR 1.07, CI95% 1.05, 1.10).  By ethnic group, the adjusted risk of non-fatal CHD was increased 
in all groups by 7%, except for the Black African/Caribbean population, for whom no difference 
in CHD risk between individuals with and without diabetes was found.   
 
Table 9.4 Incidence of non-fatal CHD according to diabetic status: non-diabetics matched sample 
 White South Asian Black Other/unknown Total 
N 508,716  15,494  8,971  521,151 1,054,308  
Incident CHD 42,260  1,076  268  32,703  76,307  
 HR [CI 95] HR [CI 95] HR [CI 95] HR [CI 95] HR [CI 95] 
Non T2DM (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM crude 1.21 [1.18, 1.24] 1.13 [0.99, 1.28] 1.05 [0.81, 1.37] 1.24 [1.21, 1.27] 1.23 [1.21, 1.26] 
T2DM adjusted 1.07 [1.05, 1.10] 1.07 [0.94, 1.21] 0.97 [0.75, 1.27] 1.07 [1.04, 1.10] 1.08 [1.06, 1.10] 
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The results from the Cox regression examining interactions between diabetic status 
demographic factors are displayed in table 9.5.  
 
As with the comparison using the random non-diabetic sample, tests for effect modification 
indicated a significant difference in the relationship between diabetes and CHD by gender, 
age and deprivation in the matched sample. No notable interaction between diabetic status 
and ethnic group was found.  
 
Table 9.5 Incidence of non-fatal CHD: Interactions between diabetic status and demographic factors 
 NON T2DM  
matched sample 
T2DM  P value for interaction with diabetic 
status 
 HR [CI 95] HR [CI 95]  
Ethnic Group      
White (ref) 1 -- 1 --  
South Asian 1.62 [0.33, 1.75] 1.32 [1.19, 1.47] 0.301 
Black 0.71 [0.43, 0.75] 0.58 [0.47, 0.72] 0.333 
Gender      
Male (ref) 1 -- 1 --  
Female 0.57 [0.56, 0.57] 0.67 [0.64, 0.69] <0.001 
Age Group      
30–39 (ref) 1 -- 1 --  
40–49 1.52 [1.42, 1.63] 1.04 [0.86, 1.27] <0.001 
50–59 2.37 [2.21, 2.55] 1.19 [0.96, 1.47] <0.001 
60–69 3.68 [3.41 3.97] 1.26 [1.01, 1.58] <0.001 
70+ 5.68 [5.25 6.16] 1.46 [1.16, 1.84] <0.001 
Deprivation Quintile      
IMD 1 (most affluent) (ref) 1 -- 1 --  
IMD 5 (least affluent) 1.39 [1.36, 1.43] 1.16 [1.10, 1.23] <0.001 
 
9.5 Crude incidence of first non-fatal CHD event  
The second objective of this study was to quantify ethnic and gender differences in crude 
incidence rate of CHD for patients with and without type 2 diabetes. The analysis presented 
below describes the crude incidence and adjusted risk (section 9.6) of CHD within the diabetic 
and non-diabetic cohorts separately, stratified by gender and ethnic group. Crude incidence 
rates are displayed in table 9.6. The crude overall rate of incident non-fatal CHD was 126.5 per 
10,000 person-years in the diabetic cohort (CI95% 124.5, 128.8), 49.1 per 10,000 person-years 
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in the non-diabetic random sample (CI95% 48.5, 49.7), and 84.7 per 10,000 person-years in the 
non-diabetic matched sample (CI95 84.0, 85.4) 
 
9.5.1 By ethnic group 
The crude cumulative incidence curves for non-fatal CHD by ethnic group and gender are 
shown in figure 9.3. In the diabetic population, overall rates for males were highest for South 
Asians followed by White and Black African/Caribbean. Amongst diabetic women, rates were 
similar for White and South Asian groups and lower for Black African/Caribbean. In the non-
diabetic random sample, crude incidence rates in both men and women were highest in the 
White group, followed by South Asian and Black African/Caribbean.  
 
Figure 9.3 Cumulative incidence of non-fatal coronary heart disease 
 
9.5.2 By deprivation quintile 
Crude incidence of non-fatal CHD was higher for patients in the most deprived quintile of IMD 
score relative to the least deprived quintile for all patients regardless of ethnicity, gender, or 
diabetic status, save for Black diabetic females, where the trend was reversed. The difference 
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by deprivation quintile was greatest for White diabetic males, for whom CHD incidence was 
increased 9.5-fold in the most deprived compared with the least deprived group. 
 
9.5.3 By baseline clinical values and medication use 
Hypertension was associated with a 2- to 3-fold increase in CHD incidence amongst non-
diabetics, and a more modest increase amongst diabetics, except for Black African/Caribbean 
men, who had a slightly lower incidence rate of hypertension. Across all populations, total 
serum cholesterol over 5 mmol/L was associated with a higher crude incidence of non-fatal 
CHD except for amongst South Asian men without diabetes, for whom high cholesterol was 
associated with a lower incidence. No consistent relationship with BMI category, smoking 
status, alcohol consumption or HbA1c was evident in the crude analysis.  
 
Amongst diabetics only, prescriptions of insulin and other antidiabetic drugs were associated 
with increased CHD incidence, while those prescribed metformin had lower, higher or 
equivalent incidence across the three major ethnic groups.  In all groups, the prescription of 
antihypertensives, lipid-lowering medications and statins were associated with an increase in 
the CHD incidence by 3- to 11-fold, though the increases were broadly more modest in the 
diabetic group compared with the non-diabetic group.  
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Table 9.6 Crude incidence rate of non-fatal CHD per 10,000 person-years 
 T2DM N=196,254 Non T2DM random sample N=665,930 
 Males Females Males Females 
 White 
South 
Asian 
Black White 
South 
Asian 
Black White 
South 
Asian 
Black White 
South 
Asian 
Black 
Number of subjects 58,045 2,877 1,160 52,135 2,643 1,252 129,776 5,841 3,577 159,352 6,306 4,557 
Number of CHD events 4,867 245 46 3,056 140 34 6,521 139 22 5,032 69 29 
Person-years of follow-up  319,966 14,984 5,718 293,928 13,959 6,430 966,176 24,845 15,618 1,239,146 29,511 20,897 
Overall Rate/10,000 pyrs 152.3 163.5 80.4 104.0 100.3 52.9 67.5 55.9 14.1 40.6 23.4 13.9 
Practice level deprivation 
1 (least deprived) 15.0 158.8 147.8 98.0 114.2 71.9 61.8 55.8 0 32.3 22.2 9.4 
5 (most deprived) 142.9 201.3 134.7 122.7 123.7 56.3 79.6 57.9 24.2 52.7 28.7 20.1 
Hypertension             
BP <=140/90 mmHg 141.3 152.6 89.9 95.6 92.8 41.7 53.7 45.1 9.6 25.8 15.4 9.9 
BP >140/90 mmHg 156.1 176.6 70.1 108.7 104.7 69.5 118.6 142.0 32.0 86.4 77.4 35.8 
Cholesterol             
Chol =<5 mmol/L 129.2 152.3 65.5 83.4 86.2 47.4 99.2 91.5 21.2 45.5 27.0 14.8 
Chol >5 mmol/L 173.2 171.3 100.0 117.0 114.4 67.0 82.5 80.6 26.1 53.0 38.1 28.3 
Smoking Status             
Non smoker 136.3 150.2 67.2 99.9 97.3 55.5 57.2 52.5 14.1 36.9 22.2 16.0 
Smoker 144.3 144.5 87.1 103.7 119.8 0 73.7 58.8 14.6 38.3 14.3 4.3 
Ex-smoker 154.7 182.0 63.4 98.3 77.2 71.0 87.0 57.3 11.1 44.9 20.7 7.2 
Alcohol Consumption 
Non-drinker 158.8 173.3 71.1 89.4 66.5 67.2 87.2 65.8 21.0 57.8 23.1 10.5 
Moderate alcohol drinker 146.7 150.5 77.0 85.4 0 36.4 69.2 47.1 11.6 33.9 9.5 22.3 
Heavy drinker 118.7 104.3 0 96.6 67.2 0 57.9 86.8 19.4 26.3 38.6 0 
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  Table 9.6 Continued... 
 T2DM N=196,254 Non T2DM random sample N=665,930 
 Males Females Males Females 
 White South Asian Black White 
South 
Asian 
Black White 
South 
Asian 
Black White 
South 
Asian 
Black 
BMI Category             
Underweight 151.6 0.0 0.0 137.5 0.0 0.0 65.5 18.5 49.3 53.4 - - 
Normal 155.4 155.2 118.1 108.3 112.4 66.4 58.9 60.9 19.0 30.4 10.6 6.7 
Overweight 156.8 176.1 65.0 113.4 93.8 59.1 75.5 61.0 11.0 43.2 30.4 30.7 
Obese 139.5 142.3 81.4 91.0 86.1 48.7 81.7 47.3 12.0 43.9 49.5 6.6 
Hba1c Category             
<5.4 131.8 131.1 116.7 108.8 252.6 0.0       
5.5-6.4 124.7 125.3 86.3 86.2 87.0 39.3       
>=6.5 154.4 169.3 78.3 106.5 95.9 59.3       
Medications             
Antihypertensives                
No 100.0 110.0 52.5 58.0 35.6 7.1 41.4 32.7 7.8 19.1 10.1 4.4 
Yes 170.0 200.0 92.4 110.0 130.0 65.8 159.0 201.1 42.5 88.3 78.7 43.3 
Statins                                  
No 162.0 135.8 60.7 115.2 91.1 43.5 55.6 40.1 13.0 33.9 13.8 9.1 
Yes 147.8 176.8 93.7 99.4 105.3 58.1 185.6 223.9 30.4 118.8 159.5 92.5 
Aspirin                                  
No 111.7 88.2 42.2 81.0 60.3 26.5 48.8 43.7 10.7 27.3 15.9 8.6 
Yes 195.9 259.5 133.2 131.0 158.5 90.4 276.6 282.1 91.9 182.1 141.5 100.1 
Insulin                                   
No 148.0 151.8 85.0 97.2 95.8 54.6       
Yes 189.9 296.0 51.1 155.3 129.7 42.7       
Metformin             
No 165.4 162.0 99.8 109.2 97.6 40.5       
Yes 145.0 164.0 72.2 101.1 101.1 56.6       
OAD             
No 143.8 137.3 70.6 88.5 73.3 43.7       
Yes 161.5 187.8 89.2 121.6 126.1 60.8       
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Table 9.6 continued... 
 Non T2DM Matched sample N= 858,054 
 Males Females 
 White South Asian Black White South Asian Black 
Number of subjects 181,564 4,754 2,900 216,972 5,220 3,635 
Number of CHD events 19,854 439 99 14,478 252 89 
Person-years of follow-up  1,667,779 29,468 17,335 2,082,204 34,979 22,772 
Overall Rate/10,000 pyrs 119.1 149.0 57.1 69.5 72.0 39.1 
Practice level deprivation 
1 (least deprived)         107.4          101.8            66.9            60.8            72.5            25.6  
5 (most deprived)         132.9          163.3            59.3            83.5            88.1            43.7  
Hypertension       
BP <=140/90 mmHg 99.3 120.4 48.1 50.3 53.7 28.2 
BP >140/90 mmHg 17201 235.9 79.2 108.3 133.5 61.3 
Cholesterol       
Chol =<5 mmol/L 142.0 184.3 47.4 83.0 82.9 53.5 
Chol >5 mmol/L 164.5 200.5 103.1 89.7 110.9 55.9 
Smoking Status       
Non smoker         103.2  131.2           52.0  63.0           71.0  42.5 
Smoker         135.5  171.0           75.2  77.7           41.5  9.1 
Ex-smoker         145.4  206.5           53.2  78.8           78.5  39.7 
Alcohol Consumption 
Non-drinker 159.6 173.1 51.9 91.9 80.0 50.8 
Moderate alcohol drinker 120.9 127.1 51.2 61.5 27.5 27.1 
Heavy drinker 104.7 164.4 68.8 52.3 79.0 28.4 
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  Table 9.6 continued... 
 Non T2DM Matched sample N= 858,054 
 Males Females 
 White South Asian Black White South Asian Black 
BMI Category       
Underweight         110.6            61.9                0              72.8            22.3  0 
Normal         103.0          128.9            47.0            53.7            56.4            41.8  
Overweight         131.2          161.9            52.7            74.9            72.3            33.4  
Obese         148.3          197.9            59.4            85.1          117.7            37.3  
Medications       
Antihypertensives          
No 77.6 81.1 24.2 35.9 28.1 7.9 
Yes 21.6 296.2 108.3 116.6 148.0 76.3 
Statins                            
No 102.5 118.8 46.6 59.1 55.5 28.5 
Yes 227.5 300.0 125.3 143.7 183.2 115.7 
Aspirin                            
No 89.4 111.2 43.2 50.0 46.6 24.2 
Yes 321.2 409.5 176.4 205.1 274.5 157.5 
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9.5.4 By age group 
The age-specific incidence rates stratified by gender are shown in Figure 9.4. The incidence 
of CHD increased with age in both diabetic population and non-diabetic random sample, with 
all rates higher in males than females. Crude rates in each age band stayed highest in the 
diabetic population until age 70, at which point the rates for diabetic and non-diabetic groups 
converge. 
 
Figure 9.4 Age-specific incidence of non-fatal CHD by gender 
 
The age-specific incidence rates stratified by ethnic group are shown in Table 9.7. In all groups, 
the age-specific rates were highest in South Asians, followed by White and Black 
African/Caribbean groups.  Crude rates in the youngest age group were between 4 and 15 
times higher in the diabetic population than in the non-diabetic population, with the largest 
difference evident for White females (crude event rate of 1.4/10,000 person-years in non-
diabetics and 21.4/10,000 person-years in diabetics). Rates increased uniformly with age, 
except for Black African/Caribbean males, where the rate in those aged 70 and older was 
lower than in those aged 60–69.  In the black male population, the amount of time at risk 
contributed by the group aged 70 or more was greater than the time at risk in all other age 
groups. In the group aged 60–69 years, 20 incident CHD events occurred over 1,471 person-
years of follow-up. In the group aged 70 year or more, 13 incident CHD events occurred over 
1,547 person-years of follow-up. 
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Table 9.7 Age-specific incidence rates of non-fatal CHD according to gender, ethnic group and diabetic status, per 10,000 person-years 
 Person-
years of 
follow-up 
Men Women 
 White South Asian Black White South Asian Black 
  Rate CI 95% Rate CI 95% Rate CI 95% Rate CI 95% Rate CI 95% Rate CI 95% 
T2DM                    
Events  4,867   245   46   3,056   140   34   
30–39 23, 902 43.5 [29.6, 63.9] 26.3 [8.5, 81.7] 41.7 [5.9, 295.8] 21.4 [12.4, 36.8] 11.1 [1.6, 78.7] 0.0 . . 
40–49 107,703 81.6 [72.3, 92.2] 106.7 [77.3, 147.3] 27.5 [8.9, 85.2] 57.3 [48.6, 67.6] 68.0 [43.9, 105.4] 36.4 [13.7, 96.9] 
50–59 239,923 130.5 [122.4, 139.1] 170.1 [136.4, 212.1] 65.9 [34.3, 126.6] 75.8 [68.6, 83.7] 81.7 [58.9, 113.2] 26.4 [9.9, 70.4] 
60–69 302,362 151.1 [143.6, 159.0] 223.8 [178.5, 280.7] 136.0 [87.8, 210.9] 93.5 [87.0, 100.4] 120.5 [89.0, 163.0] 45.4 [22.7, 90.7] 
70+ 394,758 193.0 [185.0, 201.4] 214.3 [162.9, 282.0] 84.1 [48.8, 144.8] 133.6 [127.5, 140.0] 184.8 [136.0, 250.9] 94.4 [58.7, 151.9] 
Non- T2DM random sample                  
Events  6,521   139   22   5,032   69   29   
30–39 1,206,198 4.9 [4.0, 5.9] 6.2 [3.0, 13.1] 3.4 [0.8, 13.4] 1.4 [1.0, 1.9] 1.5 [0.4, 6.0] 2.2 [0.6, 8.9] 
40–49 1,175,799 27.0 [25.0, 29.1] 51.8 [37.2, 72.2] 9.1 [3.8, 21.9] 9.8 [8.7, 11.0] 10.3 [5.1, 20.5] 3.0 [0.8, 12.0] 
50–59 948,068 67.9 [64.4, 71.5] 100.0 [74.7, 140.0] 17.6 [6.6, 46.8] 29.5 [27.4, 31.7] 35.1 [21.5, 57.3] 32.7 [17.1, 62.9] 
60–69 684,908 120.0 [120.0, 130.0] 160.0 [110.0, 230.0] 37.6 [14.1, 100.0] 61.9 [58.5, 65.4] 85.8 [56.0, 130.0] 34.5 [14.4, 82.9] 
70+ 716,573 180.0 [170.0, 180.0] 220.0 [150.0, 320.0] 83.8 [40.0, 180.0] 120.0 [120.0, 130.0] 150.0 [99.8, 230.0] 110.0 [58.7, 190.0] 
Non- T2DM matched sample                
Events   19,854   439   99   14,478   252   89  
30–39 486,124  9.4   [7.6,   11.7]   21.0  [10.5,   41.9]   5.1   [0.7,   35.9]   5.0   [3.8,   6.5]   8.6   [3.2,   22.8]   3.2   [0.5,   22.7]  
40–49 1,212,263  41.1   [38.7,  43.7]  82.7   [64.3,   110.0]   10.8   [4.5,   26.1]   16.5   [15.1,   18.1]   24.3   [15.7,   37.7]   11.6   [5.5,  24.3]  
50–59 1,922,600  95.4   [92.6,   98.3]  140.0   [120.0,   170.0]   59.1   [40.3,   86.8]   41.6   [39.8,  43.4]   70.2   [55.5,   88.9]   32.5   [20.5,   51.6]  
60–69 1,994,820  150.0   [140.0,   150.0]   230.0   [200.0,  270.0]   97.3  [70.5,   130.0]   76.3   [74.1,   78.6]   110.0   [91.2,   140.0]   65.7   [46.5,   92.9] 
70+ 1,819,198  190.0  [180.0 ,  190.0]   290.0   [240.0,  340.0]   120.0   [82.3,   170.0]   120.0   [120.0,   120.0]   160.0   [130.0,   200.0]   97.2   [68.4,  140.0]  
Rates are per 10,000 person-years [95% confidence interval] 
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9.6 Adjusted risk of non-fatal CHD by ethnic group 
The third objective of this study was to examine ethnic differences in the adjusted risk of CHD 
for patients with and without type 2 diabetes.  
 
Table 9.8a presents the results of the Cox proportional hazards models for ethnic differences 
in non-fatal CHD risk stratified by diabetic status and gender. For both the diabetic and non-
diabetic cohorts, no ethnic differences were apparent in the crude model. After adjustment or 
matching for age, South Asian ethnicity was consistently associated with a higher risk of CHD 
compared with White ethnicity. Conversely, the risk of CHD in the Black African/Caribbean 
population was reduced in comparison with the White population. 
 
9.6.1  Diabetic Cohort 
In the fully adjusted models for diabetic males, risk of incident non-fatal CHD was increased 
by 42% for South Asian males compared with White males (HR 1.42, CI95%  1.21, 1.68) and 
reduced by 42% for Black African/Caribbean males compared with White males (HR 0.58, 
CI95%  0.41,0.84). This pattern was mirrored for diabetic females, though the final differences 
were smaller than for the male cohort. In the fully adjusted models, the risk of incident non-
fatal CHD was increased by 31% for South Asian women compared with White women (HR 
1.31, CI95%  1.05, 1.63) and reduced by 37% for Black African/Caribbean women compared 
with White women, with the confidence interval crossing unity (HR 0.63, CI95%  0.38, 1.03). 
 
9.6.2 Non-Diabetic Cohorts 
In the fully adjusted models, the ethnic differences in the non-diabetic random samples were 
comparable to the fully adjusted models for the diabetic population. In the random sample, 
the risk of incident non-fatal CHD was increased by 52% for South Asian males compared with 
White males (HR 1.52, CI95% 1.21, 1.91) and reduced by 66% for Black African/Caribbean 
males compared with White males (HR 0.33, CI95% 0.71, 0.64). In the matched sample, ethnic 
differences were more modest than in the random sample, but in the same direction. The risk 
of incident non-fatal CHD was increased by 36% for South Asian males compared with White 
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males (HR 1.36, CI95% 1.18, 1.57) and reduced by 55% for Black African/Caribbean males 
compared to White males (HR 0.45, CI95% 0.32, 0.63).  
 
The excess risk of CHD for South Asian females was comparable in both the random and 
matched non-diabetic samples, with stronger evidence for increased risk in the matched 
sample than in the random sample (HR 1.40, CI95% 1.17, 1.66 vs HR 1.39, CI95% 0.99, 1.96). 
Evidence for a reduction in risk for African/Caribbean women compared to White women was 
found for the matched non-diabetic population only (HR 0.73, CI95% 0.55, 0.99). 
 
9.6.3 Sensitivity Analysis 
Sensitivity analyses replicating all of the models described above using only the complete 
cases available for the fully adjusted models are presented in table 9.8b.  In diabetics and non-
diabetics of both genders, the point estimates and confidence intervals are comparable to 
those derived in the main analysis, with no difference in the interpretation of the relative risk of 
incident non-fatal CHD by ethnic group.  
 
Sensitivity analyses replicating the analysis of non-fatal CHD in patients without both T2DM 
and T1DM are presented in table 9.6c. The patterning of differences in CHD risk by ethnic 
group closely matches those of the main analysis.  
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Table 9.8a Incidence of non-fatal CHD amongst subjects with and without type 2 diabetes 
 Males Females 
  Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 South Asian 1.10 [0.97,1.25] 1.38 [1.21,1.58] 1.49 [1.29,1.73] 1.42 [1.21,1.68] 1.00 [0.85,1.18] 1.37 [1.16,1.62] 1.51 [1.25,1.82] 1.31 [1.05,1.63] 
 Black 0.54 [0.41,0.72] 0.60 [0.45,0.80] 0.57 [0.40,0.80] 0.58 [0.41,0.83] 0.53 [0.37,0.76] 0.62 [0.44,0.88] 0.73 [0.51,1.06] 0.63 [0.38,1.03] 
Subjects  105,025 105, 025 99,917 93,787 91,525 91,525 86,684 80,587 
Non T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
Random South Asian 0.98 [0.82,1.18] 1.77 [1.49,2.11] 1.63 [1.30,2.03] 1.52 [1.20,1.93] 0.71 [0.54,0.93] 1.61 [1.22,2.11] 1.65 [1.20,2.29] 1.39 [0.99,1.96] 
Sample Black 0.25 [0.16,0.37] 0.44 [0.29,0.67] 0.34 [0.18,0.62] 0.33 [0.17,0.65] 0.42 [0.29,0.61] 1.00 [0.69,1.44] 1.03 [0.65,1.64] 0.91 [0.57,1.46] 
Subjects  321,822 321,822 123,953 107,470 344,108 344,108 140,495 124,581 
Non T2DM White (ref) 1 -- n/a  1 -- 1 -- 1 -- n/a  1 -- 1 -- 
Matched South Asian 1.66 [1.48, 1.85] Already matched 1.59 [1.39,1.83] 1.36 [1.18,1.57] 1.56 [1.37,1.77] Already matched  [1.44,1.98] 1.40 [1.17,1.66] 
Sample  Black 0.62 [0.50,0.76] on age 0.54 [0.40,0.72] 0.45 [0.32,0.63] 0.85 [0.68,1.08] on age  [0.69,1.16] 0.73 [0.55,0.99] 
Subjects  406984 -- 200374 174560 451053 -- 234678 208839 
*All models account for clustering by practice 
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Table 9.6b Incidence of non-fatal CHD amongst subjects with and without type 2 diabetes – sensitivity analysis using complete cases only 
 Males Females 
  Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 South Asian 1.17 [1.00,1.36] 1.47 [1.25,1.72] 1.52 [1.30,1.78] 1.42 [1.21,1.68] 1.02 [0.83,1.25] 1.38 [1.12,1.71] 1.49 [1.20,1.85] 1.31 [1.05,1.63] 
 Black 0.56 [0.39,0.79] 0.60 [0.42,0.86] 0.62 [0.43,0.88] 0.58 [0.41,0.83] 0.57 [0.35,0.94] 0.66 [0.41,1.08] 0.69 [0.42,1.12] 0.63 [0.38,1.03] 
Subjects  93,787 93,787 93,787 93,787 80,587 80,587 80,587 80,587 
Non T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
Random South Asian 1.07 [0.85,1.34] 1.59 [1.26,2.00] 1.69 [1.34,2.13] 1.52 [1.20,1.93] 0.83 [0.60,1.17] 1.44 [1.03,2.03] 1.66 [1.18,2.33] 1.39 [0.99,1.96] 
Sample Black 0.23 [0.12,0.45] 0.33 [0.17,0.65] 0.35 [0.18,0.68] 0.33 [0.17,0.65] 0.65 [0.41,1.03] 1.07 [0.67,1.69] 1.16 [0.73,1.85] 0.91 [0.57,1.46] 
Subjects  107,470 107,470 107,470 107,470 124581 124581 124581 124581 
Non T2DM White (ref) 1 -- n/a 
Already matched 
1 -- 1 -- 1 -- n/a 1 -- 1 -- 
Matched South Asian 1.49 [1.29,1.72] 1.60 [1.38,1.86] 1.36 [1.18,1.57] 1.45 [1.22,1.71] Already matched 1.66 [1.41,1.96] 1.40 [1.17,1.66] 
Sample  Black 0.47 [0.34,0.66] on age 0.49 [0.35,0.69] 0.45 [0.32,0.63] 0.81 [0.60,1.09] on age 0.88 [0.65,1.18] 0.73 [0.55,0.99] 
Subjects  176560 -- 176560 176560 208839 -- 208839 208839 
*All models account for clustering by practice 
 
 
Table 9.c Incidence of non-fatal CHD amongst subjects without type 2 diabetes – sensitivity analysis excluding patients with T1DM 
 Males Females 
  Crude Age Framingham Full Crude Age Framingham Full 
Non T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
Non T1DM South Asian 0.99 [0.83,1.18] 1.79 [1.50,2.13] 1.64 [1.32,2.05] 1.52 [1.20,1.93] 0.71 [0.54,0.93] 1.61 [1.21,2.12] 1.65 [1.18,2.30] 1.38 [0.97,1.96] 
 Black 0.25 [0.16,0.37] 0.45 [0.30,0.68] 0.34 [0.19,0.63] 0.33 [0.17,0.65] 0.41 [0.27,0.61] 0.98 [0.66,1.45] 1.05 [0.66,1.67] 0.95 [0.60,1.50] 
Subjects  320,667 320,667 122,961 106,572 324,281 324,281 139,806 123,946 
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9.7 Adjusted risk of non-fatal CHD by ethnic minority subgroup 
The fourth objective of this study was to examine differences in the adjusted risk of CHD for 
ethnic minority subgroups in comparison with the White majority ethnic group.  
 
Table 9.9a presents the results of the Cox proportional hazards models for ethnic differences 
in risk of non-fatal CHD between the main South Asian and Black subgroups and the White 
group as a whole, stratified by diabetic status and gender. In the diabetic population, risk was 
significantly increased for all South Asian subgroups, and significantly reduced for Caribbean 
groups in relation to the White group. No differences between African and White groups were 
evident in the adjusted analysis.  
 
In both non-diabetic populations, risk was increased for Pakistani and Indian groups 
compared to white, with no evidence for a difference between the Bangladeshi and White 
populations. Strong evidence was found for a reduction in risk for Caribbean men compared 
to White men, with no differences between African/Caribbean and White groups for women 
after full adjustment.  
 
9.7.1 Diabetic Cohort 
In the fully adjusted models for diabetic males, risk of incident non-fatal CHD was almost 
doubled for Pakistani and Bangladeshi groups compared with White (Pakistani HR 1.90, CI95%  
1.40, 2.59, Bangladeshi HR 1.90, CI95%  1.07, 3.36). The risk for Indian males was increased by 
32% in comparison with White males (HR 1.32, CI95% 1.06, 1.64) and reduced by just under 
half for Caribbean males (HR 0.52, CI95% 0.31, 0.86).  
 
Amongst diabetic females, all risk differences were smaller than for males. The largest risk 
difference observed was for Indian women compared with White (HR 1.52, CI95% 1.15, 2.00), 
followed by Pakistani (HR 1.43, CI95% 0.92, 2.24) and Bangladeshi groups (HR 1.24 CI95% 0.58, 
2.62). The reduction in the Caribbean group was slightly less than in the male diabetic 
population (HR 0.60, CI95% 0.34, 1.06). 
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9.7.2 Non-diabetic Cohort 
a) Random sample 
The patterning of risk differences in the non-diabetic cohort differed from that of the diabetic 
cohort. Compared with diabetic males, the risk difference (relative to the White group) for non-
diabetic males was larger for Indians (HR 1.42, CI95% 1.03, 1.95) and smaller for Pakistanis (HR 
1.79, CI95% 1.07, 3.02). No evidence for a difference between Bangladeshi and White groups 
was found. The difference between Caribbean and White males was much larger in the non-
diabetic random sample compared with the diabetic cohort, with a 92% reduction in risk in 
the former (HR 0.08, CI95% 0.01, 0.58).  
Though the crude and age-adjusted models for female non-diabetics suggested an increase 
in risk for Pakistani and Indian groups, no ethnic differences for any South Asian or Black 
subgroups were evident in the Framingham and fully adjusted models. 
 
b) Matched sample 
Ethnic differences in the matched non-diabetic sample were comparable in direction and 
magnitude to those of the random non-diabetic sample after adjusting for all confounders and 
controlling for the effects of clustering by practice.  
 
9.7.3 Sensitivity Analysis 
Sensitivity analyses replicating all of the models described above using only the complete 
cases available for the fully adjusted models are presented in table 9.9b.  In all subgroups the 
point estimates were increased slightly for South Asians and decreased slightly for all other 
groups. No differences in the interpretation of the relative risk of incident non-fatal CHD by 
ethnic sub group were evident. 
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Table 9.9a Incidence of non-fatal CHD amongst subjects with and without type 2 diabetes – ethnic subgroup breakdown 
    Male Female 
    Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 Indian 0.97 [0.81,1.16] 1.17 [0.98,1.40] 1.34 [1.10,1.65] 1.32 [1.06,1.64] 1.15 [0.92,1.44] 1.48 [1.18,1.85] 1.66 [1.30,2.13] 1.52 [1.15,2.00] 
 Pakistani 1.61 [1.31,1.99] 2.20 [1.76,2.76] 2.31 [1.74,3.07] 1.90 [1.40,2.59] 1.07 [0.77,1.47] 1.53 [1.10,2.13] 1.79 [1.25,2.57] 1.43 [0.92,2.24] 
 Bangladeshi 1.56 [1.03,2.36] 2.03 [1.31,3.13] 2.18 [1.30,3.64] 1.90 [1.07,3.36] 0.80 [0.39,1.64] 1.34 [0.65,2.77] 1.22 [0.57,2.62] 1.24 [0.58,2.62] 
 African 0.51 [0.31,0.85] 0.65 [0.40,1.07] 0.72 [0.39,1.35] 0.74 [0.39,1.43] 0.37 [0.12,1.14] 0.50 [0.17,1.53] 0.68 [0.23,2.05] 0.72 [0.20,2.56] 
 Caribbean 0.57 [0.37,0.87] 0.57 [0.37,0.89] 0.50 [0.31,0.81] 0.52 [0.31,0.86] 0.57 [0.36,0.92] 0.62 [0.40,0.99] 0.69 [0.42,1.13] 0.60 [0.34,1.06] 
Subjects   105,455 105,455 100,009 94,439 91,525 91,525 86,684 80,587 
Non  White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM Indian 1.02 [0.79,1.31] 1.61 [1.25,2.06] 1.49 [1.10,2.01] 1.42 [1.03,1.95] 0.71 [0.49,1.03] 1.41 [0.96,2.06] 1.47 [0.95,2.28] 1.38 [0.85,2.23] 
Random  Pakistani 1.01 [0.72,1.41] 2.28 [1.63,3.19] 1.92 [1.21,3.05] 1.79 [1.07,3.02] 0.73 [0.42,1.29] 2.06 [1.14,3.72] 1.82 [0.85,3.87] 1.23 [0.53,2.88] 
sample Bangladeshi 0.86 [0.43,1.74] 1.75 [0.86,3.57] 1.48 [0.52,4.22] 1.08 [0.32,3.68] 0.22 [0.03,1.59] 0.69 [0.09,4.99] 0.98 [0.14,6.98] --¥ -- 
 African 0.24 [0.13,0.45] 0.49 [0.26,0.94] 0.48 [0.21,1.08] 0.54 [0.24,1.22] 0.32 [0.17,0.61] 0.94 [0.52,1.71] 1.36 [0.69,2.70] 1.26 [0.63,2.50] 
 Caribbean 0.21 [0.10,0.46] 0.28 [0.13,0.60] 0.15 [0.04,0.56] 0.08 [0.01,0.58] 0.60 [0.37,0.97] 1.14 [0.70,1.86] 1.00 [0.52,1.90] 0.84 [0.44,1.61] 
Subjects   315,215 315,215 122,288 106,124 337,324 337,324 138,802 123,160 
Non  White (ref) 1 --   1 -- 1 -- 1 --   1 -- 1 -- 
T2DM Indian 1.54 [1.33,1.78] n/a 1.39 [1.15,1.68] 1.20 [1.00,1.46] 1.54 [1.32,1.80] n/a  
Already matched 
on age 
 
 
 
1.64 [1.35,1.99] 1.39 [1.12,1.72] 
Matched Pakistani 1.97 [1.61,2.42] Already matched 1.94 [1.48,2.54] 1.63 [1.22,2.17] 2.35 [1.76,3.15] 2.70 [1.99,3.67] 1.96 [1.39,2.77] 
sample Bangladeshi 2.96 [2.17,4.04] On age 2.54 [1.53,4.21] 1.68 [0.88,3.23] 1.17 [0.56,2.46] 0.84 [0.29,2.42] 0.74 [0.27,2.02] 
 African 0.69 [0.49,0.97]  0.57 [0.35,0.93] 0.50 [0.29,0.85] 0.82 [0.53,1.28] 0.80 [0.47,1.38] 0.68 [0.39,1.19] 
 Caribbean 0.57 [0.42,0.78]   0.48 [0.31,0.73] 0.37 0.85 0.85 [0.64,1.13] 0.90 [0.64, 1.28] 0.74 [0.51,1.08] 
Subjects   406,984  200,374 176,560 451,053  234,678 208,839 
¥Unable to calculate hazard ratios and point estimates due to zero counts in some cells 
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Table 9.9b Incidence of non-fatal CHD amongst subjects with and without type 2 diabetes – ethnic subgroup breakdown, complete case analysis 
    Male Female 
    Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 Indian 1.13 [0.92,1.39] 1.35 [1.09,1.68] 1.41 [1.14,1.75] 1.31 [1.06,1.63] 1.21 [0.93,1.58] 1.58 [1.21,2.06] 1.70 [1.29,2.23] 1.51 [1.15,1.99] 
 Pakistani 1.48 [1.10,1.99] 2.04 [1.49,2.78] 2.09 [1.53,2.85] 1.87 [1.37,2.54] 1.10 [0.71,1.69] 1.56 [1.00,2.42] 1.70 [1.10,2.65] 1.40 [0.90,2.18] 
 Bangladeshi 1.52 [0.89,2.61] 2.08 [1.19,3.64] 2.12 [1.22,3.70] 1.88 [1.05,3.35] 0.79 [0.38,1.67] 1.31 [0.61,2.82] 1.44 [0.67,3.09] 1.19 [0.56,2.52] 
 African 0.56 [0.28,1.10] 0.72 [0.37,1.39] 0.74 [0.38,1.43] 0.74 [0.38,1.42] 0.50 [0.14,1.77] 0.68 [0.19,2.40] 0.72 [0.20,2.54] 0.71 [0.20,2.54] 
 Caribbean 0.56 [0.34,0.93] 0.55 [0.33,0.91] 0.55 [0.33,0.92] 0.52 [0.31,0.86] 0.60 [0.33,1.10] 0.64 [0.36,1.15] 0.67 [0.37,1.20] 0.59 [0.33,1.06] 
Subjects   94,439 94,439 94,439 94,439 80,587 80,587 80,587 80, 587 
Non  White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM Indian 1.05 [0.78,1.42] 1.42 [1.05,1.92] 1.54 [1.14,2.09] 1.42 [1.03,1.95] 0.88 [0.54,1.41] 1.36 [0.85,2.17] 1.56 [0.98,2.50] 1.38 [0.85,2.23] 
Random  Pakistani 1.10 [0.69,1.76] 2.09 [1.32,3.32] 2.10 [1.31,3.37] 1.79 [1.07,3.02] 0.76 [0.35,1.64] 1.53 [0.68,3.46] 1.77 [0.78,4.01] 1.23 [0.53,2.88] 
sample Bangladeshi 0.76 [0.24,2.40] 1.40 [0.42,4.70] 1.33 [0.40,4.48] 1.08 [0.32,3.68] --¥ -- -- -- -- -- -- -- 
 African 0.32 [0.15,0.71] 0.52 [0.23,1.18] 0.56 [0.25,1.26] 0.54 [0.24,1.22] 0.65 [0.33,1.30] 1.34 [0.68,2.65] 1.52 [0.77,3.00] 1.26 [0.63,2.50] 
 Caribbean 0.076 [0.01,0.54] 0.084 [0.01,0.61] 0.086 [0.01,0.62] 0.080 [0.01,0.58] 0.78 [0.42,1.46] 1.06 [0.56,2.01] 1.14 [0.60,2.15] 0.84 [0.44,1.61] 
Subjects   106,124 106,124 106,124 106,124 123,160 123,160 123,160 123,160 
Non  White (ref) 1 --   1 -- 1 -- 1 --   1 -- 1 -- 
T2DM Indian 1.25 [1.02,1.52] n/a  
Already matched 
On age 
 
 
 
1.35 [1.11,1.66] 1.20 [1.00,1.46] 1.42 [1.16,1.74] n/a  
Already matched 
On age 
 
 
 
1.63 [1.34,2.00] 1.39 [1.12,1.72] 
Matched  Pakistani 1.99 [1.52,2.60] 2.09 [1.59,2.76] 1.63 [1.22,2.17] 2.31 [1.65,3.25] 2.64 [1.88,3.73] 1.96 [1.39,2.77] 
sample Bangladeshi 2.20 [1.25,3.88] 2.29 [1.27,4.12] 1.68 [0.88,3.23] 0.82 [0.29,2.31] 0.95 [0.34,2.71] 0.74 [0.27,2.02] 
 African 0.49 [0.29,0.83] 0.53 [0.31,0.91] 0.50 [0.29,0.85] 0.77 [0.43,1.35] 0.84 [0.47,1.48] 0.68 [0.39,1.19] 
 Caribbean 0.40 [0.25,0.65] 0.41 [0.25,0.66] 0.37 [0.22,0.60] 0.83 [0.57,1.22] 0.89 [0.60,1.30] 0.74 [0.51,1.08] 
Subjects   176,560  176,560 176,560 208,839  208,839 208,839 
¥Unable to calculate hazard ratios and point estimates due to zero counts in some cells 
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9.8 Testing the assumptions underlying Cox proportional hazards 
regression  
Cox regression modelling makes no assumptions about the form of the baseline hazard. The 
advantage of cox models over Poisson is the use of infinitesimal time bands, which allows the 
relationship between rates and time to be modelled as finely as possible. The method does not 
require a particular survival model but it is not truly non-parametric because it assumes that the 
effects of the predictor variables upon survival are constant over time. Cox regression is 
considered a ‘semiparametric’ procedure because the baseline hazard function, h0 (t), (and the 
probability distribution of the survival times) does not have to be specified. Since the baseline 
hazard is not specified and the hazard function is not restricted to a specific form, the semi-
parametric model is widely used. 
 
A key assumption underlying the Cox regression model is that of proportional hazards. The 
assumption requires that, while the individual and baseline hazard rates may vary with time, their 
ratio must remain constant. This assumption implies that the effect of the predictor variables 
included in the Cox model do not change during the time covered by the study. 
The assumptions can be tested both graphically and inferentially. 
 
Cumulative incidence plots (also known as Nelson-Aalen plots) were used to test the 
proportionality of the effect of ethnicity on incident non-fatal CHD.  
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Figure 9.5 Nelson-Aalen cumulative incidence plots for patients with and without type 2 
diabetes 
 
The plots show that the curves for each ethnic group do not cross, except for at the very 
beginning of follow-up for the diabetic population. This may be due to the fact that the time scale 
used in the Cox regression analysis allowed for delayed entry, meaning that patients entered the 
study at different points in time. In this situation graphical methods may be less useful as very 
few subjects may be in follow-up when the time scale beings, and thus cumulative incidence 
rates may be unstable at that point in time. 
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Chapter 10  
Ethnic and gender differences in CHD risk 
amongst patients with and without type 2 
diabetes: Results for fatal and non-fatal CHD 
combined 
 
10.1 Summary 
This chapter reports on the findings of the cohort study identifying ethnic and gender 
differences in incidence of fatal and non-fatal CHD combined, in a subsample of patients with 
linked ONS mortality data. Section 10.2 describes the derivation of the study populations and 
section 10.3 their demographic and baseline clinical characteristics. The next section presents 
the findings of the primary analyses, which examine ethnic differences in CHD risk amongst 
patients with and without T2DM. Sections 10.6 and 10.7 presents the results from secondary 
analyses which explored heterogeneity of risk between ethnic minority subgroups. Section 
10.8 presents a comparison of results from the main and ONS linked studies. 
 
10.2 Study Populations 
The denominator populations required for this secondary study of fatal and non-fatal CHD 
were drawn from the samples identified in chapter 9. Of the 196,254 individuals with type 2 
diabetes described in the main analysis, 86,780 (44%) had linked ONS mortality data. Of the 
665,930 non-diabetic individuals included in the previous analysis, 209,543 (31%) had linked 
ONS mortality data and were included. A final sample of 296,342 individuals was included in 
the study of fatal and non-fatal CHD (Figure 10.1). 
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Figure 10.1 Derivation of study cohorts 
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The gender and ethnic breakdown of the CPRD and ONS linked study populations is illustrated 
in figure 10.2.  
 
Figure 10.2 Breakdown of study populations by diabetic status, gender and ethnic group 
 
10.3 Demographics and Baseline Characteristics 
 
10.3.1 Demographics 
Table 10.1 shows the demographic and clinical characteristics of the subjects according to 
diabetic status.  In the diabetic cohort, a total of 9,157 incident fatal and non-fatal CHD events 
occurred, over a total of 480,030 person-years of follow-up. In the non-diabetic cohort, a total 
of 13,854 incident fatal and non-fatal CHD events occurred over a total of 1.7 million person-
years of follow-up. Median follow-up time was 4.8 years for the diabetic cohort (SD 4.1 years) 
and 6.7 years for the non-diabetic cohort (SD 6.2 years). 
 
In the diabetic cohort, the proportion of patients experiencing a fatal and non-fatal CHD event 
was highest in the White population (10.7%), followed by South Asian (9.8%) and Black 
African/Caribbean (4.6%). In the non-diabetic population, events were most common in the 
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White group (6.9%), followed by South Asian (3.7%) and Black African/Caribbean (1.2%) 
groups. 
 
The median age at baseline was 63.8 for diabetic participants (SD 13.1) and 44.0 for non-
diabetic participants (SD 17.1).  In both the diabetic and non-diabetic cohorts, the median age 
at study entry was 10 years lower for South Asian and 8 years lower for Black patients 
compared with White patients.  
 
10.3.2 Medications 
The prescription of all medications was slightly higher in the ONS-inked subset compared to 
the main study sample. The largest difference was for antihypertensive medications, which 
were prescribed for 36.5% of the ONS linked subset and 28.6% of the main study sample. Over 
the course of follow-up, insulin was prescribed for 15.2% of diabetics, metformin for 71.9% and 
other antidiabetic drugs for 52%. Prescription of OAD and insulin was comparable between 
ethnic groups, while metformin prescription was 11% higher for the South Asian group (83.0%) 
compared with the White group (71.63%). The prescription of cardiovascular medications was 
3–6 times higher in the diabetic compared with the non-diabetic cohort and highest in the 
White group compared with all others.  
 
10.3.3 Clinical covariates 
Completeness of all clinical covariates was higher in the ONS-linked subset compared with 
the main study sample. A baseline blood pressure value was available for 99.9% of diabetics 
and 93.4% of non-diabetics, with hypertension recorded in 42.9% of diabetics and 22.3% of 
non-diabetics. Prevalence of hypertension at baseline was higher in the ONS-linked subset 
compared with the main study sample. Hypertension was most prevalent in the White group, 
followed by Black and South Asian groups in both diabetic and non-diabetic cohorts. 
 
Total cholesterol values were available for 98.0% of diabetics and 50.1% of non-diabetics, with 
raised cholesterol at baseline evident in 30.7% of diabetics and 31.8% of non-diabetics. Raised 
cholesterol was more prevalent amongst non-diabetics in the ONS subset compared to the 
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main study sample. The proportion of patients with raised baseline cholesterol did not vary by 
ethnic group amongst diabetics, but in the non-diabetic cohort was highest in the White group, 
followed by South Asian and Black groups.  
 
Smoking status was recorded for 99.0% of diabetics and 94.1% of non-diabetics. At baseline, 
fewer diabetics than non-diabetics had their latest smoking status recorded as “current 
smoker”, (15.6% vs. 26.1%). In both the diabetic and non-diabetic cohorts, the proportion of 
current and ex-smokers was highest in the White group and lowest in the South Asian group.  
  
Alcohol usage was recorded for 95.2% of diabetics and 83.2% of non-diabetics.  The majority 
of South Asians in both diabetic and non-diabetics had their baseline alcohol status recorded 
as “non-drinker” (65.3% diabetic, 55.4% non-diabetic). In both diabetic cohorts, heavy drinking 
was 4–8 times more prevalent in the White group than in the South Asian and Black groups. 
 
Body mass index was recorded for 98.1% of diabetics and 83.9% of non-diabetics. While 81.0% 
of diabetics were overweight or obese, only 41.0% of non-diabetics were so. In the diabetic 
cohort, the majority of White and Black groups were obese, while the majority of South Asian 
patients fell into the overweight category. In the non-diabetic cohort, the majority of patients of 
all ethnic groups fell into the normal weight category. 
 
A total of 98.2% of diabetics had HbA1c values recorded at baseline, of whom 72.9% had a 
baseline value greater than 6.5%. The proportion of patients with HbA1c greater than or equal 
to 6.5% was highest for South Asian patients (77.5%), followed by Black (72.9%) and White 
(68.3%) patients.  
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Table 10.1 Demographic, clinical, and therapeutic characteristics of CPRD patients with and without T2DM 
 T2DM N=86,778 Non T2DM N=209,543 
 White South Asian Black Other Total White South Asian Black Other Total 
 N % N % N % N % N % N % N % N % N % N % 
Total 71,403 100 3,120 100 1,500 100 10,755 100 86,778 100 165,780 100 4,872 100 3,833 100 35,058 100 209,543 100 
Male 36,522 51.1 1,529 49 694 46.3 5,668 52.7 44,413 51.2 68,981 41.6 1,737 35.7 1,287 33.6 15,096 43.1 87,101 41.6 
Female 34,881 48.9 1,591 51 806 53.7 5,087 47.3 42,365 48.8 96,799 58.4 3,135 64.3 2,546 66.4 19,962 56.9 122,442 58.4 
Incident fatal/non-fatal 
CHD 
7,651 10.7 307 9.8 69 4.6 1,128 10.5 9,155 10.5 11,367 6.9 182 3.7 46 1.2 2,259 6.4 13,854 6.6 
Median follow-up (SD) 7.8 ±4.3 7.8 ±4.4 8.0 ±4.5 7.4 ±4.2 7.8 ±4.3 12.5 ±6.2 8.2 ±5.7 7.8 ±5.8 11.5 ±6.1 12.2 ±6.2 
Age at study entry                     
30-39 2,531 3.5 364 11.7 125 8.3 461 4.3 3,481 4 66,640 40.2 3,088 63.4 2,306 60.2 15,321 43.7 87,355 41.7 
40-49 8,306 11.6 789 25.3 339 22.6 1,436 13.4 10,870 12.5 30,062 18.1 800 16.4 869 22.7 63, 84 18.2 38,115 18.2 
50-59 15,436 21.6 918 29.4 387 25.8 2,454 22.8 19,195 22.1 24,749 14.9 473 9.7 318 8.3 4,427 12.6 29,967 14.3 
60-69 20,142 28.2 675 21.6 378 25.2 2,784 25.9 23,979 27.6 19,667 11.9 300 6.2 182 4.7 3,331 9.5 23,480 11.2 
70+ 24,988 35 374 12 271 18.1 3,620 33.7 29,253 33.7 24,662 14.9 211 4.3 158 4.1 5,595 16 30,626 14.6 
Median age (SD) 62.9 ±12.0 54.0 ±11.3 58.8 ±11.8 61.5 ±12.2 62.5 ±12.1 5.5 ±15.2 41.5 ±13.4 40.3 ±12.7 48.1 ±15.6 49.9 ±15.3 
Median age Male (SD) 63.0 ±12.3 54.0 ±11.9 58.4 ±12.6 61.8 ±12.6 62.5 ±12.4 45.5 ±15.9 37.9 ±13.5 39.2 ±12.7 42.7 ±16.3 44.6 ±15.9 
Median age Female (SD) 66.1 ±13.4 53.9 ±12.2 56.0 ±12.5 65.3 ±14.1 65.4 ±13.6 43.7 ±17.8 33.8 ±12.0 35.6 ±11.3 42.6 ±18.6 42.7 ±17.9 
Individual level IMD score                    
1 (most affluent) 13,303 18.6 456 14.6 76 5.1 2,415 22.5 16,250 18.7 37,038 22.3 842 17.3 264 6.9 8,756 25 46,900 22.4 
2 16,411 23 493 15.8 130 8.7 2,370 22 19,404 22.4 39,254 23.7 850 17.4 346 9 8,000 22.8 48,450 23.1 
3 14,289 20 673 21.6 228 15.2 2,289 21.3 17,479 20.1 32,846 19.8 1,010 20.7 563 14.7 7,114 20.3 41,533 19.8 
4 14,402 20.2 653 20.9 471 31.4 2,104 19.6 17,630 20.3 30,688 18.5 1,065 21.9 1,234 32.2 6,341 18.1 39,328 18.8 
5 (least affluent) 12,710 17.8 828 26.5 591 39.4 1,533 14.3 15,662 18 24,690 14.9 1,058 21.7 1,389 36.2 4,607 13.1 31,744 15.1 
Unknown 288 0.4 17 0.5 4 0.3 44 0.4 353 0.4 1,264 0.8 47 1.0 37 1 240 0.7 1,588 0.8 
Medications ever prescribed                   
Insulin 11,082 15.5 454 14.6 279 18.6 1,398 13 13,213 15.2           
Metformin 51,117 71.6 2,589 83 1,186 79.1 7,527 70 62,419 71.9           
OADs 37,141 52 1,692 54.2 762 50.8 5,533 51.4 45,128 52           
Antihypertensives 59,886 83.9 2,294 73.5 1,142 76.1 8,529 79.3 71,851 82.8 63,142 38.1 1,156 23.7 985 25.7 11,140 31.8 76,423 36.5 
Lipid lowering 56,095 78.6 2,448 78.5 1,050 70 7,673 71.3 67,266 77.5 29,201 17.6 660 13.5 372 9.7 4,036 11.5 34,269 16.4 
Aspirin 39,872 55.8 1,638 52.5 695 46.3 5,282 49.1 47,487 54.7 30,461 18.4 543 11.1 316 8.2 5,205 14.8 36,525 17.4 
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Table 10.1 Continued… 
  T2DM N=86,778 Non T2DM N=209,543 
  White South Asian Black Other Total White South Asian Black Other Total 
  N % N % N % N % N % N % N % N % N % N % 
Blood Pressure                     
≤140/90 mmHg    40,531  56.8    1,914  61.3       877  58.5    6,121  56.9    49,443  57 117629 71 3982 81.7 2950 77 24412 69.6 148973 71.1 
>140/90 mmHg    30,809  43.1    1,206  38.7       621  41.4    4,605  42.8    37,241  42.9 37981 22.9 558 11.5 659 17.2 7553 21.5 46751 22.3 
Unknown           63  0.1         -    0           2  0.1         29  0.3           94  0.1 10170 6.1 332 6.8 224 5.8 3093 8.8 13819 6.6 
Cholesterol                     
≤5 mmol/L    48,394  67.8    2,200  70.5    1,016  67.7    6,886  64    58,496  67.4 30622 18.5 1307 26.8 1000 26.1 5344 15.2 38273 18.3 
>5 mmol/L    21,826  30.6       910  29.2       465  31    3,443  32    26,644  30.7 55797 33.7 1220 25 795 20.7 8923 25.5 66735 31.8 
Unknown      1,183  1.7         10  0.3         19  1.3       426  4      1,638  1.9 79361 47.9 2345 48.1 2038 53.2 20791 59.3 104535 49.9 
Smoking Status                     
Non    36,743  51.5    2,423  77.7    1,058  70.5    5,908  54.9    46,132  53.2 88171 53.2 3773 77.4 2684 70 19210 54.8 113838 54.3 
Current    11,162  15.6       294  9.4       161  10.7    1,592  14.8    13,209  15.2 48723 29.4 638 13.1 770 20.1 9210 26.3 59341 28.3 
Ex    22,887  32.1       386  12.4       273  18.2    3,015  28    26,561  30.6 20005 12.1 261 5.4 225 5.9 3468 9.9 23959 11.4 
Unknown         611  0.9         17  0.5           8  0.5       240  2.2         876  1 8881 5.4 200 4.1 154 4 3170 9 12405 5.9 
Alcohol consumption                    
Non    17,229  24.1    2,037  65.3       640  42.7    2,884  26.8    22,790  26.3 25137 15.2 2701 55.4 1543 40.3 5996 17.1 35377 16.9 
Moderate    45,332  63.5       888  28.5       760  50.7    6,313  58.7    53,293  61.4 99956 60.3 1306 26.8 1628 42.5 19120 54.5 122010 58.2 
High      5,714  8         70  2.2         28  1.9       755  7      6,567  7.6 14228 8.6 71 1.5 86 2.2 2467 7 16852 8 
Unknown      3,128  4.4       125  4         72  4.8       803  7.5      4,128  4.8 26459 16 794 16.3 576 15 7475 21.3 35304 16.8 
BMI                     
Underweight         675  0.9         19  0.6           5  0.3         91  0.8         790  0.9 3680 2.2 230 4.7 70 1.8 793 2.3 4773 2.3 
Normal    11,171  15.6       767  24.6       220  14.7    1,903  17.7    14,061  16.2 67479 40.7 2226 45.7 1273 33.2 14043 40.1 85021 40.6 
Overweight    23,112  32.4    1,240  39.7       537  35.8    3,656  34    28,545  32.9 47107 28.4 1295 26.6 1238 32.3 8901 25.4 58541 27.9 
Obese    35,226  49.3    1,074  34.4       720  48    4,747  44.1    41,767  48.1 22300 13.5 519 10.7 807 21.1 3852 11 27478 13.1 
Unknown      1,219  1.7         20  0.6         18  1.2       358  3.3      1,615  1.9 25214 15.2 602 12.4 445 11.6 7469 21.3 33730 16.1 
HbA1c                     
<5.5%      5,202  7.3       178  5.7       110  7.3       773  7.2      6,263  7.2           
5.5-6.4%    16,207  22.7       500  16       268  17.9    2,258  21    19,233  22.2           
≥6.5%    48,760  68.3    2,419  77.5    1,094  72.9    7,422  69    59,695  68.8           
Unknown      1,234  1.7         23  0.7         28  1.9       302  2.8      1,587  1.8                     
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10.4 Comparison of incident fatal and non-fatal CHD risk according to 
diabetic status  
 
The entire ONS-linked study population of 296,342 patients was used to compare the 
incidence of fatal and non-fatal CHD between individuals with and without type 2 diabetes. 
Table 10.2 displays the crude and adjusted hazard ratios for the entire study population and 
stratified by ethnic group. The crude risk of non-fatal CHD was 36% higher in the diabetic 
population than in the non-diabetic reference population (HR 1.36, CI 95 1.32, 1.39).  
 
After adjustment for age gender and individual-level deprivation, the excess risk in the diabetic 
population was reduced to 20% (HR 1.20, CI95% 117, 1.23).  The adjusted risk of fatal and non-
fatal CHD was increased in the White diabetic population by 22% compared with the White 
non-diabetic population (HR 1.22, CI95% 1.18, 1.26). The point estimates for South Asian and 
Black groups suggested an increased risk in the diabetic population, though the 95% 
confidence intervals crossed unity. 
 
Table 10.2 Incidence of non-fatal CHD according to diabetic status 
  White South Asian Black Other/unknown Total 
N 237,199 7,992 5,333 45,818 296,341 
Incident CHD 19,034 489 115 3,392 23,030 
  HR [CI 95] HR [CI 95] HR [CI 95] HR [CI 95] HR [CI 95] 
Non-T2DM (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM crude 1.37 [1.32, 1.41] 1.31 [1.08, 1.58] 1.40 [0.92, 2.12] 1.31 [1.21, 1.40] 1.36 [1.32, 1.39] 
T2DM adjusted 1.22 [1.18, 1.26] 1.20 [0.99, 1.45] 1.46 [0.95, 2.26] 1.14 [1.06, 1.23] 1.20  [1.17, 1.23] 
N 237,199 7,992 5,333 45,818 296,342 
 
The results from the Cox regression examining interactions between diabetic status 
demographic factors are displayed in table 10.3. Tests for effect modification by gender, age 
and deprivation were found to be statistically significant. No significant interaction between 
diabetic status and ethnic group was found.  
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Table 10.3 Risk of non-fatal CHD: Interactions between diabetic status and demographic factors 
 NON T2DM T2DM P value for interaction with diabetic status 
 HR [CI 95] HR [CI 95]  
Gender      
Male (ref) 1 -- 1 --  
Female 0.54 [0.52, 0.56] 0.64 [0.61, 0.67] <0.001 
Age Group      
30-39 (ref) 1 -- 1 --  
40-49 1.40 [1.24, 1.58] 1.14 [0.87, 1.50] <0.001 
50-59 1.78 [1.55, 2.04] 1.27 [0.951.71] <0.001 
60-69 2.46 [2.12, 2.86] 1.37 [1.01, 1.87] <0.001 
70+ 3.50 [3.00, 4.12] 1.53 [1.11, 2.11] <0.001 
Individual Level Deprivation Quintile    
IMD 1 (most affluent) (ref) 1 -- 1 --  
IMD 5 (least affluent) 1.43 [1.35, 1.53] 1.13 [1.05, 1.22] <0.001 
Ethnic Group      
White (ref) 1 -- 1 --  
South Asian 1.64 [1.39, 1.92] 1.37 [1.22, 1.56] 0.993 
Black 0.96 [0.91, 1.02] 0.56 [0.44, 0.73] 0.855 
 
The interaction between diabetic status and gender indicates that the relative risk of CHD for 
females compared with males differs between diabetic and non-diabetic patients. The 
reduction in CHD risk for females was greater in the non-diabetic cohort (HR 0.54, CI95% 0.52, 
0.56 vs. HR 0.64, CI95% 0.61, 0.67). Similarly, the increase in CHD risk by 10-year age band was 
significantly greater for diabetic patients than for non-diabetic patients. In the non-diabetic 
cohort, CHD risk was increased by 3.5 times in the oldest group compared with the youngest 
group (CI95% 3.00, 4.12). In the diabetic cohort, CHD risk was 1.5 times higher in the oldest 
group than in the youngest group (CI95% 1.11, 2.11).  
 
The increase in CHD risk for those in the least affluent quintile compared with those in the 
most affluent quintile was larger for non-diabetics than for diabetics (HR 1.43, CI95% 1.35, 1.53 
vs. HR 1.13, CI95% 1.05, 1.22). The test for interaction between ethnic group and diabetic status 
was non-significant, as indicated by the overlapping confidence intervals for diabetic/non-
diabetic South Asian patients and diabetic/non-diabetic Black patients. Thus, the difference in 
CHD risk for ethnic minority groups compared with White does not depend on diabetic status.  
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10.5 Crude incidence of first fatal and non-fatal CHD event 
The analysis presented below describes the crude incidence rates and adjusted hazard ratios 
for fatal and non-fatal CHD within the diabetic and non-diabetic cohorts separately, stratified 
by gender and ethnic group.  Crude incidence rates are displayed in table 10.4. The crude 
overall rate of incident fatal and non-fatal CHD was 190.3 per 10,000 person-years in the 
diabetic cohort (CI95%  186.4, 194.2) and 82.8 per 10,000 person-years in the non-diabetic 
cohort (CI95%  81.4, 84.1). Compared with the main study sample, overall rates in the ONS-
linked subset were raised by 50% in the diabetic cohort and 68% in the non-diabetic cohort. 
 
10.5.1 By ethnic group 
In both diabetic and non-diabetic men, crude rates were highest for South Asians, followed by 
White and Black African/Caribbean groups. This pattern differs from the main study cohort, 
where the rate of non-fatal CHD for non-diabetic men was highest in the White group. In 
diabetic and non-diabetic females, rates were highest for the White group, followed by South 
Asian and Black/African Caribbean (Figure 10.2).  
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Figure 10.3 Cumulative incidence of non-fatal coronary heart disease 
 
10.5.2 By deprivation quintile 
In the diabetic cohort, crude incidence was higher in the most deprived quintile for White 
males and females and lower in the most deprived quintile for South Asian males and females.  
Crude incidence rates were higher in the most deprived quintile of all non-diabetic groups. In 
contrast to the main study sample, differences in rates by deprivation quintile were modest 
across all groups. Differences could not be calculated for Black female diabetics, who had no 
events in the most affluent group.  
 
10.5.3 By baseline clinical values and medication use 
Incidence was higher for patients with hypertension at baseline compared to those without 
hypertension in all groups except for Black African/Caribbean men, who had a slightly lower 
incidence rate if hypertensive. Hypertension was associated with a 2- to 3-fold increase in CHD 
incidence amongst non-diabetics and a more modest increase amongst diabetics. Across all 
populations, total serum cholesterol over 5 mmol/L was associated with a higher crude 
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incidence of non-fatal CHD except for Black African/Caribbean women without diabetes, for 
whom high cholesterol was associated with a lower incidence.  
 
Turning to body mass index, amongst diabetics, an inverse relationship between BMI category 
and incidence rate was found for White males and females with diabetes. In most ethnic 
groups the highest incidence rates occurred in those who were underweight at baseline, 
excepting all Black females and South Asian female non-diabetics. No consistent relationship 
with smoking status or alcohol consumption was evident.  Hba1c over 6.5% at baseline was 
associated with the highest incidence of fatal and non-fatal CHD in all diabetic males and 
Black African/Caribbean females. Amongst White and South Asian females, incidence was 
highest in those with a baseline HbA1c <5.4%. 
 
Amongst diabetics only, prescriptions of insulin and other antidiabetic drugs were associated 
with increased CHD incidence, with no clear pattern for those prescribed metformin.  In all 
groups, the prescription of antihypertensives, lipid-lowering medications and statins were 
associated with an increase in the CHD incidence by 3- to 11-fold, though the increases were 
broadly more modest in the diabetic group compared with the non-diabetic group.  
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Table 10.4 Crude incidence rate of fatal and non-fatal CHD according to diabetic status, gender, and ethnic group, per 10,000 person-years 
 T2DM N=86,778 Non T2DM N=209,543 
 Males Females Males Females 
 White South 
Asian 
Black White South 
Asian 
Black White South 
Asian 
Black White South 
Asian 
Black 
Number of subjects 36,522 1,529 694 34,881 1,591 806 68,981 1,737 1,287 96,799 3,135 2,546 
Number of CHD events 4,507 194 40 3,144 113 29 6,179 123 20 5,188 59 26 
Person years of follow-up 203,870 8,239 3,640 196,910 8,562 4,319 566,227 9,667 6,957 800,488 17,072 12,966 
             
Overall Rate 221.1 235.5 109.9 159.7 132.0 67.1 109.1 127.2 28.7 64.8 34.6 20.1 
             
Patient-level IMD             
1 (least deprived) 201.2 260.8 84.3 130.2 162.8 0 94.9 118.3 17.4 48.5 41.8 9.6 
5 (most deprived) 252.5 247.9 80.8 192.5 149.7 61.9 129.0 123.4 24.5 88.6 25.3 20.4 
             
Hypertension             
BP <=140/90 211.9 227.3 115.0 147.9 110.0 54.7 89.1 110.3 19.5 42.4 23.5 14.8 
BP >140/90 232.0 243.4 101.2 175.1 151.0 84.1 174.3 244.6 54.3 124.7 101.6 45.3 
             
Cholesterol             
=<5 mmol/L 196.8 217.9 94.5 134.7 114.9 57.9 143.2 154.3 36.3 74.6 43.4 39.7 
>5 mmol/L 248.3 256.8 127.6 175.7 146.0 87.3 151.9 170.2 50.5 89.0 69.6 25.3 
             
Smoking Status             
Non smoker 210.1 232.5 105.0 159.6 122.0 73.9 94.9 120.0 29.7 60.1 34.4 21.3 
Smoker 219.1 212.4 140.9 158.2 149.6 0 110.0 130.0 21.7 55.0 12.1 6.2 
Ex-smoker 226.0 245.4 70.2 154.1 249.5 78.0 140.0 150.0 37.7 66.3 55.9 11.1 
             
Alcohol Consumption             
Non-drinker 259.5 262.1 101.3 189.1 130.9 93.6 153.0 159.6 56.1 95.7 41.4 13.7 
Moderate alcohol drinker 214.3 215.2 103.2 137.4 56.1 55.0 107.8 100.7 13.8 50.3 13.4 27.2 
Heavy drinker 185.5 184.0 0.0 143.4 566.5 0 90.4 90.7 55.7 39.0 0.0 0.0 
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Table 10.4 Continued... 
 T2DM N=86,778 Non T2DM N=209,543 
 Males Females Males Females 
 White South 
Asian 
Black White South 
Asian 
Black White South 
Asian 
Black White South 
Asian 
Black 
BMI Category             
Underweight 261.5 243.7 155.3 199.1 151.2 68.4 144.5 89.9 122.5 96.4 16.4 0.0 
Normal 227.1 234.9 87.4 170.1 114.1 63.1 98.8 148.8 28.3 48.7 18.6 13.7 
Overweight 201.0 222.5 147.4 148.0 95.7 62.1 115.3 125.1 20.6 62.3 46.1 33.0 
Obese 183.3 174.2 0.0 120.2 133.3 82.9 123.3 89.3 37.8 61.4 57.2 8.2 
Hba1c Category             
<5.4 209.1 171.5 79.5 168.1 425.8 0       
5.5-6.4 188.4 188.6 90.1 134.9 100.8 67.3       
>=6.5 226.9 243.9 119.6 166.5 123.3 72.6       
Medications             
Antihypertensives             
No 143.4 178.0 70.0 77.6 47.2 10.4 67.1 81.2 16.5 29.0 16.2 6.2 
Yes 248.0 265.2 125.0 178.2 167.8 83.4 236.8 313.6 72.5 137.9 104.8 61.9 
Statins             
No 232.7 183.8 95.2 182.2 117.8 58.6 94.2 102.1 28.2 55.9 22.5 14.7 
Yes 215.3 258.7 118.7 149.7 139.5 71.9 252.0 314.3 34.5 171.9 212.1 109.0 
Aspirin             
No 159.1 139.6 65.9 119.8 80.6 16.5 78.4 102.9 19.8 43.3 24.6 14.8 
Yes 284.6 332.9 161.8 205.9 195.1 131.9 393.4 386.7 173.9 269.0 164.5 97.8 
Insulin             
No 212.4 219.2 108.8 149.2 131.0 70.2       
Yes 290.8 385.9 115.3 232.4 138.0 52.8       
Metformin             
No 233.4 217.1 149.5 165.1 154.5 68.6       
Yes 214.0 243.0 93.4 156.6 125.9 66.7       
OAD             
No 203.3 199.6 89.3 130.4 98.1 56.2       
Yes 239.4 267.1 127.5 191.6 161.4 76.2       
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10.5.4 By age group 
The age-specific incidence rates stratified by gender are shown in Figure 10.3. The incidence 
of CHD increased with age in both diabetic and non-diabetic groups, with all rates higher in 
males than females. Crude rates in each age band stayed highest in the diabetic population 
until age 70, at which point the rates for the non-diabetic group overtook those for the diabetic 
group. 
 
 
Figure 10.4 Age-specific incidence of fatal and non-fatal CHD by gender 
 
The age-specific incidence rates stratified by ethnic group are shown in Table 10.5. In the 
diabetic cohort, the crude incidence rate increased with age band for White men and women. 
In South Asian men and women, rates peaked in those aged 60–69 years. In the non-diabetic 
cohort group, the crude incidence rate increased steadily with age band regardless of ethnicity 
or gender. Rates at all age strata were higher in the diabetic cohort than the non-diabetic 
cohort until age 70+, where rates for South Asian and Black African/Caribbean men and 
women overtook those in the diabetic cohort.  
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Table 10.5 Age-specific incidence rates of fatal and non-fatal CHD combined according to gender, ethnic group, and diabetic status 
Rates are per 10,000 person-years [95% confidence interval] 
 
 Person-
years of 
follow-up 
Men Women 
 White South Asian Black White South Asian Black 
  Rate CI 95% Rate CI 95% Rate CI 95% Rate CI 95% Rate CI 95% Rate CI 95% 
T2DM                    
CHD events  4,507   194   40   3,144   113   29   
30-39 9,944 59.7 [38.5, 92.6] 46.7 [11.7, 186.7] 0.0 . . 22.2 [11.6, 42.7] 18.4 [2.6, 130.8] 0.0 . . 
40-49 44,238 96.7 [83.5, 112.1] 157.7 [106.6, 233.4] 17.1 [2.4, 121.7] 65.4 [54.0, 79.3] 65.3 [36.2, 117.9] 41.4 [13.4, 128.4] 
50-59 93,194 167.0 [155.1, 179.8] 239.4 [185.9, 308.3] 91.4 [43.6, 191.8] 93.2 [83.2, 104.4] 104.1 [71.4, 151.8] 20.1 [5.0, 80.5] 
60-69 134,704 199.6 [188.8, 211.1] 306.8 [239.7, 392.7] 180.0 [114.8, 282.2] 122.6 [113.3, 132.5] 164.9 [119.5, 227.6] 66.0 [33.0, 132.0] 
70+ 199,054 303.1 [291.2, 315.6] 264.2 [196.6, 355.1] 115.6 [67.1, 199.0] 224.8 [215.4, 234.6] 247.0 [179.0, 341.0] 132.5 [81.2, 216.3] 
Non- T2DM                    
CHD events  6,179   123   20   5,188   59   26   
30-39 386,710 7.8 [6.3, 9.6] 8.6 [2.8, 26.8] 17.2 [6.5, 45.8] 1.5 [1.0, 2.2] 2.5 [0.6, 10.1] 3.4 [0.8, 13.5] 
40-49 376,761 40.4 [37.1, 44.1] 110.0 [74.7, 160.0] 17.4 [6.5, 46.2] 11.5 [10.0, 13.2] 11.5 [4.8, 27.6] 4.9 [1.2, 19.6] 
50-59 323,448 89.4 [84.3, 94.9] 170.0 [120.0, 250.0] 25.6 [8.3, 79.4] 36.2 [33.3, 39.4] 36.4 [18.9, 70.0] 39.1 [17.6, 87.1] 
60-69 267,650 160.0 [150.0, 170.0] 260.0 [180.0, 380.0] 30.8 [7.7, 120.0] 80.5 [75.7, 85.6] 130.0 [79.0, 200.0] 73.6 [33.1, 160.0] 
70+ 319,625 280.0 [270.0, 290.0] 420.0 [300.0, 580.0] 140.0 [66.1, 290.0] 200.0 [200.0, 210.0] 280.0 [190.0, 410.0] 160.0 [86.3, 300.0] 
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10.6 Adjusted risk of fatal and non-fatal CHD by ethnic group 
Table 10.6a presents the results of the Cox proportional hazards models for ethnic differences 
in fatal and non-fatal CHD risk stratified by diabetic status and gender. Compared with the full 
study sample, CHD risk differences in the ONS-linked subset were attenuated for the 
comparison between South Asians vs. White and increased for the comparison between Black 
African/Caribbean vs. White.  
 
In both diabetic and non-diabetic males, adjusted risk of CHD was higher in the South Asian 
group than in the White group, and lower in the Black African/Caribbean group. Adjusted 
models for diabetic females showed no difference in CHD risk between South Asian and White 
groups and reduced risk in the Black African/Caribbean group. Adjusted models for non-
diabetic females showed that the risk of CHD was significantly reduced for both South Asian 
and Black African/Caribbean groups compared to White. 
 
10.6.1 Diabetic Cohort 
In the fully adjusted models for diabetic males, risk of incident fatal and non-fatal CHD was 
increased by 25% for South Asians compared to White (HR 1.25, CI95%  1.04, 1.50) and 
reduced by 51% for Black African/Caribbean compared to White (HR 0.49, CI95%  0.34, 0.72). 
In the fully adjusted models for women, no excess risk was evident for South Asian women 
(HR 1.04, CI95% 0.82, 1.33) while risk was reduced by 45% for Black African/Caribbean women 
(HR 0.55, CI95% 0.36, 0.83). 
 
10.6.2 Non-diabetic Cohort 
In the fully adjusted models, the ethnic differences in the non-diabetic cohort were larger than 
in the diabetic cohort. Amongst non-diabetic males, the risk of incident fatal and non-fatal CHD 
was increased by 55% for South Asians compared with the White group (HR 1.55, CI95% 1.20, 
2.00) and reduced by 72% for the Black African/Caribbean group compared with the White 
group (HR 0.28, CI95% 0.13, 0.63). No ethnic differences were apparent in the fully adjusted 
models for non-diabetic women, with all 95% confidence intervals crossing unity. 
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10.6.3 Sensitivity Analysis 
Sensitivity analyses replicating all of the models described above using only the complete 
cases available for the fully adjusted models are presented in table 10.6b.  In diabetics and 
non-diabetics of both genders, the point estimates are slightly larger, and confidence intervals 
are comparable to those derived in the main analysis, with no difference in the interpretation 
of the relative risk of incident fatal and non-fatal CHD by ethnic group.  
 
Sensitivity analyses replicating the analysis of non-fatal CHD in patients without both T2DM 
and T1DM are presented in table 10.6c. The patterning of differences in CHD risk by ethnic 
group closely matches those of the main analysis. 
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Table 10.6a Incidence of fatal and non-fatal CHD amongst subjects with and without type 2 diabetes 
 Males Females 
  Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 South Asian 1.09 [0.95, 1.26] 1.34 [1.16, 1.55] 1.40 [1.19, 1.65] 1.25 [1.04, 1.50] 0.86 [0.72, 1.04] 1.27 [1.05, 1.53] 1.32 [1.06, 1.63] 1.04 [0.82, 1.33] 
 Black 0.51 [0.38, 0.70] 0.56 [0.41, 0.76] 0.53 [0.37, 0.77] 0.49 [0.34, 0.72] 0.44 [0.31, 0.64] 0.55 [0.38, 0.79] 0.63 [0.43, 0.93] 0.55 [0.36, 0.83] 
Subjects  44,413 44,413 42,313 39,637 42,365 42,365 40,480 37,460 
Non  White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM South Asian 1.22 [1.02, 1.46] 1.89 [1.58, 2.26] 1.73 [1.37, 2.20] 1.55 [1.20, 2.00] 0.60 [0.46, 0.77] 1.49 [1.15, 1.92] 1.58 [1.14, 2.18] 1.35 [0.95, 1.92] 
 Black 0.28 [0.18, 0.43] 0.47 [0.30, 0.73] 0.40 [0.21, 0.76] 0.28 [0.13, 0.63] 0.35 [0.24, 0.51] 0.98 [0.66, 1.44] 0.89 [0.53, 1.51] 0.71 [0.41, 1.24] 
Subjects  87,101 87,101 43,857 38,255 122,442 122,442 58,449 51,950 
          
Table 10.6b Incidence of fatal and non-fatal CHD amongst subjects with and without type 2 diabetes – complete case analysis 
 Males Females 
  Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 South Asian 1.10 [0.92, 1.31] 1.34 [1.12, 1.61] 1.38 [1.16, 1.66] 1.25 [1.04, 1.50] 0.79 [0.63, 1.00] 1.18 [0.93, 1.50] 1.27 [1.00, 1.62] 1.04 [0.82, 1.33] 
 Black 0.51 [0.35, 0.74] 0.54 [0.37, 0.79] 0.55 [0.38, 0.80] 0.49 [0.34, 0.72] 0.53 [0.35, 0.79] 0.65 [0.43, 0.97] 0.67 [0.45, 1.02] 0.55 [0.36, 0.83] 
Subjects  39,637 39,637 39,637 39,637 37,460 37,460 37,460 37,460 
Non  White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM South Asian 1.23 [0.95, 1.58] 1.67 [1.30, 2.16] 1.74 [1.35, 2.24] 1.55 [1.20, 2.00] 0.83 [0.58, 1.16] 1.51 [1.07, 2.13] 1.63 [1.15, 2.31] 1.35 [0.95, 1.92] 
 Black 0.22 [0.10, 0.48] 0.30 [0.13, 0.66] 0.31 [0.14, 0.69] 0.28 [0.13, 0.63] 0.50 [0.29, 0.86] 0.89 [0.51, 1.53] 0.94 [0.54, 1.62] 0.71 [0.41, 1.24] 
Subjects  38,255 38,255 38,255 38,255 51,950 51,950 51,950 51,950 
          
Table 10.6c Incidence of fatal and non-fatal CHD amongst subjects without type 2 diabetes – excluding patients with T1DM  
 Males Females 
  Crude Age Framingham Full Crude Age Framingham Full 
Non  White (ref) 1 -- 1 -- 1 -- 1 [1.00,1.00] 1 -- 1 -- 1 -- 1 -- 
T2DM South Asian 1.22 [1.02,1.46] 1.90 [1.59,2.28] 1.76 [1.39,2.23] 1.59 [1.24,2.05] 0.59 [0.46,0.77] 1.49 [1.15,1.93] 1.57 [1.13,2.18] 1.37 [0.96,1.95] 
 Black 0.28 [0.18,0.43] 0.47 [0.30,0.73] 0.40 [0.21,0.78] 0.34 [0.16,0.72] 0.33 [0.23,0.50] 0.95 [0.64,1.41] 0.91 [0.53,1.53] 0.84 [0.49,1.42] 
Subjects  86,616 86,616 43,415 38,083 122,060 122,060 58,115 51,971 
Table shows hazard ratios and 95% confidence intervals 
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10.7 Adjusted risk of fatal and non-fatal CHD by ethnic minority subgroup 
 
Table 10.7a presents the results of the Cox proportional hazards models for ethnic differences 
in risk of fatal and non-fatal between the main South Asian and Black subgroups compared 
with the White group as a whole, stratified by diabetic status and gender. In the fully adjusted 
analyses for males, risk was significantly increased for all South Asian subgroups, and 
significantly reduced for Caribbean groups in relation to the White group. No differences 
between African and White males were evident in the adjusted analysis. Fully adjusted models 
for women showed no differences by ethnicity in the non-diabetic cohort, but a significant 
reduction in risk for diabetic women of Caribbean ethnicity.  
 
10.7.1 Diabetic Cohort 
The ethnic differences in risk were smaller for South Asian groups and larger for Black groups 
in the ONS-linked subset compared with the full study sample. In the fully adjusted models for 
diabetic males, risk of incident fatal and non-fatal CHD increased by 84% for Pakistani males 
compared with White males (HR 1.84, CI95% 1.23, 2.75) and reduced by 61% for Caribbean 
males compared with White males (HR 0.39, CI95% 0.23, 0.67). No differences in risk of fatal 
and non-fatal CHD were found between Indian, Bangladeshi and African males compared 
with White males in either the crude or adjusted analysis except for in the Framingham model, 
where risk was significantly increased in the Pakistani group. 
 
Amongst diabetic females, all risk differences were smaller than for males. In the fully adjusted 
models for diabetic females, risk of incident fatal and non-fatal CHD was increased by 45% for 
Indian females compared with White females (HR 1.45, CI95%  1.11, 0.90) and reduced by 30% 
in Caribbean females compared with White females (HR 0.60, CI95%  0.37, .97). No differences 
in risk of fatal and non-fatal CHD were found between Pakistani, Bangladeshi and African 
females compared with White females in either the crude or fully adjusted analysis, though an 
increase in risk for Indian females was observed in the age- and Framingham-adjusted 
models. 
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10.7.2 Non-diabetic Cohort 
The patterning of risk differences in the non-diabetic cohort differed from that of the diabetic 
cohort. Compared to diabetic males, no differences in risk between the South Asian subgroups 
and the White group were evident in the fully adjusted analysis, though risk was significantly 
increased for Indian and Pakistani groups in the Framingham adjusted model (Indian HR 1.56 
CI95%  1.13,2.15 Pakistani HR 2.42 CI95%  1.30,4.51). The difference between Caribbean and 
White males was much larger in the non-diabetic cohort compared to the diabetic cohort, with 
a 90% reduction in risk amongst non-diabetics (HR 0.10 CI95% 0.01, 0.71).  
 
Though the age adjusted models for female non-diabetics suggested an increase in risk for 
Pakistani women (HR 1.89 CI96 1.02, 3.52), no ethnic differences for any South Asian or Black 
subgroups were evident in the Framingham and fully adjusted models. 
 
10.7.3 Sensitivity Analysis 
Sensitivity analyses replicating all of the models described above using only the complete 
cases available for the fully adjusted models are presented in table 10.7b.  In all subgroups the 
point estimates were increased slightly for all groups. No differences in the interpretation of 
the relative risk of incident non-fatal CHD by ethnic sub group were evident. 
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Table 10.7a Incidence of fatal and non-fatal CHD amongst subjects with and without type 2 diabetes – ethnic subgroup breakdown 
    Male Female 
    Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 Indian 1.01 [0.83, 1.23] 1.2 [0.99, 1.46] 1.31 [1.06, 1.62] 1.16 [0.92, 1.47] 0.99 [0.78, 1.25] 1.36 [1.06, 1.73] 1.45 [1.11, 1.90] 1.24 [0.92, 1.67] 
 Pakistani 1.74 [1.30, 2.32] 2.28 [1.71, 3.04] 2.33 [1.68, 3.24] 1.84 [1.23, 2.75] 0.81 [0.53, 1.24] 1.34 [0.88, 2.05] 1.50 [0.94, 2.40] 1.03 [0.61, 1.76] 
 Bangladeshi 1.12 [0.62, 2.03] 1.38 [0.77, 2.50] 1.43 [0.71, 2.86] 1.37 [0.65, 2.89] 0.52 [0.22, 1.26] 1.01 [0.42, 2.44] 0.56 [0.14, 2.26] 0.5 [0.12, 2.00] 
 African 0.64 [0.38, 1.07] 0.78 [0.46, 1.31] 0.78 [0.43, 1.41] 0.71 [0.37, 1.37] 0.33 [0.15, 0.75] 0.49 [0.22, 1.09] 0.64 [0.29, 1.44] 0.62 [0.26, 1.48] 
  Caribbean 0.46 [0.30, 0.71] 0.47 [0.30, 0.71] 0.43 [0.26, 0.71] 0.39 [0.23, 0.67] 0.49 [0.32, 0.77] 0.56 [0.36, 0.87] 0.6 [0.37, 0.97] 0.57 [0.35, 0.93] 
Subjects 44413 44413 42313 39637 42365 42365 40480 37460 
Non  White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM Indian 1.24 [0.97, 1.58] 1.68 [1.32, 2.14] 1.56 [1.13, 2.15] 1.4 [1.00, 1.97] 0.63 [0.45, 0.89] 1.36 [0.97, 1.90] 1.4 [0.91, 2.15] 1.22 [0.76, 1.95] 
 Pakistani 1.29 [0.86, 1.95] 2.83 [1.88, 4.26] 2.42 [1.30, 4.51] 1.9 [0.98, 3.68] 0.61 [0.33, 1.13] 1.89 [1.02, 3.52] 1.99 [0.95, 4.18] 1.73 [0.82, 3.65] 
 Bangladeshi 0.91 [0.38, 2.18] 1.71 [0.71, 4.11] 1.66 [0.53, 5.15] 1.16 [0.29, 4.64] 0.23 [0.03, 1.60] 0.79 [0.11, 5.61] 1.38* [0.19, 9.77] --* -- 
 African 0.26 [0.13, 0.49] 0.5 [0.26, 0.96] 0.53 [0.22, 1.27] 0.36 [0.12, 1.12] 0.28 [0.15, 0.53] 1 [0.54, 1.86] 0.98 [0.40, 2.35] 0.69 [0.26, 1.83] 
  Caribbean 0.26 [0.13, 0.56] 0.35 [0.17, 0.73] 0.19 [0.05, 0.75] 0.1 [0.01, 0.71] 0.49 [0.30, 0.82] 1.01 [0.61, 1.67] 0.85 [0.43, 1.71] 0.73 [0.36, 1.46] 
Subjects 87101 87101 43857 38255 122442 122442 58449 51950 
*Confidence intervals not estimated due to small sample size and zero counts in at least one subgroup 
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Table 10.7b Incidence of fatal and non-fatal CHD amongst subjects with and without type 2 diabetes – ethnic subgroup breakdown, complete case analysis 
    Male Female 
    Crude Age Framingham Full Crude Age Framingham Full 
T2DM White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
 Indian 1.06 [0.84, 1.34] 1.25 [0.99, 1.58] 1.06 [0.84, 1.34] 1.25 [0.99, 1.58] 0.97 [0.72, 1.29] 1.37 [1.02, 1.83] 1.47 [1.09, 1.98] 1.24 [0.92, 1.67] 
 Pakistani 1.57 [1.06, 2.33] 2.07 [1.40, 3.07] 1.57 [1.06, 2.33] 2.07 [1.40, 3.07] 0.74 [0.44, 1.26] 1.25 [0.74, 2.12] 1.37 [0.81, 2.32] 1.03 [0.61, 1.76] 
 Bangladeshi 1.19 [0.57, 2.49] 1.51 [0.72, 3.18] 1.19 [0.57, 2.49] 1.51 [0.72, 3.18] 0.32 [0.08, 1.26] 0.58 [0.15, 2.34] 0.65 [0.16, 2.60] 0.5 [0.12, 2.00] 
 African 0.59 [0.31, 1.14] 0.73 [0.38, 1.41] 0.59 [0.31, 1.14] 0.73 [0.38, 1.41] 0.44 [0.18, 1.05] 0.64 [0.27, 1.54] 0.68 [0.28, 1.63] 0.62 [0.26, 1.48] 
  Caribbean 0.46 [0.27, 0.77] 0.44 [0.26, 0.75] 0.46 [0.27, 0.77] 0.44 [0.26, 0.75] 0.62 [0.39, 1.00] 0.7 [0.43, 1.13] 0.73 [0.45, 1.17] 0.57 [0.35, 0.93] 
Subjects 39637 39637 39637 39637 37460 37460 37460 37460 
Non  White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 1 -- 
T2DM Indian 1.17 [0.83, 1.64] 1.48 [1.06, 2.08] 1.57 [1.12, 2.20] 1.4 [1.00, 1.97] 0.81 [0.51, 1.29] 1.33 [0.84, 2.12] 1.43 [0.90, 2.28] 1.22 [0.76, 1.95] 
 Pakistani 1.38 [0.72, 2.66] 2.71 [1.41, 5.23] 2.52 [1.31, 4.85] 1.9 [0.98, 3.68] 0.96 [0.46, 2.03] 2.09 [0.99, 4.39] 2.29 [1.09, 4.81] 1.73 [0.82, 3.65] 
 Bangladeshi 0.91 [0.23, 3.65] 1.43 [0.36, 5.72] 1.3 [0.32, 5.19] 1.16 [0.29, 4.64] --* -- --* -- --* -- --* -- 
 African 0.23 [0.08, 0.73] 0.36 [0.12, 1.13] 0.38 [0.12, 1.17] 0.36 [0.12, 1.12] 0.36 [0.13, 0.95] 0.82 [0.31, 2.19] 0.89 [0.33, 2.37] 0.69 [0.26, 1.83] 
  Caribbean 0.09 [0.01, 0.67] 0.11 [0.01, 0.76] 0.11 [0.02, 0.78] 0.1 [0.01, 0.71] 0.68 [0.34, 1.36] 0.93 [0.47, 1.87] 0.97 [0.49, 1.95] 0.73 [0.36, 1.46] 
Subjects 38255 38255  38255 51950 51950 51950 51950 
*Confidence intervals not estimated due to small sample size and zero counts in at least one subgroup 
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10.8 Comparison of results from the main and ONS-linked studies 
Forest plots illustrating the crude and adjusted hazard ratios for South Asian and Black 
African/Caribbean groups compared with the White group for both of the CPRD and ONS-
linked study populations are displayed in figure 10.4. 
 
Overall, ethnic differences in CHD risk were comparable for the study of non-fatal CHD alone 
and for fatal and non-fatal CHD combined.  
 
The risk of incident CHD was increased in the South Asian population in both study cohorts in 
males and females with and without type 2 diabetes.  Amongst patients with diabetes, the 
magnitude of the effect size was larger in the full CPRD cohort than in the ONS-linked cohort. 
Amongst patients without diabetes, the effect size was comparable between the CPRD and 
ONS-linked cohorts. 
 
For Black African/Caribbean patients with type 2 diabetes, the risk of CHD was decreased 
uniformly for males and females. Amongst those without type 2 diabetes, there was strong 
evidence of a large risk decrease for males, but no evidence of a risk difference for females. 
The reduction in CHD risk for males without type 2 diabetes was larger than for males with 
type 2 diabetes in both the main CPRD and ONS-linked cohorts. 
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Figure 10.5 Crude and multivariable adjusted hazard ratios for all study populations stratified by gender and diabetic status  
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Chapter 11  
Discussion of Ethnic differences in Diabetes 
Mellitus and Coronary Heart Disease 
 
11.1 Summary 
This study utilized a cohort of almost 900,000 patients registered with the CPRD to identify 
ethnic differences in risk of non-fatal coronary heart disease amongst adults aged 30 and over 
with and without type 2 diabetes. This is the first UK- based study to make use of routinely 
recorded ethnicity data to explore the relationship between ethnicity, diabetes and CHD in a 
large population-based database known to be representative of the UK population as a whole. 
Linkage between the CPRD and ONS mortality data further enabled further exploration of 
ethnic differences in fatal and non-fatal CHD combined in a subset of almost 300,000 patients. 
 
Summarised below are the findings of the study in relation to the objectives described in 
chapter 8, to other published studies and the strengths and limitations of the study.  
 
11.2 Main findings 
11.2.1 Differences in CHD risk according to diabetic status 
The first hypothesis of higher CHD risk amongst patients with diabetes compared to those 
without was supported by the findings of the study. Crude results showed that the presence 
of diabetes increased the risk of CHD by almost 40% in both the main and ONS-linked cohorts, 
reducing to 20% after accounting for age, gender and deprivation. The excess risk associated 
with diabetes was markedly higher for ethnic minority groups in the main study cohort, with 
an adjusted increase of 60% and 75% in South Asian and Black groups respectively, compared 
with 28% in the White groups. In the ONS subgroup, the excess risk of fatal and non-fatal CHD 
combined due to diabetes was comparable in White and South Asian groups, at around 20%, 
but notably higher for Black African/Caribbean patients, at 46%.  
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11.2.2 Ethnic differences in CHD amongst patients with type 2 diabetes 
The second hypothesis of the study was borne out, with higher incidence in South Asian and 
lower incidence in Black African/Caribbean groups, with differences more pronounced for 
males than females. These findings are consistent with previous literature on the risk of CHD 
according to ethnic group and diabetic status.(277,306)  
 
In both the main and ONS-linked cohorts, the risk of either non-fatal CHD alone or in 
combination with fatal CHD was not significantly different between South Asian and White 
groups in the crude model. Adjustment for age increased the strength of the association 
between South Asian ethnicity and CHD risk significantly. In both diabetic cohorts, the largest 
difference between South Asian and White groups was found after adjusting for the variables 
found in the Framingham risk score (blood pressure, smoking status and total cholesterol) 
with further adjustment for clinical covariates, medications and demographic factors 
attenuating the excess risk in South Asians, to the point of parity for diabetic females in the 
ONS subgroup. 
 
The risk of CHD for Black African/Caribbean groups compared with the White group was 
consistently reduced in both the crude and adjusted models in both the main and ONS-linked 
cohorts by approximately 50%, with increasing levels of adjustment having little or no effect 
on the observed relationship. 
 
The estimates found in both our study and the CALIBER study may be lower than those 
reported elsewhere, where diabetes mellitus is reported to double the risk of CHD. This may 
be due to our use of patients aged 30 and over, rather than a more restricted age range, such 
as 45 and older, as was used in the Atherosclerosis Risk in Communities (ARIC) study, in the 
US, which reported a doubling of incident CHD and CHD mortality amongst individuals with 
diabetes during the period 1987–2009.(307) 
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Furthermore, our study uses an unselected general practice population rather than a 
population of hospital or clinic attendees. Lower estimates may also be due to poorer capture 
of the outcome compared with intervention studies or trials, where all relevant data are 
completely recorded for all participants. However, the concordance between these two 
observational studies using the same database over a comparable time period is reassuring. 
 
11.2.3 Ethnic differences in CHD amongst patients without type 2 diabetes 
The third hypothesis that ethnic differences in CHD risk would be more pronounced in the 
diabetic population compared with the non-diabetic population was not supported by the 
results of this study. Ethnic differences in CHD risk amongst those without diabetes were 
consistently more pronounced than for those with diabetes in both the main and ONS-linked 
study populations. In the main cohort, CHD risk was increased by 50% in the diabetic group 
and approximately 65% in the non-diabetic group, while in the ONS-linked subgroup, risk was 
increased by up to 73% in non-diabetic males compared with 40% in diabetic males 
(Framingham models). 
 
Since the primary mechanism by which ethnicity increases CHD is via diabetes and insulin 
resistance, it is possible that the independent effect of ethnicity on CHD risk was attenuated in 
the diabetic population. Furthermore, though risk factors such as blood pressure, cholesterol 
level and BMI were worse in diabetic cohort at baseline, our use of time-updated covariates 
may mean that individuals saw improvements in their risk factors between the time of diabetes 
onset and first incident CHD event, due to behavioural change or pharmacological 
intervention. The relationship between the coronary heart disease risk and pharmacological 
treatment is complex and cyclical. Medication use is both an indicator of severity of disease 
and also improvement in cardiovascular risk profile. The time-updated values for clinical 
covariates may result from increasing severity, which necessitates medication use, which then 
improves the status of the clinical measures, and accounts for a reduction in both absolute 
risk and relative differences by ethnicity. 
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This mechanism may be supported by our data, as Cox regression models adjusting for 
medication use revealed a smaller risk difference between South Asian and White groups than 
the models adjusting only for the variables in the Framingham risk score, suggesting that 
inclusion of these measures attenuates the independent effect of ethnicity on CHD risk.  
 
Type 1 diabetes, undiagnosed diabetes, or pre-diabetic states such as insulin resistance or 
metabolic syndrome may have also have been present in the non-diabetic sample, thus 
attenuating differences between the diabetic and non-diabetic cohorts.  
 
11.2.4 Differences in CHD incidence according to ethnic minority subgroup 
The fourth hypothesis, positing that CHD risk will be raised for all South Asian subgroups, and 
be highest for the Pakistani group, in comparison with the White group was supported by the 
results of this study in the male population only.  Amongst females, risk was highest in the 
Indian population compared with the White population in both diabetic and non-diabetic 
cohorts. One exception was in the ONS-linked cohort, where the risk amongst non-diabetic 
females was highest in the Pakistani group.  
 
11.3 Comparisons with previous research 
The findings of this study echo those of others based in the UK. Ethnic differences in 
cardiovascular outcomes of CHD were explored in the UK Prospective Diabetes Study 
(UKPDS).(308) Similar to our study, the UKPDS results demonstrated a protective effect of 
Black African/Caribbean ethnicity on the incidence of myocardial infarction and death 
compared with the White population. In contrast, no differences with respect to cardiovascular 
risk between the White and South Asian populations were evident. 
 
Results from the Southall and Brent Revisited (SABRE) study examining CHD risk in a multi-
ethnic London-based cohort lend further support to the findings reported here. The study 
authors reported an adjusted hazard ratio of 1.45 (CI95%  1.28, 1.64) for South Asian compared 
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with White participants and 0.74 (CI95%  0.60, 0.92) for Black African/Caribbean compared 
with White participants.(282)  
 
A recent study in the CALIBER (CArdiovascular disease research using LInked Bespoke studies 
and Electronic health Records) database, a resource which contains CPRD patients with data 
linked to HES and the Myocardial Ischaemia National Audit Project (MINAP), found an 
increase in risk for 9 out of 12 CVD subtypes amongst patients with T2DM after adjusting for 
age, sex and cardiovascular risk factors.(309) Though ethnicity data was available in the 
dataset, it was not considered as an explanatory variable or as a covariate for adjustment. The 
relative risk increases attributable to T2DM observed in this study were comparable to those 
found in the study presented above in both magnitude and direction. 
 
The differences between ethnic minority subgroups reported in this study are supported in the 
literature; previous studies have demonstrated that risk in Pakistani and Bangladeshi is higher 
than in Indians.(6,310–312) Furthermore, the decline in CHD mortality since 1971 in the UK has 
been slower for South Asian men and women than for the rest of the UK population.(313) In 
both study cohorts there was weak or no evidence of a difference between Black 
African/Caribbean subgroups and the White population with respect to CHD risk, regardless 
of diabetes status.  
 
Much of the variation in health status by ethnic group can be attributed to differences in socio-
economic status. For conditions such as diabetes and CHD though, as discussed in the 
background of this study, the findings of my study suggest an independent effect of ethnicity 
above and beyond that of social deprivation, with significant differences in CHD risk apparent 
after adjusting for social deprivation, both at the practice level in the main study and at patient 
level in the ONS-linked study.  
 
Finally, increased risk in South Asians may be related to factors around access to and the use 
of health services, which may be worse for older patients or new migrants, who may find it 
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difficult to communicate in English. Though provision of translated materials and interpreting 
services is a central aspect of equitable care in the NHS,  the social distance created in 
interpreted consultations has been shown to hinder the sharing of pertinent information, and 
to sometimes create misunderstandings between the patient and practitioner.(77,314–316) 
 
11.4 Strengths 
The study made use of a population-based sample using patients drawn from primary care 
practices across the UK. In order to be eligible for inclusion into the study, all patients had to 
have been registered for a minimum of 12 months at their practice, allowing sufficient time for 
disease outcomes and risk factors to be recorded by the GP. 
 
The study included non-fatal CHD, thus allowing for the inclusion of patients who do not reach 
hospital. Including both fatal and non-fatal CHD allowed the effect of ethnicity in the general 
population to be established, which is difficult to do in smaller or regional studies, which are 
less generalisable to the UK as a whole. ONS mortality data are near complete, due to 
mandatory death registration in the UK. 
 
11.5 Limitations 
11.5.1 Missing data 
Missingness of covariate data differed according to study population and diabetic status. The 
completeness of ethnicity and covariate recording was higher in the diabetic population than 
the non-diabetic population. This contributed to problems with small sample size in adjusted 
models in the non-diabetic and ethnic minority populations due to lack of covariate availability. 
Greater amounts of missing data in the non-diabetic cohort compared with the diabetic cohort 
meant that individuals included in the adjusted analysis may not have been representative of 
the wider CPRD or UK population. Sensitivity analysis explored this and found the results 
between the full and complete-case cohorts to be comparable. Greater levels of missing data 
in the population without diagnosed diabetes mellitus is to be expected as these individuals 
are likely to be considered low risk.  
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Missingness of clinical measures such as BMI, Hba1c, cholesterol level, smoking status and 
alcohol consumption is a limitation of routine electronic patient data not collected for the 
express purpose of research. This limited the power to determine an independent association 
between these covariates and the outcome. Furthermore, this may have introduced selection 
bias in the multivariate analysis. Covariate completeness is likely to be higher for patients who 
are perceived to be at higher risk by their general practitioners, for those have pre-existing 
conditions and for those who consult more often. This may include differential measurement 
of risk factors by ethnicity due to known differences in risk.  
 
Because the mechanisms of missingness cannot be determined and the assumption of that 
it is random phenomenon may not be valid, multiple imputation was not pursued. A further 
exploration of the missingness mechanism with more data may aid our interpretation of these 
results and provide better evidence for the ways in which ethnicity, diabetes and CHD are 
causally related. 
The fact that the fully adjusted models for CHD risk showed a smaller effect size than the 
models adjusted for the Framingham models is likely due to the fact that the additional 
covariates tended to reduce the number of complete cases available for analysis.  
 
11.5.2 Timing and ascertainment of clinical events 
The first diagnosis in the primary care record may not necessarily correlate to onset of disease. 
Patients may not consult with their primary care physician in the first instance, and may instead 
present in hospital. Some patients may not present in primary care at all, leading to an 
underestimation of the outcome – though this is unlikely to account for the observed 
differences by ethnicity.  
 
Secondly, the non-diabetic population may be artificially healthy, as, in order to be included in 
the analysis, they must have been disease free from 1990 onwards. Our non-diabetic 
population does not include individuals who were disease-free in that period who went on to 
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develop type 2 diabetes during the follow-up period. CHD may be under-captured in primary 
care, as acute myocardial infarction tends to present initially in hospital. 
 
In addition, the amount of follow-up time available in the CPRD may have been insufficient to 
adequately typify the relationship between diabetes and incident CHD. The median follow-up 
time for all patients contributing to the study was five years. Since the South Asian population 
was, on average, 10 years younger at T2DM onset, it is possible that they may not yet have 
experienced the CHD outcome of interest. This group may have subclinical CHD which had 
not been detected, or at least recorded, by the general practitioner. A study with longer follow-
up time may yield a better measure of ethnic differences in this population.  
 
Time updated measures of BMI, BP, cholesterol and HbA1c have cyclical relationship with 
medications, showing improvements in response to treatment. As a result, the risk of the 
outcome may not have been clearly related to these confounders, which may have been better 
controlled in the time leading up to the CHD event.  
 
The data available may have led to an underestimate of the time lag between T2DM and CHD. 
Type 2 diabetes has been found to be identified in primary care on average 7 years after its 
true onset; therefore, the effect of diabetes on CHD may have been underestimated because 
we have not allowed sufficient time with the disease to pass.  
 
Next steps would be to make more use of the linked HES data. For example, additional incident 
non-fatal events could be identified from the database. Furthermore, ethnic differences in fatal 
CHD alone could be typified to better understand the contribution of death to the estimates of 
ethnic differences in incidence. 
 
11.5.3 Prescriptions 
Cardiovascular prescriptions based on those issued in primary care. Issues of prescriptions 
do not tell us whether the medication was actually used as indicated, this drug exposure may 
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have been misclassified. This study is also unable to account for over-the-counter 
prescriptions of aspirin, leading to a potential underestimate of the exposure to this particular 
drug. We took only the first ever prescription to denote an ever/never exposure. This is a simple 
and pragmatic approach as we were not hypothesising about the relationship between drug 
exposure and the outcome, though we did want to account for the fact that exposures will 
influence the pathway between ethnicity and outcome. 
 
11.5.4 Co-morbidities 
The analysis did not adjust for co-morbidities such as chronic kidney disease or 
cerebrovascular disease (principally stroke or transient ischaemic attacks), which contribute 
to the 2-fold increase in CVD risk for diabetics observed globally.(275,306,317) There is a 
complex relationship between all cardio-metabolic diseases and hypothesising about where 
they lie on the causal pathway can be problematic. Further research into this topic would 
benefit from including co-morbidities as confounders in the analysis model. 
 
Using body mass index instead of central adiposity or waist circumference, which are not 
routinely available in electronic health records, may not have adequately captured the excess 
risk conferred by central adiposity known to manifest more frequently in the South Asian 
population.   
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Chapter 12  
Discussion 
 
12.1 Introduction 
This chapter integrates the key discussion points of the three main studies comprising this 
thesis. Following a summary of the research project as a whole and a review of the current 
used of routinely recorded ethnicity data for UK-wide epidemiological research, the 
completeness and usability of ethnicity data in routine electronic health databases are 
considered. Following a presentation of the key findings of each of the studies, the chapter 
discusses the strengths and limitations of the work overall, and the implications for future 
policy and research. 
 
Three distinct but related studies were undertaken over the course of the research presented 
in this thesis to answer the question of whether routine electronic health records can be used 
to conduct epidemiological research that would substantively increase our knowledge of the 
relationship between ethnicity and health. Ethnic differences in diabetes and coronary heart 
disease were chosen as example conditions because of their increasing prevalence in the UK 
and their strong relationship with modifiable risk factors, which can be targeted for primary 
and secondary prevention.  
 
Prior to the commencement of this research project, no reliable data were available on: 
1. the quality and completeness of ethnicity data in UK-based primary and secondary 
care electronic health databases; 
2. contemporary measures of ethnic differences in the prevalence and incidence of type 
1 and type 2 diabetes in the CPRD; 
3. ethnic differences in the initial presentation of coronary heart disease for patients with 
and without type 2 diabetes in the CPRD. 
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12.2 Summary of research undertaken 
I. A systematic literature review to identify the extent to which patient-level ethnicity 
routinely available in electronic health databases has been used for UK-wide 
epidemiological research. 
II. A cross-sectional investigation of the completeness and quality of ethnicity data 
available in the CPRD and HES and the comparability of ethnic population estimates 
in the CPRD to those of the UK population according to the 2011 Census.  
III.  A retrospective study using prospectively collected data of ethnic differences in the 
incidence and prevalence of type 1 and type 2 diabetes mellitus using definitions of 
diabetes derived using algorithms designed to improve the correct classification and 
identification of diabetes in electronic health records. 
IV. A prospective study of ethnic and gender differences in the incidence of fatal and non-
fatal CHD amongst CPRD patients with and without type 2 diabetes mellitus. 
 
12.3 Review of current uses of routinely recorded ethnicity data for UK 
wide epidemiological research 
 
12.3.1 Key findings 
 From a total of 1,232 observational studies using UK-wide electronic health databases 
identified, 15 (1.3%) utilised the patient-level ethnicity data available. Ten studies 
utilised HES, three utilised the QRESEARCH database and two utilised the THIN 
database. None of the included studies drew on the CPRD. 
 Completeness of ethnicity data in the studies was relatively high and allowed 
important differences by ethnic group to be distinguished. 
 The fact that all 15 studies were published after the financial incentivisation of ethnicity 
recording in primary care in 2004 may reflect increased confidence in data quality and 
completeness brought about by this top-down initiative.    
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12.3.2 Findings in the context of previous research 
 The literature review established that routinely collected ethnicity data in UK based 
healthcare databases are under-utilised in observational epidemiological studies.  To 
date, these data have not been widely used to investigate possible inequalities 
between ethnic groups in healthcare usage and disease outcomes across the whole 
UK population. Principal reasons for this may include perceptions of lack of 
completeness and poor quality of these data.(318) 
 
12.4 Completeness and usability of ethnicity data in routine electronic 
health databases 
 
12.4.1 Key findings 
 The completeness and consistency of routinely recorded ethnicity data in UK primary 
and secondary care has improved considerably over time and, with certain caveats, 
can be usefully incorporated into health research.   
 In primary care, recording of valid ethnicity for new patients registering with general 
practices across the UK improved dramatically following incentivisation under the 
Quality and Outcomes Framework. At the time of the study in 2012, valid ethnicity was 
being recorded for 86% of newly registered patients in primary care, 77% of HES 
inpatients, and 50% of both HES A&E patients and outpatients.  
 Over 80% of patients with multiple ethnicities in both CPRD and HES had ethnicity 
which was truly identical, or fell into the same five high-level categories. One exception 
was for the HES outpatient population, where only 10% of patients with multiple 
ethnicities had codes which were truly identical or categorically matched, limiting the 
usefulness of the ethnicity data available in this dataset.   
 Linking the CPRD and HES inpatient data improved completeness of ethnicity 
recording to 88.9% overall and to 97.1% for those registered from 2006 onwards, with 
high levels of agreement between linked sources for patients of White and South Asian 
ethnicity. 
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 The ethnic breakdown of the CPRD, which has already been shown to be 
representative of the UK population in terms of age and gender, was found to be 
comparable to that of the combined censuses for England, Wales, Scotland and 
Northern Ireland.  
 
12.4.2 Findings in the context of previous research 
 Previous methods of assigning patient ethnicity such as using name-recognition 
software or extrapolating from area-based measures of ethnic prevalence are of 
questionable validity, particularly for individuals of mixed ethnicity and for descendants 
of migrants. 
 The overall completeness of ethnicity recording in the whole of the CPRD and HES 
was found to be comparable to that reported in other recent studies using these 
resources.(122,125)  
 The findings around agreement between linked datasets mirror those of a recent NHS-
based study which reported high accuracy of coding for patients of White British 
ethnicity, but far weaker agreement for all other ethnic groups amongst patients on a 
cancer registry.(319) 
 Since the publication of my work in 2013, a further study comparing the CPRD 
population to the 2011 census has been conducted. As with the majority of research 
conducted using the CPRD to date, this contemporaneous project did not examine 
ethnicity, but did further confirm that the CPRD database is representative of the UK 
population with respect to age, gender and region.(320) 
 My study has not explored ethnicity beyond what has been recorded in routine 
databases. Due to the observational nature of this study, we are not in a position to 
explore the reasons as to why ethnicity is not recorded, or recorded inconsistently, or 
indeed incorrectly, over time and between data sources. 
 As service-level factors are not recorded in routine health databases, this study was 
unable to establish whether the likelihood of having complete and consistent ethnicity 
data was related to service provider factors such as staff availability, workload and 
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time pressures at the surgery/ward, or time available in the consultation in which to 
ask about ethnicity. 
 
12.5 Ethnic differences in the incidence and prevalence of diabetes 
mellitus in the CPRD 
 
12.5.1 Key findings 
 Based on populations identified using the algorithms, there were a total of 334,584 
prevalent cases of diabetes, giving an overall prevalence of 0.26% for type 1 diabetes 
and 2.87% for type 2 diabetes over the study period of January 1990 to August 2013. 
While the prevalence of type 1 diabetes increased minimally over time, the prevalence 
of type 2 diabetes rose 6-fold over the study period, increasing from 0.6% in 1990 to 
3.7% in 2012. 
 The prevalence of type 1 diabetes in the White population was over double that of the 
non-White ethnic groups, with incidence significantly raised rates in the White group 
compared with the Black and South Asian groups. Age standardisation did not alter 
the crude prevalence in any notable way. 
 The prevalence of type 2 diabetes was highest for South Asian groups (4.7%) followed 
by White (3.9%) and Black African/Caribbean groups (3.2%). The age-standardised 
prevalence was doubled in the South Asian and Black African/Caribbean populations, 
to 10.7% and 7.4%, respectively. 
 The incidence of type 2 diabetes was raised 2-fold in the Black African/Caribbean 
group and 3-fold in the South Asian group relative to the White population.  
 The prevalence and incidence of both type 1 and type 2 diabetes was higher in males 
than in females. This pattern was displayed consistently across all calendar years, 
ethnic groups and age groups. 
 T2DM onset occurred a decade earlier in the South Asian and Black African/Caribbean 
groups compared with the White group. Mean age at onset declined over the study 
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period, with the largest decline observed in the Black African/Caribbean population 
and smallest decline in the South Asian population. 
 The study revealed significant heterogeneity in diabetes risk according to ethnic 
minority subgroup: type 2 diabetes risk was increased by 2.6-fold in Indians, 4-fold in 
Pakistanis and 6-fold in Bangladeshis relative to the White population. Risk in both 
African and Caribbean subgroups was doubled relative to the White population.  
 These findings support use of ethnicity over race as an epidemiological variable, as it 
is able to identify differences between populations which may arise from cultural and 
socio-demographic differences rather than genetic differences alone.  
 
12.5.2 Findings in the context of previous research 
 This study represents the first implementation of a series of algorithms in a large 
database representative of the UK population as a whole, and also the first assessment 
of ethnic differences in diabetes burden for the entire cohort of patients contributing to 
the CPRD. 
 This study improved upon the original implementation of the algorithms in the Welsh 
SAIL database by utilising the patient-level ethnicity data available in the CPRD to 
improve the identification of patients with type 2 diabetes.(321)  
 The study confirmed the hypothesis that onset of T2DM occurs at younger ages in 
South Asian populations compared with the White population. The 10-year difference 
in median age at onset was comparable to that found in non-database studies of 
diabetes in the UK.(12,195,322) 
 The spike in incidence of both type 1 and type 2 diabetes in the year 2006 may be 
related to the Quality and Outcomes Framework, which changed  from rewarding the 
coding of diabetes as a whole to rewarding the coding of specific diabetes type.(323) 
The fact that incidence rates returned to 2005 levels the year after suggests that this 
finding is artefactual, reflecting a shift in case ascertainment rather than a true jump in 
incidence.  
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 Globally, the UK has the fifth highest incidence of T1DM amongst children aged under 
14 years. A report by the International Diabetes Federation found that in 2013, the 
incidence of T1DM in this age group was 2.5 per 10,000 person-years.(229) This is 
comparable with the findings of this study, where the incidence of T1DM was 2.06 per 
10,000 person-years in the group aged 0–9 years and 2.96 per 10,000 person-years in 
the group aged 10–19 (averaging 2.51 across the two age groups). 
 Diabetes is primarily managed in primary care, so the CPRD should capture all cases. 
The fact that estimates of prevalence and incidence are comparable to those found in 
other UK-based studies indicates that the CPRD is a valuable resource for conducting 
research in this area and can be used more widely for health policy and establishing 
the evidence base. 
 
12.6 Ethnic and gender differences in the risk of incident CHD amongst 
patients with and without type 2 diabetes mellitus 
 
12.6.1 Key findings 
 The presence of diabetes increased the risk of CHD by 40% in both the main and ONS-
linked cohorts, although this was reduced to 20% after accounting for age, gender and 
deprivation. The excess risk associated with diabetes was markedly higher for ethnic 
minority groups compared with the White population in the main study cohort.  
 In the ONS subgroup, the excess risk of fatal and non-fatal CHD combined due to diabetes 
was significantly higher in the Black African/Caribbean group compared with the White 
and South Asian groups. 
 Though tests for effect modification by gender, age and deprivation were found to be 
statistically significant, no significant interaction between diabetic status and ethnic group 
was found, suggesting that the effect of ethnicity on CHD risk does not differ for those with 
and without diabetes. 
 The risk of incident CHD was significantly raised in the South Asian population relative to 
the White population for both males and females. The magnitude of the risk difference 
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between ethnic groups was larger for those without type 2 diabetes than for those with 
diabetes.  
 The protective effect of Black African/Caribbean ethnicity on CHD risk was stronger for 
males than for females relative to the White population. 
 
12.6.2 Findings in the context of previous research 
 This is the first UK-based study to make use of routinely recorded ethnicity data to 
explore the relationship between ethnicity, diabetes and CHD in a large population-
based database known to be representative of the UK population as a whole. 
 The findings of this study echo those of others based in the UK. Findings from both the 
UKPDS and the SABRE studies have demonstrated a protective effect of Black 
African/Caribbean ethnicity on the incidence of myocardial infarction and death 
compared with the White population. 
 The findings suggest that the CPRD is well suited for observational research into ethnic 
inequalities and that important ethnic differences can be well characterised using this 
resource.  
 
12.7 Strengths and limitations of electronic health data 
A discussion of the methodological strengths and weaknesses of each of the three main 
studies has been reported in chapters 5, 7 and 11.  This section focuses on the strengths and 
limitations of the databases used to address the study questions, which influence all aspects 
of the research reported in this thesis. 
 
12.7.1 Strengths 
a) Sample size 
The size of the CPRD patient population resulted in a large number of incident and prevalent 
events of diabetes and coronary heart disease being identified during the study period. This 
allowed for sufficient power to detect relationships between populations stratified by both 
gender and ethnic group, which is often unfeasible in smaller studies where population sizes 
do not allow for such granular comparisons. Often other studies resort to collapsing together 
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disparate ethnic groups to make general comparisons, for example between “White” and 
“Non-White” populations.(121) This study identified over 340,000 patients with diabetes 
mellitus in the whole of the CPRD and over 36,000 patients with incident CHD in a subsample 
of the database. National databases such as the CPRD provide enormous gains in terms of 
efficiency and cost over studies which involve more costly and time-consuming methods of 
participant recruitment and data collection. 
 
b) Prospectively collected data 
The data in the CPRD are prospectively collected and, as a result, the data are not subject to 
recall bias (the presence of a disease outcome affects the reporting of exposure status) or 
observer bias (the knowledge of the patient’s disease status influences ascertainment or 
recording of exposure). Furthermore, the CPRD is updated regularly, allowing for the 
interrogation of the complete database at any time to investigate a wide range of 
epidemiological research questions using timely and relevant data. The CPRD holds all coded 
data entered onto the patient’s medical record and thus can provide a comprehensive 
overview of the patient’s care history throughout their period of registration with the general 
practitioner.  
 
c) Representativeness of the UK population 
Though general practices opt in to contributing data to the CPRD, the patient population has 
been found to be broadly representative of the UK population as a whole with respect to age, 
gender and region – and, now, ethnicity.(74,143,320)  In 2015, the CPRD database will expand 
to include general practices using clinical systems other than Vision, further improving the 
representation of the UK population in this resource.  
 
d) Linkage to the hospital episode statistics and ONS data 
Linkage of datasets allowed an analysis of concordance of ethnicity between primary and 
secondary care sources, and provided a measure of assurance regarding the reliability of 
ethnic coding and completeness from using combined sources. Linkage to the HES and ONS 
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data further allowed the identification of deaths related to coronary heart disease and 
information on patient-level deprivation for the final study.  
 
12.7.2 Potential limitations 
a) Capture of clinical measures 
The primary purpose of the clinical data held in the CPRD is for patient care, rather than 
research. By its nature it only includes information gathered at consultation and is thus 
routinely collected rather than researcher-led. As a result, the completeness and accuracy of 
data are subject to temporal changes in coding practices, health priorities and population 
need. 
 
Anything not reported to the general practitioner is necessarily not recorded. The absence of 
a code does not necessarily mean that an individual is free from that condition, but must also 
be interpreted as being unknown. Similarly, covariate data are missing if unmeasured. This is 
a greater problem for studies focusing on these measures as a main exposure or outcome. 
For the purposes of this study, clinical measures such as blood pressure, BMI and cholesterol 
were considered in order to reduce confounding on the pathway between ethnicity and the 
outcome.  
 
In addition to incomplete data, a further potential problem with routinely electronic health 
records is incorrect coding stemming from errors in the way data is entered. A wide range of 
studies have found the validity of diagnoses and process of care measures in CPRD to be 
high.(140,142,324,325) Combined with the fact that the CPRD data are subject to ongoing 
internal quality checks and that concerns with data quality are fed back to the general 
practices, researchers can be reassured that errors which do occur in the database are kept 
to a minimum.  
 
b) Capture of prescriptions 
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All prescriptions issued in primary care are automatically added to the electronic patient 
record. Though electronic health records contain a complete history of prescriptions issued 
by the GP there is no way to determine whether the drugs prescribed are  taken appropriately. 
Furthermore, there is no way to capture over-the-counter prescriptions for medications such 
as aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), or prescriptions issued in 
secondary care. This can lead to ascertainment bias due to the potential for differential capture 
of prescriptions depending on the propensity to have them issued in primary care. 
 
Furthermore, though some medications are available over the counter, patients eligible for 
free prescriptions such as those under 16 or over 60, with certain medical conditions including 
diabetes, or on a low income, may be more likely to obtain their necessary medications via 
prescription rather than over the counter, further complicating the issue of ascertainment bias.  
Though medications issued in secondary care can be examined for patients with linkage to 
HES, there is no way to link medications purchased over the counter to the primary care 
record.  
 
Although the effect of medications was not a primary question under study for the thesis, the 
potential for residual confounding due to the incomplete ascertainment of medications, 
particularly aspirin, may have impacted the observed relationship between ethnicity, diabetes 
and coronary heart disease.  Determining the causal relationships between medication use, 
disease process measures and outcomes is complex; as it was not the main purpose of this 
study, a simple measure of ever/never exposure to medications was used.  
 
c) Capture of biomarker and biological data 
Neither of the electronic health databases used in the research captured information on 
biomarkers or biological measures salient to our understanding of the underlying mechanisms 
relating ethnicity to diabetes and heart disease. It is known that ethnic differences in the 
pathogenesis of these conditions relate to differences in insulin resistance, endothelial 
function, adiposity and the atherosclerotic process. Despite the data available in the CPRD 
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having limited scope for investigating the pathogenesis of cardio-metabolic disease, the data 
do allow for the characterisation of observed ethnic differences in disease risk and outcomes, 
which is vital for developing health policies and care guidelines which are appropriate to the 
needs of the UK population. Planned linkages between the CPRD and resources such as the 
UK Biobank and laboratory results data may make studies into these areas feasible in the 
future.  
 
d) Capture of socio-demographic data 
Researchers only have access to the health and demographic data available in GP records 
and linked datasets. Other factors salient to ethnic differences such as education, income, 
household size, home ownership, living conditions, migration history are all relevant but 
unavailable in routine electronic health records. In my study, I was able to use the index of 
multiple deprivation in my analysis, and found that, after adjustment for socio-economic status, 
significant ethnic differences remained apparent. Data on country of birth, language and 
religion are available in the CPRD – though not for all individuals; making more use of these 
data in the future may prove valuable in better typifying population groups, and first- and 
subsequent-generation migrants. 
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12.8 Ethnicity in research 
When considering how ethnicity can be best used in epidemiological and social research, two 
main questions arise. Firstly, how well does the ‘ethnicity’ variable reflect the sociological 
concept? Secondly, how useful is this variable in identifying populations between whom 
important differences in health exist? This thesis has focused on the latter by exploring how 
routinely recorded ethnicity as captured in primary and secondary care can be maximised for 
research into healthcare and outcomes for the entire UK population.  
 
Ethnic monitoring was introduced into the NHS for the purposes of describing variations 
between groups and uncovering potential patterns of disadvantage and racism which may 
otherwise remain insidious.(94) The categories are intended to delineate populations that 
share some combination of traits such as language, culture, migration history, biological 
background, religion and socio-political influences. These factors shape the use of healthcare 
services and impact upon the natural history, prevalence, and management of disease.(326) 
The resulting single variable available for researchers is intended to be a distillation of each of 
these factors, which have been operationalised into a pragmatic and usable version of the 
concept of ethnicity. Currently, the UK is the only European country which collects ethnicity 
data in the census. This express intention differentiates the UK from countries such as France, 
where ethnicity data are considered sensitive and monitoring is prohibited on the grounds of 
discrimination.(46)  
 
A key challenge when using ethnicity in research is the tension between ethnicity as a 
sociological concept and ethnicity as an epidemiological variable. A principle upheld across 
the UK National Health Service is that ethnicity should be self-reported. A question for debate 
is whether the variable of ethnicity has construct validity, that is, how well the variable captures 
the multidimensional concept it is intended to represent.(136,327) Measures of ethnicity can 
be conceptualised as falling along a continuum from the least stable (self-reported) to most 
stable (country of birth/ethnic origin), with ethnicity defined using broad categories falling in 
between.  Self-reported ethnicity is arguably the best measure of the sociological concept of 
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ethnicity, in that it captures the individual’s own identity, encompassing both ancestry and 
social group membership. 
 
By its nature, this allows individuals to change their ethnic identification over time should they 
choose to. This poses a challenge when utilising the variable of ethnicity in epidemiological 
research as it is impossible to ascertain from a coded anonymised database whether changes 
in ethnicity coding over time are errors, or actual changes, and how these changes relate to 
health profile. The utility of repeat coding of ethnicity over multiple consultations has been 
debated; a UK-based qualitative study of South Asian patients reported that patients felt that 
being asked about their ethnicity repeatedly was not necessary. Instead, they felt that wider 
questions about religion and diet would be more useful, as these dimensions are also salient 
to understanding lifestyle influences on health risk.(112) For the purposes of this thesis I have 
considered discrepant ethnicities to be erroneous, and have strived to develop a classification 
system which assigns each individual a single ethnic category which is fixed over time.  
 
The observational data available to researchers using the CPRD and HES contains no 
information on how ethnicity is captured; while we can assume that the information was self-
reported by the individual via questionnaire or a face-to-face consultation, there is no way to 
verify this. It is possible that in some conditions, ethnicity information may be recorded without 
directly consulting the patient. Such scenarios include occasions where the clinician has 
previously asked the individual and is updating the record, or where the individual is unable to 
communicate the information directly.  
 
A second tension in the use of ethnicity for research is that between using ethnicity to describe 
disease patterns and using ethnicity to attribute disease causation. There is concern that 
though ethnicity is a useful lens through which to identify and describe differences in health 
and healthcare, it may not be as well suited to identifying causal mechanisms through which 
disease outcomes occur, particularly when relying on standard categories such as those of 
the census.(328) The intended use and meaning of ethnicity must be explicitly stated by the 
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authors, as it will depend on the context of the research.(329) Use of pragmatic categorisation 
which recognises that heterogeneity within groups may exist and that the category may not 
apply equally to all members is necessary in order for research into inequalities to progress. 
Furthermore, it is important for researchers to recognise that meaningful categorisation must 
be responsive to the social and political context, with relevance changing over time and 
between regions.(330) 
 
Finally, previous studies have ascribed patient ethnicity indirectly by using name-recognition 
software or by using country of birth as a proxy.(102,287,331–337) Each of these methods is of 
questionable validity, particularly for individuals of mixed ethnicity and for descendants of 
migrants, and is likely to become less meaningful over time.  Though these methods have 
been useful for certain situations in the past, they are increasingly less useful now, especially 
in countries such as the UK, where large proportions of current ethnic minority groups are UK 
born. 
 
Taken in isolation, the variable of ethnicity does not necessarily capture all of the information 
necessary to understand variations between population groups. In subsequent research, 
making use of ethnicity data combined with information on religion, language, country of birth, 
diet and deprivation will be necessary to gain as complete a picture as possible. Data relating 
to social class, education, housing and employment are not available in routine health 
databases. Access to these data could be made possible via linkage between the CPRD and 
the Census for England and Wales, as in Scotland, where linkage is routinely performed for 
the purposes of health research.(338)  
 
 
 
  
Chapter 12: Discussion 
242 
 
12.9 Implications for health policy and clinical practice 
Increasing levels of ethnicity recording in routine databases will prove vital for estimating the 
healthcare needs of the UK population as it ages. The incentivisation for the recording of 
ethnicity for all newly registered patients was discontinued in 2011 as it was expected that 
practices would continue to record this information routinely in order to best assess the needs 
of their patient population.(339) However, it will be important to examine whether rates of 
ethnicity recording in primary care continue to stay high or decline in the absence of financial 
reward.  
 
Ethnicity is an important factor in planning and costing future health need in the UK. As the 
population makeup changes and life expectancy increases, rates of chronic disease will 
increase significantly in ethnic minority populations, and at a faster rate than in the white 
population. A recent study simulating the future burden of chronic disease across England has 
demonstrated that the greatest health need is projected to be in areas with large South Asian 
populations such as Leicester and east London, where the prevalence of both diabetes and 
heart disease are estimated to be the highest.(340) 
 
Though ethnicity has now been incorporated into care guidelines, such as those for 
hypertension and diabetes, there is still much scope to extend this to a wider range of 
conditions known to be ethnically patterned.(299,341) NICE acknowledges in its existing 
guidance that further research into ethnic differences is necessary in order for it to better tailor 
its recommendations to the UK population.(342,343) Research using national databases such 
as the CPRD, THIN and QRESEARCH will be able to provide much of the evidence base for 
treatment and care guidelines.  
 
Ethnicity is already routinely incorporated into primary care risk scores such as those 
developed by QRESEARCH for cardiovascular disease, diabetes and kidney disease. (114–
116) These data will provide a cost-effective resource for investigating ethnic differences in 
comparison with interventional research. One example is the use of these databases for 
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pragmatic clinical trials, which offer cost and efficiency benefits relating to the recruitment of 
patients into trials and collection of outcomes data in comparison with traditional randomised 
controlled trials. There are also scientific benefits in that it is possible to conduct comparisons 
with patients not recruited as their data are still available in the database.(344) 
 
12.10 Future Research 
12.10.1 Increasing the use of ethnicity in research using electronic health records 
Continuing to streamline data entry into medical records will ensure that diseases can be 
identified using standard code sets. At the practice, where data are first entered, it is important 
to ensure that input of codes and corresponding dates is as accurate as possible. 
Standardised data entry templates have been shown to greatly improve the accuracy of 
disease coding as well as the completeness of relevant clinical information such as routine 
measures and test results.(345) Increasing the use of such templates across a range of clinical 
domains may serve to improve data quality throughout the medical record, and subsequently 
improve their suitability for research purposes.   
 
At the researcher end, where data are extracted, standardising the definitions of disease using 
uniform code lists and algorithms, as demonstrated in this thesis, will allow for research to be 
replicable, comparable and validated. For example, the CALIBER programme based at 
University College London has set out to establish a common data model with reproducible 
variables and analytic protocols available to anyone interested using UK-based primary and 
secondary care electronic health records.(346) 
 
12.10.2 Validating ethnicity coded on patient records 
Research validating the coding of ethnicity for patients in the CPRD will give insight into the 
extent to which ethnicity is accurately coded on medical records and may also allow an 
opportunity to investigate reasons why ethnicity may be unrecorded. These data are not 
missing at random and the absence of data can be informative as this group may differ in 
important ways such as health-seeking behaviour and beliefs, access to healthcare and socio-
economic status. Furthermore, such qualitative research will also provide valuable insight into 
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what individuals perceive ethnicity to mean, and how closely the standard categories align 
with individual self-identification. This will prove particularly important for individuals with 
mixed ethnic backgrounds and for UK-born descendants of migrants  
 
12.10.3 Identifying health need in the future 
The advantage of routine electronic health databases is that they are regularly updated and 
can be used to provide timely information on the demographic makeup of the general 
population and on areas of growing healthcare need. Examining ethnic differences regularly 
will be of great importance as the makeup of the UK population changes. In the future the 
ethnically ‘mixed’ population will become much larger and their health experiences will differ 
both from those of previous generations and from those of their contemporaries from different 
ethnic groups. Not only will healthcare needs evolve over time, but our use of ethnicity as a 
concept in health research will need to evolve in order to continue to be a meaningful marker 
of population groups whose health needs and experiences may differ. 
 
Continued and critical appraisal of the concept of ethnicity is necessary. The standard 
categories of the Census will continually need revision in order to best capture the ethnic 
diversity of the UK population. The inclusion of the group “Gypsy or Irish Traveller” on the 2011 
census marks a recognition by the UK government that the concept of ethnicity can be used 
to identify population groups with differing needs and health experiences based defined by 
socio-economic and cultural factors rather than solely genetic factors. In the future, the 
concept of ethnicity as a social stratification variable may become less salient for identifying 
groups with different health need and outcomes; factors such as educational attainment, 
employment status and deprivation may better explain disparities in health outcomes in the 
UK population as the currently observed ethnic differences potentially diminish over 
subsequent generations.  
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12.10.4 Ethnicity and cardio-metabolic disease 
As with the ethnicity, the validation of adjudicated diabetes status will be an essential next step 
in determining the merit of the algorithms in improving the identification and classification of 
diabetes in electronic health records. An extension to this would be to use linked data from 
hospitals or disease registries to provide further information to support or refute diabetes 
classification. One such resource is the UK Biobank, which may be better positioned to 
characterise the ethnic differences in cardio-metabolic risk in the UK population. In addition to 
a planned future linkage to the CPRD, Biobank already includes data gathered by interview 
pertaining to waist circumference, fat mass, diet, education and employment status.  
 
As discussed in chapter 7, correctly identifying and reducing the burden of undiagnosed 
diabetes in the UK is a key public health priority.  Routine electronic health records will be of 
increasing value in generating timely estimates of the prevalence of undiagnosed diabetes 
across the UK as a whole. In this thesis, algorithms identifying patients with diagnostic codes 
for diabetes were used. This work is being taken forward by the Biobank diabetes adjudication 
team, who are in the process of developing new algorithms to identify diabetes in patients 
without diagnostic Read codes, but with supporting information such as prescriptions, raised 
blood glucose and process-of-care measures. The testing of these algorithms in population 
databases such as the CPRD and validation of the resulting diagnoses will help improve the 
way in which screening and diagnosis of diabetes is primary care are undertaken.   
 
The use of risk stratification and clinical prediction tools is widespread in UK primary care. 
While some risk scores recommended for use by the NHS already incorporate ethnicity into 
the risk prediction models, several in current use do not.(347–351) These tools rely almost 
exclusively on data coded onto the electronic patient record. Improving the quality and 
completeness of ethnicity and clinical management data in routine electronic health records 
will improve the identification of populations with the highest health need. There are concerns 
that existing risk scores may not be effective at screening for undiagnosed conditions, and 
thus improving these scores, will be of great value.(352)  
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12.11 Overall Conclusions 
This thesis has provided a demonstration of the value of electronic health records for 
examining ethnic differences in health for UK populations. The significance of the results 
presented in the thesis is three-fold. Firstly, the thesis has reported novel results which provide 
valuable information about the usability and generalisability of ethnicity data available in UK-
based electronic health records. Secondly, the research has replicated findings from other 
studies around the prevalence and incidence of diabetes and patterning of ethnic differences 
in heart disease outcomes, providing reassurance about the quality of these data and their 
suitability for investigating ethnic differences in major disease outcomes. Thirdly, the thesis 
has extended our knowledge of the ethnic patterning of disease by further investigating trends 
in ethnic minority subgroups.  
 
Together, the findings reported in this thesis provide a unique insight into the ways in which 
routinely recorded ethnicity data can be maximised for the purposes of epidemiological 
research into health inequalities across the UK. Each of the studies undertaken represents a 
novel use of the CPRD and its linked datasets. The results suggest these data need to be used 
more widely in order to examine a wide range of questions relating to ethnic differences in the 
utilisation of health services, management of existing health conditions and predicting the 
future burden of disease in the UK population.   
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